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Abstract 
 
The development of two catalytic asymmetric synthetic methods is presented and 
culminates with studies of their application to the synthesis of a natural product.  The 
intramolecular variant of the Morita-Baylis-Hillman (MBH) reaction has remained 
almost untouched by asymmetric catalysis.  A significant advance in the field is 
demonstrated with the development of a highly enantioselective intramolecular MBH 
reaction employing a co-catalytic system of N-methylimidazole (NMI) and pipecolinic 
acid (Pip).  The optimization of various reaction parameters and the use of protic 
conditions (THF-H2O, 3:1) afforded the desired products in up to 82% yield and 80% ee.    
The extension of this methodology to include the use of vinylogous reaction partners in 
the Rauhut-Currier (RC) reaction has been achieved, establishing the first highly 
enantioselective RC reaction.  A single amino acid derivative of cysteine, in the presence 
of potassium tert-butoxide and a critical concentration of water in acetonitrile, was 
demonstrated to function as a highly selective catalyst providing products in up to 95% 
ee.  Finally, the application of the MBH and RC reactions to the synthesis of complex 
molecules presents highly useful methodology for the formation of a new C–C bond in 
the generation of densely functionalized enantiopure products.  Preliminary studies 
toward the application of this methodology to the stereoselective synthesis of (+)-Sch 
642305 are described.  Examination of the catalyst’s ability to dictate the 
stereoselectivity of the key step (catalyst control) and allow the synthesis of both the 
natural product, and difficult-to-obtain unnatural stereoisomeric analogs, will be the 
subject of on-going studies. 
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1 Development of the Enantioselective Morita-Baylis-Hillman 
Reaction 
1.1 Introduction 
The formation of carbon–carbon bonds in an efficient manner is an important 
challenge in synthetic organic chemistry.  Moreover, the ability to catalyze the formation 
of new C–C bonds in a highly enantioselective and chemoselective fashion is critical to 
the effective synthesis of natural products and biologically and medicinally interesting 
molecules.1  Research efforts to control these processes have driven the development of 
many synthetically useful methods and continue to fuel advancements in synthetic 
chemistry.  
The Morita-Baylis-Hillman (MBH) reaction is a powerful transformation that has 
attracted the attention of many research groups for over five decades.2  This C–C bond 
forming reaction involves the selective coupling of an activated alkene with an aldehyde 
through nucleophilic catalysis to produce an α-methylene-β-hydroxycarbonyl.  Although 
catalysis of the reaction has traditionally suffered from slow reaction rates as well as low 
chemo- and enantioselectivity, the last decade has seen much progress in the way of 
catalyst design leading to heightened reactivity, stereoinduction, and ultimately the 
                                                 
1 (a) Hong, B.-C.; Nimje, R. Y. Curr. Org. Chem. 2006, 10, 2191-2225. (b) Taylor, M. S.; Jacobsen, E. N. 
Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 5368-5373. (c) Douglas, C. J.; Overman, L. E. Proc. Natl. Acad. 
Sci. U.S.A.  2004, 101, 5363-5367. 
2 For selected reviews, please see: (a) Drewes, S. E.; Roos, G. H. P. Tetrahedron 1988, 44, 4653-4670. (b) 
Basavaiah, D.; Rao, P. D.; Hyma, R, S. Tetrahedron 1996, 52, 8001-8062. (c) Basavaiah, D.; Rao, A. J.; 
Satyanarayana, T. Chem. Rev. 2003, 103, 811-891. (d) Lee, K. Y.; Gowrisankar, S.; Kim, J. N. Bull. Kor. 
Chem. Soc. 2005, 26, 1481-1490. (e) Masson, G.; Housseman, C.; Zhu, J. Angew. Chem., Int. Ed. 2007, 46, 
4614-4628. 
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expansion of reaction scope.  While success in the intermolecular MBH has been 
substantial, a parallel success in the intramolecular variant (Figure 1.1), which would 
provide access to densely functionalized cyclic products in one step, has been slower.  
Herein, we present a significant advance in the field through the development of an 
enantioselective intramolecular Morita-Baylis-Hillman reaction with high levels of 
stereoinduction (84% ee) using a co-catalyst system of pipecolinic acid (Pip) and N-
methylimidazole (NMI).3 
Figure 1.1: Intramolecular Morita-Baylis-Hillman reaction. 
O
R O
n
O
R
OH
n
Nucleophilic Catalyst
 
1.2 Overview of Catalytic Intramolecular Morita-Baylis-Hillman 
Reactions 
The MBH reaction was first discovered in 1968 by Morita and co-workers,4 
followed by a report in 1972 in a German patent by Baylis and Hillman. 5   The 
intermolecular variant of the MBH reaction has received much attention in the literature, 
benefitting from countless studies, thus becoming a synthetically useful reaction. 6  
Several extensive reviews have been written on the intermolecular variant and will not be 
covered here. 7   Furthermore, another derivative known as the aza-Baylis-Hillman 
                                                 
3 Aroyan, C. E.; Vasbinder, M. M.; Miller, S. J. Org. Lett. 2005, 7, 3849-3851. 
4 Morita, K.; Suzuki, Z.; Hirose, H. Bull. Chem. Soc. Jpn. 1968, 41, 2815. 
5 Baylis, A. B.; Hillman, M. E. D. German Patent 2155113, 1972; Chem. Abstr. 1972, 77, 34174q. 
6 (a) Lee, K. Y.; Gowrisankar, S.; Kim, J. N. Bull. Korean Chem. Soc. 2005, 26, 1481-1490. (b) Reddy, L. 
R.; Saravanan, P.; Corey, E. J. J. Am. Chem. Soc. 2004, 126, 6230-6231. 
7 (a) Basavaiah, D.; Kalapala, V. R.; Reddy, R. J. Chem. Soc. Rev. 2007, 36, 1581-1588. (b) Krishna, P. R.; 
Sharma, G. V. M. Mini-Rev. Org. Chem. 2006, 3, 137-153 and references therein. 
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reaction, has been investigated by multiple research groups and has been discussed 
elsewhere.8 
The study of the intramolecular reaction, on the other hand, which would lead to 
highly versatile cyclization products, has remained essentially undeveloped.  For 
example, the first account of an intramolecular variant, and the only enantioselective 
variant (until our report in 2005), was documented by Fráter and co-workers9 in 1992, 
twenty-four years after the initial discovery of Morita.10  Cyclization of substrate 1 in the 
presence of chiral phosphine (-)-CAMP (2, 18 mol %) provided cyclopentenol 3 (40% 
yield) with 14% enantiomeric excess after a reaction time of ten days (Scheme 1.1). 
Scheme 1.1: First intramolecular MBH reaction. 
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One year later, Drewes and co-workers11 documented the cyclization of substrate 
4 leading to crystalline coumarin salt 5 (Scheme 1.2).  The structure of 5 was confirmed 
by X-ray crystallography and lent credence to the proposed mechanism and 
understanding that the MBH product was the outcome of an addition-elimination 
sequence involving a nucleophilic catalyst, activated alkene, and electrophile. 
                                                 
8 Shi, Y.-L.; Shi, M. Eur. J. Org. Chem. 2007, 2905-2916. 
9 Roth, F.; Gygax, P.; Fráter, G. Tetrahedron Lett. 1992, 33, 1045-1048. 
10 Masson, G.; Housseman, C.; Zhu, J. Angew. Chem., Int. Ed. 2007, 46, 4614-4628. 
11 Drewes, S. E.; Njamela, O. L.; Emslie, N. D.; Ramesar, N.; Field, J. S. Synth. Commun. 1993, 23, 2807-
2815. 
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Scheme 1.2: Mechanistic support provided by Drewes and co-workers. 
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Murphy and co-workers have also reported on the intramolecular cyclization of 
both five- and six-membered enone-aldehydes.12   Piperidine (30 mol %) was found to be 
the best nitrogen-based catalyst, leading to the desired cyclization products 8 and 9 in 
moderate yield after long reaction times (n=1, 55% yield, 7 days; n=2, 30% yield, 14-28 
days).  Phosphines and thiols were reported to catalyze the reaction as well; however, 
phosphine catalysis led to variable yields, and thiol catalysis led to the single aldol 
addition by-product (10) in lieu of the desired MBH products (Scheme 1.3). 
Scheme 1.3: Amine-catalyzed intramolecular MBH cyclization.  
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Although it has been demonstrated that enoates are much less reactive towards 
conjugate addition than their enone counterparts, and thus difficult substrates for the 
                                                 
12 Richards, E. L.; Murphy, P. J.; Dinon, F.; Fratucello, S.; Brown, P. M.; Gelbrich, T.; Hursthouse, M. B.  
Tetrahedron 2001, 57, 7771-7784. 
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intramolecular MBH reaction, thioenoates have been shown to have heightened 
reactivity; their reactivity lies closer to that of enones.13  For example, Murphy and co-
workers demonstrated that cyclization of enoate-aldehyde 11 under nitrogen-based 
catalysis (piperidine or DABCO) did not provide the desired MBH product and under 
phosphine-based catalysis (n-Bu3P) provided product 12 in moderate yield (40%, Scheme 
1.4).12  On the other hand, Keck and co-workers demonstrated that cyclization of 
thioenoate 13 in the presence of the mixed catalyst system of DMAP (1 equiv) and 
DMAP·HCl (0.25 equiv) provided the MBH product, 14, in 82% yield. 
Scheme 1.4: Intramolecular MBH of thioenoates. 
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O
H
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CDCl3, 28 d
(a) no reaction
(b) 40%
 
Oshima and co-workers demonstrated the use of Lewis acids (Et2AlI and TiCl4) in 
the intramolecular MBH cyclization (Scheme 1.5).  Employing diethylaluminum iodide, 
they were able to catalyze the Michael aldol cyclization of α,β-unsaturated enone 7 to 
provide the six-membered ring MBH product 9 in 80% yield.  Using titanium 
tetrachloride and benzylammonium chloride (BnNEt3Cl) they were able to access the 
                                                 
13 Keck, G. E.; Welch, D. S. Org. Lett. 2002, 4, 3687-3690. 
- 6 - 
five-membered ring product, 8, however in low yield (33%) in addition to the 
corresponding elimination product 15 (28%) and hydroxyl ketone 16 (25%).14 
Scheme 1.5: Lewis acid catalyzed MBH reaction. 
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Koo and co-workers were able to extend the substrate scope to include enone-
aldehyde 17 providing a seven-membered ring MBH product, 18 (Scheme 1.6).  Catalysis 
with a stoichiometric amount of triphenylphosphine in t-BuOH led to the desired product 
in 84% yield.15 
Scheme 1.6: Extension of reaction scope to include seven-membered ring formation. 
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84%
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18
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In 2005, Krishna and co-workers reported exquisite control over 
diastereoselectivity in the development of the first diastereoselective intramolecular 
MBH reaction (Scheme 1.7).16  Chiral enone-aldehyde 19 underwent DABCO-catalyzed 
(0.5 equiv) MBH cyclization to provide product 20 as a single isomer (>95%) in 62% 
yield. 
                                                 
14 Yagi, K.; Turitani, T.; Shinokubo, H.; Oshima, K. Org. Lett. 2002, 4, 3111-3114. 
15 Yeo, J. E.; Yang, X.; Kim, H. J.; Koo, S. Chem. Commun. 2004, 236-237. 
16 Krishna, P. R.; Kannan, V.; Sharma, G. M. J. Org. Chem. 2004, 69, 6467-6469. 
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Scheme 1.7: First diastereoselective intramolecular MBH reaction.  
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Shortly after our report on the enantioselective intramolecular MBH reaction in 
2005,3 Hong and co-workers reported a nitrogen-catalyzed enantioselective variant as 
well (Scheme 1.8).17  Interestingly, it was determined that proline, in combination with 
imidazole, catalyzed the transformation of enedial 21 to (R)-22 with 93% ee in 72% 
yield, while proline in combination with DMF led to the opposite enantiomer, (S)-22, 
with 60% ee in 69% yield.  Mechanistically, in the imidazole-catalyzed reaction, it was 
proposed that initial conjugate addition was directed by a hydrogen bond with the 
carboxylate to afford enamine 23.  An unfavorable 1,3-diaxial interaction was minimized 
in intermediate 24, leading to R-enriched allylic alcohol 22.  Alternatively, the iminium 
species could undergo tautomerization to enamine 25 which would then proceed through 
a Zimmerman-Traxler transition state (26) to furnish (S)-22.  These mechanistic issues 
will be discussed in more detail below. 
                                                 
17 Chen, S.-H.; Hong, B.-C.; Su, C.-F. Sarshar, S. Tetrahedron Lett. 2005, 46, 8899-8903. 
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Scheme 1.8: Proline and proline/imidazole catalyzed enantioselective intramolecular MBH 
reaction. 
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Finally, Gladysz and co-workers presented a phosphine-catalyzed enantioselective 
intramolecular MBH reaction in 2007 (Scheme 1.9).18  Using catalyst 27 (10 mol %), the 
cycloisomerization of various enone-enals provided the corresponding substituted 
cyclopentene and cyclohexene products in good yield (88-99%) and with modest to good 
enantioselectivity (38-74%).  It was proposed that the basicity and nucleophilicity of the 
donor atom (CH2D:) in the active catalyst (η5-C5H5)Re(NO)(PPh3)(CH2PPh2) was 
enhanced due to the incorporation of the 18-electron rhenium fragment. 
Scheme 1.9: Enantioselective MBH reaction presented by Gladysz and co-workers. 
ReON PPh3
PPh2
27 (10 mol %)H
R
O
n = 1, 2
R = Ph, i-PrS, p-Tol, Me
O
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OH
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88-99%
38-74% ee
O n
n
 
                                                 
18 Seidel, F.; Gladysz, J. A. Synlett 2007, 6, 986-988. 
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1.3 Mechanistic Details 
Formally, the Morita-Baylis-Hillman reaction involves a one-pot combination of 
three consecutive transformations: Michael addition, aldol reaction, and β-elimination.  
The most widely accepted mechanism of the reaction is presented in Figure 1.2.2c  The 
reaction is believed to proceed via initial conjugate addition of a nitrogen-, phosphorous-, 
or sulfur-based nucleophile to the activated alkene (I) to generate zwitterionic 
intermediate II.  This latent enolate then undergoes nucleophilic attack on the aldehyde, 
generating a second zwitterionic species, III, followed by subsequent proton transfer and 
extrusion of the catalyst to generate MBH adduct V. 
Figure 1.2: Proposed mechanism of the MBH reaction. 
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It was long believed that the rate-determining step (RDS) was carbon–carbon 
bond formation in the aldol reaction of intermediate II with the aldehyde.2  However, 
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there have been several revisions of the mechanism recently by the research groups of 
Aggarwal and McQuade suggesting that the RDS is not yet fully understood. 19   In 
studying isotopic-labeling and kinetic experiments in the acrylate-based MBH reaction, 
McQuade and co-workers have proposed that the reaction was second order in aldehyde 
and that the RDS involved proton transfer in the cleavage of the α-position C-H bond.  
This modification of the mechanism involves analogous steps to provide zwitterionic 
intermediate III, at which point the generated alkoxide undergoes nucleophilic attack on 
a second equivalent of aldehyde, providing hemi-acetal intermediate IV which is poised 
for facile proton transfer (Figure 1.3).  
Figure 1.3: Revision of the mechanism proposed by McQuade and co-workers.   
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19 For mechanistic studies regarding the MBH reaction, see: (a) Aggarwal, V. K.; Fulford, S.; Lloyd-Jones, 
G. C. Angew. Chem., Int. Ed. 2005, 44, 1706-1708. (b) Price, K. E.; Broadwater, S. J.; Walker; B. J.; 
McQuade, D. T. J. Org. Chem. 2005, 70, 3980-3987. (c) Price, K. E.; Broadwater, S. J.; Jung, H. M.; 
McQuade, D. T. Org. Lett. 2005, 7, 147-150.  For mechanistic studies regarding the related aza-MBH 
reaction, please see: (d) Buskens, P.; Klankermayer, J.; Leitner, W. J. Am. Chem. Soc. 2005, 127, 16762-
16763. (e) Raheem, I. T.; Jacobsen, E. N. Adv. Synth. Catal. 2005, 347, 1701-1708. 
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In the presence of a protic additive, Aggarwal and co-workers also proposed that 
abstraction the α-H atom of intermediate III was rate-limiting and suggested intermediate 
VI to explain the proton shift (Figure 1.4).  
Figure 1.4: Transition state proposed by Aggarwal and co-workers. 
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1.4 Dual Catalyst Control in the Enantioselective MBH Reaction 
1.4.1 Prior Studies of Metal-Free Peptide-Based Catalysis 
It is known that nature has the ability to catalyze various transformations with 
exquisite levels of chemo-, regio-, and stereoselectivity. 20   Enzyme conformation, 
hydrogen bonding, proton transfer, and nucleophilic addition are several factors that 
control enzymatic activity and the ability to confer high levels of selectivity in a desired 
process.  The question we were interested in pursuing regarded what fraction of an 
enzyme is critical for selective catalysis.  Translating this quest into an on-going study, 
we set out to build synthetic mimics of biosynthetic tools by creating powerful small 
peptide-based catalysts for synthetic organic transformations.21  With this goal in mind, 
our laboratory has studied nucleophile-embedded peptides that can serve as highly 
efficient catalysts for a variety of transformations: π-(methyl)histidine (Pmh)-based 
                                                 
20 For the use of enzymes as catalysts in organic synthesis, see: Wong, C.-H.; Whitesides, G. M. Enzymes 
in Synthetic Organic Chemistry; Elsevier Science Ltd.; Oxford, 1994. 
21 For a review of peptides as asymmetric catalysts, see: (a) Davie, E. A. C.; Mennen, S. M.; Xu, Y.; Miller, 
S. J. Chem. Rev. 2007, 107, 5759-5812. (b) Revell, J. D.; Wennemers, H. Curr. Opin. Chem. Biol. 2007, 
11, 269-278. (c) Miller, S. J. Acc. Chem. Res. 2004, 37, 601-610 and references therein. 
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peptides for asymmetric group transfer reactions (acylation, 22 
phosphorylation, 23 sulfinylation, 24  thionoformylation 25 ), τ-benzyl histidine for azide 
conjugate addition,26 thiazolyl alanine (Taz) for intermolecular aldehyde-imine cross-
coupling, 27  diphenylphosphinoserine (Pps) for [3+2]-cycloadditions, 28  and finally 
aspartate-embedded peptides for enantioselective epoxidation (Figure 1.5).29   
Figure 1.5: Synthetic tool box of nucleophile-embedded peptide-based catalysts. 
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When the work described in this thesis was initiated, the ability to catalyze 
carbon–carbon bond-forming reactions employing peptide-based catalysis was not well 
developed.  Thus, with the goal of extending our group methodology to transformations 
involving the formation of a new C–C bond, exploration of the Morita-Baylis-Hillman 
                                                 
22 Copeland, G. T.; Miller, S. J. J. Am. Chem. Soc. 2001, 123, 6496-6502. 
23 Sculimbrene, B. R.; Miller, S. J. J. Am. Chem. Soc. 2001, 123, 10125-10126. 
24 Evans, J. W.; Fierman, M. B.; Miller, S. J.; Ellman, J. A. J. Am. Chem. Soc. 2004, 126, 8134-8135. 
25 Sánchez-Roselló, M.; Puchlopek, A. L. A.; Morgan, A. J.; Miller, S. J. J. Org. Chem. 2008, 73, 1774-
1782. 
26 Guerin, D. J.; Miller, S. J. J. Am. Chem. Soc. 2002, 124, 2134-2136. 
27 Mennen, S. M.; Gipson, J. D.; Kim, Y. R.; Miller, S. J. J. Am. Chem. Soc. 2005, 127, 1654-1655. 
28 Cowen, B.J.; Miller, S.J. J. Am. Chem. Soc. 2007, 129, 10988-10989. 
29 Peris, G.; Jakobsche, C. E.; Miller, S. J. J. Am. Chem. Soc. 2007, 129, 8710-8711. 
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reaction began.  Initial studies of the MBH reaction began with an investigation of the 
intermolecular variant.  As illustrated in Figure 1.6, it was determined that co-catalysis 
(N-methylimidazole (NMI) and proline) was essential in the methyl vinyl ketone (MVK)-
based MBH reaction with o-nitrobenzaldehyde to achieve efficient conversion to the 
desired products.30  
Figure 1.6: Essential co-catalysis of NMI and proline in the intermolecular MBH reaction. 
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Once sufficient reactivity was established with N-methylimidazole and proline, 
the possibility of rendering the reaction enantioselective was explored.  Therefore, NMI 
was incorporated into peptide-based catalysts in the form of an N-terminal π-
(methyl)histidine residue, and screened in combination with L-proline (Scheme 1.10).  
Ultimately, through the optimization of multiple parameters of the reaction and co-
catalytic system, peptide catalyst 28 was found to be highly efficient in the catalysis of 
the intermolecular MVK-based MBH reaction with various activated aromatic aldehydes 
providing the coupled products in 52-95% yield and with 63-81% enantiomeric excess.  
                                                 
30 (a) Imbriglio, J. E.; Vasbinder, M. M.; Miller, S. J. Org. Lett. 2003, 5, 3741-3743. (b) Vasbinder, M. M.; 
Imbriglio, J. E.; Miller, S. J. Tetrahedron 2006, 62, 11450-11459.  This finding was in analogy to 
observations by Shi and Jiang in their studies employing a cinchona alkaloid catalyst: Shi, M.; Jiang, J.-K. 
Tetrahedron: Asymmetry 2002, 13, 1941-1947. 
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At the time of this study, these results represented the highest enantioselectivities 
reported to date for the ketone-based MBH reaction. 
Scheme 1.10: Optimized conditions for the intermolecular MBH reaction. 
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1.4.2 Intramolecular MBH: Distinct from Intermolecular MBH  
Our study of the intramolecular Morita-Baylis-Hillman reaction commenced with 
the investigation of the cyclization shown in Scheme 1.11.  In analogy to work that had 
been on-going in our laboratory in both the intermolecular MBH reaction as well as other 
peptide-catalyzed processes, we began our study with the catalytic system of N-
methylimidazole (NMI) and proline.  We were optimistic that upon demonstration of 
sufficient co-catalysis and reactivity, the N-methylimidazole moiety could subsequently 
be embedded into a peptide catalyst and used in combination with proline in order to 
achieve substantial enantioselectivity.  
Scheme 1.11: Intramolecular MBH reaction. 
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 Similar to our findings in the intermolecular MBH reaction,30 co-catalysis was 
essential to achieve conversion to the desired products (Figure 1.7).  In the cyclization of 
enone-aldehyde 7 to provide cyclized product 9, the use of N-methylimidazole as the sole 
catalyst resulted in low reactivity (50% conv, 24 h), whereas no reaction occurred with 
proline alone.  However, in the presence of both NMI and proline we observed significant 
rate acceleration (100 % conv, 24 h).  Excitingly, instead of producing a racemic product 
(as in the intermolecular reaction) these conditions provided product 9 with moderate 
enantioselectivity (60% ee). 
Figure 1.7: Catalysis of the intramolecular MBH reaction with (a) NMI, (b) proline, (c) co-
catalysts NMI and proline. 
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Once sufficient reactivity was established under co-catalysis, we explored the 
possibility of enhancing the enantioselectivity of the reaction.  Thus, NMI was 
incorporated into small nucleophilic oligopeptides in the form of π-methyl(histidine) 
(Pmh).  As demonstrated in the intermolecular case, as well as in previous methodology 
within our group, we believed that the chiral environment provided by the peptide 
secondary structure would confer high enantioselectivity in the reaction.  In stark contrast 
to this precedence in the intermolecular MBH reaction, a screen of approximately 160 
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peptides in combination with L-proline did not lead to a significant improvement of 
enantioselectivity.  Peptides varying in chain length, ranging from the single amino acid 
up to a decapeptide, as well as variations in secondary structure (random and discrete β–
turn peptides) were tested.  Peptide catalyst 29 was found to provide the highest level of 
stereoinduction, producing cyclized product 9 in 67% ee (Figure 1.8).31  Notably, this 
was not an appreciable increase in stereoinduction when compared to employing just 
NMI and proline alone, which led to desired product 9 in 60% ee. 
Figure 1.8: Co-catalysis of the intramolecular MBH reaction: (a) peptide/proline versus (b) 
NMI/proline. 
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In addition to screening the aforementioned peptides, we also looked more closely 
at known peptide catalyst 30, which was found to be a moderately selective catalyst in 
combination with L-proline (42% ee).  This peptide was previously discovered in our 
laboratory through a combinatorial screen as an excellent catalyst in the kinetic resolution 
                                                 
31 Vasbinder, M. M. Ph.D. Thesis, Boston College, 2004. 
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of various secondary alcohols.22  Interestingly, it was found that an alanine scan32 of 
peptide 30, where each amino acid was sequentially substituted with alanine using the 
original stereochemistry, elucidated new derivatives that were substantially more 
selective (Figure 1.9).33  For example, while peptide 30 was able to resolve alcohol 32 
with observed krel = 17, peptide 31 (alanine substitution at the i+2 position) afforded krel > 
50. 
Figure 1.9: Alanine scan of peptide 30 in the kinetic resolution of secondary alcohols.  
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We investigated the possibility of a similar boost in stereoselectivity in the MBH 
reaction by screening an alanine scan of peptide 30 in combination with L-proline (Table 
1.1).  As expected, elimination of the terminal nucleophilic π-methyl histidine residue 
(peptide 33) rendered the catalyst inactive and resulted in <5% conversion of 7 to 9.  On 
the other hand, several peptides were found to provide a modest enhancement in 
                                                 
32 Morrison, K. L.; Weiss, G. A. Curr. Opin. Chem. Biol. 2001, 5, 302-307. 
33 Fierman, M. B.; O’Leary, D. J.; Steinmetz, W. E.; Miller, S. J. J. Am. Chem. Soc. 2004, 126, 6967-6971. 
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enantioselectivity, with substitution at the i + 3 position providing 52% ee (catalyst 35) 
and at the i + 5 position (catalyst 37) providing 55% ee.  In order to investigate the 
proline-peptide catalyst interaction, D-proline and racemic proline were also examined in 
conjunction with each alanine scan peptide.  It can be seen that there were matched and 
mismatched pairs of co-catalysts, such that D-proline/peptide led to a slight preference for 
the formation of the opposite enantiomer of product 9 while D/L-proline/peptide led to 
non-selective transformations. 
Table 1.1: Alanine scan of peptide 30 in combination with proline. 
(L)-Proline +42 +42 +37 +52 +50 +55 +46 +46
(D)-Proline -3 -21 -15 -15 -15 -17 -12 -17n.r.
(i) (i + 1) (i + 2) (i + 3) (i + 4) (i + 5) (i + 6) (i + 7)
(D/L)-Proline -4 -3 +2 -2 -5 -5 -1 +2
n.r.
n.r.
PMH Thr(t-Bu) D-Val His(Trt) D-Phe D-Val Thr(t -Bu) Ile
Peptide
(aa replaced)
-
-
O
O
H
N
H (10 mol %)
CO2H
peptide catalyst (10 mol %)
CDCl3, 0.1 M, 24 h
O OH
7
9
O
N
H
H
N
O
H
N
O
BocHN
N
N
Me
N
H
H
N
N
H
H
N
O
O
O
O
i-Pr O
OMe
Me Ot-Bu
N
Trt
N
Me Ot-Bu
Me
Me
Ph
i-Pr
30
33 34 31 35 36 37 38 3930
(reported as % ee)  
In light of the fact that the examined peptide catalysts used co-catalytically with 
proline maintained similar reactivity to that of NMI with proline, in addition to the 
understanding that the inter- and the intramolecular MBH reactions were dramatically 
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distinct processes, 34  we embarked on a new optimization study that addressed each 
component in the reaction.  
1.4.3 Development of the Co-Catalytic System: Pipecolinic acid/NMI  
Having explored the chiral space around the NMI moiety of our co-catalytic 
system by way of peptide screening, we determined that the modifications were not 
significantly beneficial and could be deleterious to stereoselectivity in the mismatched 
cases.  Alternatively, we were intrigued with the possibility of altering the chiral space 
around proline in an attempt to surpass the moderate selectivity achieved with 
NMI/proline (60% ee). 
With this in mind, we began our optimization studies by exploring the role of the 
proline component in the co-catalytic system.  As shown in Figure 1.10, we examined the 
cyclization of 7 to 9 catalyzed by multiple proline analogs in combination with NMI.  
The free carboxylic acid was found to be critical, as masking of the acid moiety with a 
methyl ester or replacement with an amide or tetrazole35  led to negligible levels of 
stereoinduction (<10% ee).  α-Methyl substitution36 as well as acid homologation were 
also unsuccessful, providing <10% ee and modest enantioselectivity (28% ee), 
respectively.  Finally, substitution in and around the ring was deleterious, with only 
hydroxy-substitution leading to detectable levels of enantioselectivity (<20% ee). 
                                                 
34 This idea is reflected in the literature as well, with very few successful reports of the intramolecular 
MBH while numerous reports on the intermolecular reaction continue to be published.  See; Basavaiah, D.; 
Rao, A. J.; Satyanarayana, T. Chem. Rev. 2003, 103, 811-891. 
35 (a) Torii, H.; Nakadai, M.; Ishihara, K.; Saito, S.; Yamamoto, H. Angew. Chem., Int. Ed. 2004, 43, 1983-
1986. (b) Cobb, A. J. A.; Shaw, D. M.; Ley, S. V. Synlett 2004, 558-560. (c) List, B. Tetrahedron 2002, 58, 
5573-5590. 
36 Vignola, N.; List, B. J. Am. Chem. Soc. 2004, 126, 450-451. 
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Figure 1.10: Proline derivatives tested as co-catalysts with NMI in the intramolecular MBH 
reaction. 
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With the exception of pipecolinic acid (Pip), the proline surrogates examined led 
to diminished enantioselectivity, low reactivity, or the formation of intermolecular aldol 
dimerization by-product 40 (Figure 1.11).  Interestingly, homologation of the five-
membered ring of proline to the six-membered ring derivative, L-pipecolinic acid, in 
combination with NMI, led to catalysis of the cyclization with indistinguishable results 
from that catalyzed using L-proline/NMI.  Due to the unique ability of proline and 
pipecolinic acid to catalyze the reaction with significant enantioselectivity, we elected to 
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proceed with both co-catalytic systems, NMI/proline and NMI/pipecolinic acid, in our 
further optimization studies. 
Figure 1.11: Aldol dimerization by-product 40. 
O O O
40  
1.4.4 Optimization of Reaction Conditions: Solvent 
One method employed in the Morita-Baylis-Hillman reaction to overcome slow 
reaction rates is the fine-tuning of solvent.  Protic solvents have been shown to accelerate 
the reaction, presumably through hydrogen bonding to either stabilize the formed enolate 
or activate the aldehyde.37  In our studies, we found that the choice of solvent had a 
dramatic effect not only on the reaction rate, but also on product distribution and the 
enantioselectivity of the desired product. 
Beginning with the NMI/proline co-catalytic system, we were able to obtain 
complete control over product distribution by simply changing our solvent system (Table 
1.2).  The cyclization of phenyl ketone-based substrate 7 in the presence of NMI and 
proline (10 mol % each) in a non-polar solvent, toluene, was unreactive and we recovered 
only starting material (entry 1).  Alternatively, in a highly polar solvent, DMF, under the 
same reaction conditions, we observed full conversion to the intermolecular aldol 
dimerization by-product (40) instead of desired product 9 (entry 7).  Examining various 
solvents with dielectric constants ranging between toluene (2.0) and DMF (38.3) led to 
                                                 
37 (a) Methot, J. L.; Roush, W. R. Org. Lett. 2003, 5, 4223-4226. (b) Aggarwal, V. K.; Dean, D. K.; Mereu, 
A.; Williams, R. J. Org. Chem. 2002, 67, 510-514. (c) Keck, G. E.; Welch, D. S. Org. Lett. 2002, 4, 3687-
3690 and references therein. 
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mixed results.  The rate of this reaction in Et2O and THF was sluggish, with 25% 
conversion to by-product 40 in 20 h with little or no detectable cyclized product 9 (entries 
2 and 4).  Chloroform, CH2Cl2, and acetonitrile all led to moderate levels of 
enantioselectivity (53%, 73%, and 67%, respectively) with varying degrees of conversion 
and product distribution (entries 3, 5, and 6).  Although methylene chloride looked 
promising from the standpoint of stereoinduction (73% ee, entry 5), it suffered from poor 
product distribution.  It is important to note that the conversion of the MBH reaction in 
CDCl3 was substantially lower than that previously reported (30% versus full conversion) 
due to the change in reaction concentration (0.6M to 0.3M).  Although we later found that 
more concentrated reaction conditions were optimal (0.6M), the solvent screen at 0.3M 
was a highly informative comparison of reaction efficiency in varying solvents. 
Table 1.2: Solvent effects in the intramolecular cyclization of 7 to 9 catalyzed by Pro/NMI. 
O
O
H
O O
(10 mol %)
N
H
CO2H
(10 mol %)N
N
Me
20 h, 23 °C
Toluene
Et2O
CDCl3
THF
CH2Cl2
MeCN
DMF
THF:H2O (3:1)
2.4
4.3
4.8
7.6
9.1
37.5
36.7
-
-
-
53
-
73
67
-
33
100 : 0 : 0
75 : 0 : 25
70 : 30 : 0
65 : 10 : 25
20 : 65 : 15
0 : 30 : 70
0 : 0 :100
0 : 100 : 0
Aldol dimerization
by-product
9
O OH O
+
dielectric
constant (ε) % ee 7 : 9 : 40solvent(0.3 M)
407
1
2
3
4
5
6
7
8
entry
 
- 23 - 
In accord with the literature, it appeared that more polar solvents correlated to 
higher levels of conversion, however, there was not an obvious correlation to reaction 
outcome; formation of by-product 40 was an important factor that reduced efficiency in 
the intramolecular MBH reaction.  A critical discovery was the impact of protic reaction 
conditions, THF-H2O (3:1).  Ultimately using this solvent system, we were able to 
completely suppress the formation of 40 and obtain full conversion to desired product 9.  
Although the enantioselectivity of this reaction was relatively low (33% ee), we were 
optimistic that with the heightened reactivity and chemoselectivity we would be able to 
further optimize the reaction to restore stereoselectivity. 
Eager to test the new protic solvent conditions with our alternative co-catalyst 
system, we next investigated the cyclization of 7 to 9 with NMI and pipecolinic acid 
(Scheme 1.12).  Excitingly, in THF-H2O we were now able to obtain the desired product 
with 69% enantiomeric excess, a modest increase in enantioselectivity compared to 
catalysis in CDCl3 (60% ee, Figure 1.10), yet a bold increase in enantioselectivity when 
compared with NMI/proline (33% ee) in THF-H2O.  Unfortunately, with the increase in 
enantioselectivity obtained by using NMI/pipecolinic acid, we saw a decrease in 
reactivity (35% conversion). 
Scheme 1.12: Catalysis of the MBH reaction with pip/NMI under protic reaction conditions. 
THF:H2O (3:1), 0.3 M, 23 h
(10 mol %)
O
O
H
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7 9
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1.4.5 Re-Examination of Peptide Catalysts 
Our initial investigations into the intramolecular MBH reaction demonstrated that 
enriching the chiral information around the nucleophilic NMI moiety, in as many as 
160 peptides, did not provide a noticeable improvement from simply employing NMI as 
the sole nucleophilic catalyst.  However, having been able to demonstrate the dramatic 
effects of solvent on this reaction leading to the identification of optimal protic 
conditions, as well as a new co-catalyst (pipecolinic acid), we turned to reinvestigate the 
possibility of using of a peptide-based catalyst. 
An examination of solvent effects in the cyclization of 7 to 9 catalyzed by alanine 
scan peptide 36 in combination with proline revealed similar results to those previously 
disclosed in the case of NMI/proline; the choice of solvent directly affected reactivity, 
stereoselectivity, and chemoselectivity.  In addition to intermolecular aldol dimerization 
by-product 40, peptide catalysis also led to dehydrated by-product 41.  Notably, catalysis 
of this cyclization in toluene/CDCl3 (0.3M) provided the desired product with 60% 
enantiomeric excess and 80% conversion.38  Under protic conditions (THF-H2O), we 
obtained 60% conversion to product 9 with 46% ee (Table 1.3).  Once again the levels of 
stereoinduction observed did not surpass those obtained when using the more simple 
catalyst NMI.  Additionally, we were intrigued about the prospect of catalyzing the MBH 
reaction under aqueous conditions and, therefore, decided to continue our optimization 
study in THF-H2O. 
                                                 
38 A concentration screen was run for the cyclization reaction using peptide 39/proline in which it was 
determined that a reaction concentration of 0.3M was ideal.  All the following peptide work was conducted 
at this concentration, in contrast to 0.1M from the previous screen of the alanine scan peptides. 
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Table 1.3: Solvent effects in the cyclization of 7 to 9 catalyzed by peptide 36/proline. 
O
O
H
(10 mol %)
N
H
CO2H
Peptide 36 (10 mol %)
48 h, 23 °C
CH2Cl2
CCl4
CDCl3
Tol/CDCl3
THF/CDCl3
MeCN
THF:H2O (3:1)
56
-
31
60
54
55
46
0 : 50 : 35 : 15
70 : 0 : 30 : 0
10 : 45 : 35 : 10
10 : 80 : 10 : 0
0 : 50 : 50 : 0
0 : 40 : 50 : 10
0 : 60 : 30 : 0
9
O OH
+
% ee 7 : 9 : 40 : 41solvent(0.3 M)
40
7
1
2
3
4
5
6
7
entry
Ph
O
+
41
 
Having adopted aqueous reaction conditions, we proceeded to test a small 
sampling of the best peptides in combination with each co-catalyst, proline and 
pipecolinic acid.  As illustrated in Figure 1.12, we determined that the optimal peptide-
based catalyst in combination with proline was alanine scan peptide 39, affording product 
9 with 40% enantiomeric excess.   
Figure 1.12: Catalysis of the intramolecular MBH under protic conditions with various 
peptides/proline. 
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Several peptides (28, 42, 43, and 44, Figure 1.13) that were known to be 
successful catalysts for other transformations in our laboratory (asymmetric 
phosphorylation,23 acylation,22 and intermolecular MBH)30 were included in the screen; 
however, they were found to be less efficient (Figure 1.12).   
Figure 1.13: Alternative peptides tested under protic reaction conditions. 
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As illustrated in Figure 1.14, the best alanine scan peptide, 39, was then employed 
in the cyclization of enone-aldehyde 7 to 9 with the alternative co-catalyst, pipecolinic 
acid.  Under the optimized solvent conditions (THF-H2O, 3:1) peptide 39/proline 
provided 45% conversion to 9 with 40% enantioselectivity, while peptide 39/pipecolinic 
acid provided similar reactivity (40% conv) but now with higher stereoinduction (71% 
ee). 
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Figure 1.14: Catalysis of the MBH reaction with peptide 39. 
N
H
CO2HNH
CO2H
40% conv
71% ee
45% conv
40% ee
O
O
H
O OH
co-catalyst (10 mol %)
THF-H2O (3:1), 0.3 M, 25 h7 9
peptide 39 (10 mol %)
(a) (b)
co-catalysts:
 
Although the enantioselectivity provided by the co-catalysis of peptide 39 with 
pipecolinic acid was substantial, it was instructive to perform a direct comparison of the 
nucleophilic catalysts, NMI and peptide, with each co-catalyst, proline and pipecolinic 
acid (Figure 1.15).  Considering peptide 39 first, it was clear that catalysis with 
pipecolinic acid led to much higher levels of enantioselectivity than with proline (68% ee 
versus 40% ee), with both co-catalysts providing similar levels of conversion (40-45%).  
Analysis of NMI with each co-catalyst showed that conversion of 7 to 9 was low with 
pipecolinic acid (35% conversion) while very high (>90%) with proline.  On the other 
hand, enantioselectivity was high (69%) when NMI/pipecolinic acid was used and low 
with NMI/proline (33%).  Importantly, we noticed that the levels of stereoinduction 
obtained when using either NMI or peptide 39 were very similar.  This analysis reiterated 
our previous conclusion which suggested that altering the chiral space around the N-
methylimidazole moiety did not provide enhanced selectivity, and that we should 
maintain our focus on optimization of the proline component as well as reaction 
parameters.  
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Figure 1.15: Cross-comparison of the co-catalytic systems. 
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1.4.6 Optimization: Catalyst Loading and Stoichiometry 
In the continued optimization of reaction parameters, a critical discovery was the 
impact of optimal catalyst loading under protic conditions (THF-H2O, 3:1), which both 
accelerated the reaction rate and increased enantioselectivity.  As illustrated in Figure 
1.16, a dramatic distinction between the two co-catalytic systems was revealed in both 
CDCl3 and under protic conditions with increased loading of the co-catalyst to 20 mol %.  
Importantly, the combination of pipecolinic acid and NMI now proved to be an excellent 
co-catalytic system in the cyclization of 7 to 9, leading to 80% enantiomeric excess with 
100% conversion.  Proline, on the other hand, in combination with NMI, was an inferior 
catalyst, providing only 23% ee with the formation of multiple by-products. 
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Figure 1.16: Comparison of proline and pipecolinic acid in CDCl3 and THF-H2O. 
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This dramatic improvement in stereoinduction and reactivity was demonstrated 
more extensively using the co-catalytic system pipecolinic acid/NMI.  As shown in Table 
1.4 (entry 1), low conversion was observed (45%) when the Morita-Baylis-Hillman 
reaction was carried out at 0.6 M with NMI/pipecolinic acid, 10 mol % each, while good 
enantioselectivity was maintained (64% ee).  However, a stark change was observed 
when the cyclization was run under the same reaction conditions with increased co-
catalyst loading (NMI/pipecolinic acid, 20 mol % each, entry 2).  Within the same time 
frame, the reaction underwent full conversion to product 9 with increased 
enantioselectivity (76% ee).   
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Table 1.4: Effect of catalyst loading and stoichiometry. 
NMI
(mol %)
pipecolinic acid
(mol %)
% eeentry
O
O
H
O OH
THF-H2O (3:1), 0.6 M, 48 h
N
N
Me
N
H
CO2H
1a
2
3
4
5
6
7
10
20
10
10
10
20
30
10
20
20
30
40
10
10
64
76
80
76
75
50
30
7 9
a 45% conv  
Furthermore, a subtle change in catalyst loading displayed another modest boost 
in enantioselectivity; NMI (10 mol %)/pipecolinic acid (20 mol %) led to 80% ee with 
full conversion (entry 3).  No significant improvement occurred by increasing the ratio 
further from 2:1 pipecolinic acid/NMI to 3:1 (76% ee) and 4:1 (75% ee) (entries 4 and 5).  
Importantly, pipecolinic acid was required in equal or greater quantity than NMI for a 
productive reaction (1:1 or greater, pipecolinic acid/NMI).  When the cyclization was 
performed with greater equivalents of NMI than pipecolinic acid, lower enantioselectivity 
was observed.  For example, 1:2 pipecolinic acid/NMI produced 50% ee (entry 6) and 1:3 
pipecolinic acid/NMI led to 30% enantiomeric excess.  Additionally, these reactions were 
less chemoselective, leading to the formation of by-products.  Excess NMI in the reaction 
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was found to catalyze an unselective reaction, exemplified in the decreased 
enantioselectivity.  This will be discussed further in our mechanistic studies. 
1.4.7 Extension of Proline Surrogates: Ring Size 
Having demonstrated the dramatic difference between proline and its six-
membered ring derivative as co-catalysts in the MBH reaction, we sought to explore this 
further by looking at various ring contraction or ring expansion derivatives.  For example, 
catalysis with the four-membered ring azetidine derivative (45) provided moderate 
enantioselectivity (60% ee) with low conversion (40%) (Figure 1.17).  The seven-
membered ring azepines, both saturated (46) and unsaturated (47), were also inferior to 
pipecolinic acid, providing product 9 as a complex mixture in 50% ee and 70% ee, 
respectively.  Pipecolinic acid proved to be unique and unequivocally outperformed any 
of the other co-catalysts in both its efficiency for the transformation of 7 to 9 and its 
ability to induce high stereoselectivity in combination with NMI. 
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Figure 1.17: Investigation of pipecolinic acid derivatives of varying ring size. 
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As illustrated in Scheme 1.13, the seven-membered ring pipecolinic acid 
derivatives, 46 and 47, were synthesized from the methyl ester (48) of (S)-C-allylglycine.  
Mono-alkylation of the primary amine was achieved by protection of the primary amine 
as o-nitrobenzenesulfonamide (nosyl-amide) as described by Fukuyama and co-workers 
(82% yield), 39  followed by Mitsunobu 40  N-alkylation via treatment with 
diethylazodicarboxylate and triphenylphosphine (DEAD-PPh3) and homoallyl alcohol to 
provide 50 in 95% yield. Compound 50 was then subjected to ring-closing metathesis41 
(RCM) conditions using Grubbs’ second-generation catalyst (92% yield) and subsequent 
deprotection of the Ns group by treatment with thiophenol to produce secondary amine 
                                                 
39 (a) Kan. T.; Fukuyama, T. Chem. Commun. 2004, 353-359. (b) Fukuyama, T.; Jow, C.-K.; Cheung, M. 
Tetrahedron Lett. 1995, 36, 6373-6374. 
40 Mitsubobu, O. Synthesis 1981, 1-28. 
41 Miller, S. J.; Blackwell, H. E.; Grubbs, R. H. J. Am. Chem. Soc. 1996, 118, 9606-9614. 
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52 (44% yield).  Hydrogenation of 52 using Adam’s catalyst (PtO2) followed by 
hydrolysis and filtration through an acidic ion-exchange resin generated the saturated 
seven-membered ring pipecolinic acid derivative, 46.  Alternatively, direct hydrolysis of 
compound 52 and conversion to the zwitterion generated unsaturated analog 47. 
Scheme 1.13: Synthesis of proline derivatives 46 and 47. 
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1.4.8 Determination of Absolute Stereochemistry 
The method of Mosher analysis42 was used in order to determine the absolute 
stereochemistry of the cyclization products from the intramolecular MBH reaction.  As 
illustrated in Scheme 1.14, optically enriched product 9 (80% ee) was first 
diastereoselectively hydrogenated using Crabtree’s catalyst ([Ir(cod)py(PCy3)]PF6)43 to 
provide compound 54, which served as the substrate for Mosher analysis.  Both the (R)- 
and (S)-methoxy trifluoromethylphenyl acetate (MTPA) esters of 54 were prepared (55 
and 56) and subjected to 1H NMR analysis. 
Scheme 1.14: Mosher analysis of intramolecular MBH product 9. 
O OHO OH Crabtree's catalyst
(10 mol %)
O
O
CF3
Ph O
MeO Ph
O
O
CF3
Ph O
Ph OMe
54
55 (R,R)
56 (R,S)
9
(80% ee)
Ir
[Ir(cod)py(PCy3)]PF6
PF6
N PCy3
CH2Cl2
74%
(R)-MTPA-OH
(S)-MTPA-OH
 
The different chemical shifts of resonances corresponding to diagnostic proton Hb 
from both diastereomers, 55 and 56, were then compared (Figure 1.18).  Due to the 
anisotropic magnetic shielding induced from the phenyl ring, Hb was shifted upfield in 
compound 56 compared to the shift seen in compound 55, determining the products to be 
optically enriched with the (R) configuration.  
                                                 
42 (a) Dale, J. A.; Dull, D. L.; Mosher, H. S J. Org. Chem. 1969, 34, 2543-2549. (b) Dale, J. A.; Mosher, H. 
S. J. Am. Chem. Soc. 1973, 95, 512-519. (c) Ward, D. E.; Rhee, C. K. Tetrahedron Lett., 1991, 32, 7165-
7166.  (d) Ohtani, I.; Kusumi, T.; Kashman, Y.; Kakisawa, H. J. Org. Chem. 1991, 56, 1296-1298. 
43 Crabtree, R. H.; Davis, M. W. J. Org. Chem. 1986, 51, 2655. 
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Figure 1.18: Comparison of Hb in Mosher esters 55 and 56. 
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1.4.9 Mechanism 
The exact mechanism of the MBH reaction has been elusive and is of debate in 
the current literature.19  Although there is a generally accepted mechanism of the 
reaction, involving conjugate addition followed by aldol reaction and β-elimination, it 
appears to vary with each system and has been difficult to generalize.  Shi and co-
workers44 reported an intermolecular version of the MBH reaction catalyzed by imidazole 
in the presence of proline as a co-catalyst (30 mol % each), affording yields from 30% to 
90% for various activated aldehydes.  The proposed mechanism involved generation of 
an imminum species from activation of methyl vinyl ketone (MVK) by proline, followed 
by the accepted MBH catalytic cycle (Figure 1.19). 
                                                 
44 Shi, M.; Jiang, J. K.; Li, C. Q. Tetrahedron Lett. 2002, 43, 127-130. 
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Figure 1.19: Mechanism of the intermolecular MVK-MBH reaction proposed by Shi and co-
workers.  
O
Me+
N
H
CO2H
(30 mol %)
(30 mol %) OH
Ar Me
O
30 - 91%
O
Me
O
HAr
OH
Ar
O
Me
O
HAr
N
H
CO2H
N
Me
CO2
N
H
N
DMF
N
H
N
+ H2O
N
Me
CO2
N
H
N
N
H
CO2H
N
HN
N
Me
CO2
N N
OH
Ar
H2O
+
 
Herein, we suggest two possible mechanisms for the enantioselective 
intramolecular MBH reaction of enone-aldehyde 7 to 9, as just described, under the co-
catalytic system of pipecolinic acid/NMI.  Mechanism A, in analogy to that reported by 
Shi and co-workers, would involve activation of the enone by pipecolinic acid to form an 
imminium species (Figure 1.20).  This intermediate would then undergo nucleophilic 
attack by N-methylimidazole followed by enamine cyclization, proton shift and 
elimination of the catalyst, and finally hydrolysis to generate the desired product.  An 
analogous transition state structure can be drawn, 57, that closely compares to that 
presented by List and co-workers, 58, in the highly enantioselective proline catalyzed 
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enolexo aldolizations where they achieved up to 99% ee. 45   This analysis of the 
mechanism would be supportive of the formation of an imminium species followed by 
enamine cyclization. 
Figure 1.20: Potential mechanism A. 
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Alternatively, mechanism B may be operative in the enantioselective cyclization 
reaction where enone-aldehyde 7 would first undergo direct nucleophilic conjugate 
addition of pipecolinic acid, followed by attack of the ensuing enolate on the internal 
aldehyde.  N-methylimidazole in this case would act as a base to maintain the enolate 
during the reaction (Figure 1.21).  As described previously, the chiral space around NMI 
does not drive the stereoselectivity of the reaction, as could be reasoned by model B and 
                                                 
45 (a) Pidathala, C.; Hoang, L.; Vignola, N.; List, B. Angew. Chem. Int. Ed. 2003, 42, 2785-2788. (b) 
Bahmanyar, S.; Houk, K. N. J. Am. Chem. Soc. 2001, 123, 12911-12912. 
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transition state 59; the R group (where R = H or peptide) would not necessarily affect the 
formation of the stereogenic center, and could be inconsequential or deleterious to 
enantioselectivity.   
Figure 1.21: Potential mechanism B. 
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Furthermore, studies by Stork and co-workers46 suggest that mechanism A may 
not be operative for this specific catalytic system.  Their study showed that the rate of 
formation of enamines, 47  in addition to the efficiency of alkylation of the formed 
enamines, was greater with pyrrolidine than with piperidine.  Since the basicity and steric 
environment of the secondary amino group as well as the nature of the carbonyl were 
                                                 
46 Stork, G. A.; Landesman, B. H.; Szmuszkovicz, J.; Terrell, R. J. Am. Chem. Soc. 1963, 85, 207-222. 
47 Brown, H. C. J. Chem. Soc. 1956, 1248-1268. 
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similar, this difference was attributed to the greater ease of formation of a trigonal carbon 
in a five-membered ring than in a six-membered ring.  With the understanding that 
enamine formation/alkylation is not as facile with piperidine, it would suggest that 
transition structure 57 may not actually resemble 58 with regard to reactivity. 
Although we have not performed an extensive study of the reaction mechanism, 
we have begun an initial investigation to clarify the role of NMI in the cyclization of 7 to 
9, in the hopes of eventually deciphering the true mechanism.  Therefore, pipecolinic acid 
was held constant, while other possible Lewis bases/co-catalysts were screened.  As 
illustrated in Table 1.5, catalysis of the cyclization with pipecolinic acid and 2,6-lutidine 
(entry 1) led to no reaction.  This could support either mechanism, as it is possible that 
lutidine was too hindered to act as a nucleophile or too weak to be a general base.  
Catalysis with pipecolinic acid and 1,4-diazabicyclo[2.2.2]octane (DABCO) (entry 3), on 
the other hand, provided full conversion to the desired cyclic product, however with 
dramatically reduced enantioselectivity.  In this case, it is possible that DABCO reacted 
faster as the nucleophilic catalyst than pipecolinic acid, and therefore catalyzed a non-
selective MBH cyclization, represented in the diminished enantioselectivity, supporting 
the second mechanism.  Additionally, triethylamine, 1,2,2,6,6-pentamethyl piperidine 
(PEMP), and Hünig’s base were examined in combination with pipecolinic acid.  All 
three co-catalysts provided the desired product in slightly depressed enantioselectivity 
(approximately 70% ee), with varying levels of efficiency that appeared to reflect the 
steric hindrance of the base.  Triethyl amine and Hünig’s base led to similar results, 60% 
(entry 4) and 55% conversion (entry 6), while low conversion was achieved with PEMP 
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(35%, entry 5).  The slight depression of stereoselectivity could be ascribed to “leakage” 
in catalysis where triethyl amine or Hünig’s base served as the nucleophile, whereby out-
competing pipecolinic acid and catalyzing a non-selective MBH cyclization. 
Table 1.5: Screen of co-catalyst combinations. 
N
Me
Me
Me
Me
Me
co-catalyst
-
80
19
68
71
70
0
100
100
60
35
55
1
2
3
4
5
6
O
O
H
O OHN
H
CO2H (20 mol %)
co-catalyst (10 mol %)
THF:H2O (3:1), 48 h
N
N
N
N
Me
N
N
7 9
N MeMe
% conv % eeentry
 
In the case of PEMP, it is not believed that this severely hindered tertiary amine 
could act as a nucleophile.  In this case, a third possible mechanism may account for the 
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10% decrease in enantioselectivity; γ-deprotonation would lead to intermediate 60 which, 
in turn, could undergo cyclization and olefin isomerization to provide 9 (+/-). 
O OHO O
7 9 (+/-)
O O
60  
Considering the presented data, it is possible that the mechanism may indeed 
change with each co-catalytic system, such that catalysis with proline/NMI may proceed 
by mechanism A, while pipecolinic acid/NMI through mechanism B.  A kinetics study 
and isotopic-labeling experiments would be required in future studies to determine the 
rate determining step and lend further credence to one of the aforementioned 
mechanisms, or possibly a new mechanism. 
1.4.10 Substrate Scope 
With a set of optimized reaction parameters in hand for the intramolecular MBH 
reaction, we were interested in exploring the scope of our newly developed methodology.  
Ultimately, using the co-catalytic system of pipecolinic acid/NMI (20 mol %/10 mol %) 
under protic conditions (THF-H2O, 3:1), we were able to catalyze the cyclization of 
several activated aromatic enones with good enantioselectivities and yields.  As 
illustrated in Figure 1.22, product 9 could be isolated with 80% ee in 82% yield after 
extractive work up, and in 51% yield after silica gel chromatography.  Although the 
MBH products were not stable to various purification methods (which led to 
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corresponding diene 61 as a result of dehydration),48 it was determined that the purity of 
the cyclized products was very high (>90%)49 prior to chromatography.  Lowering the 
reaction temperature had a nominal effect on enantioselectivity, providing 50% 
conversion to 9 at 4 °C with a slight increase in enantioselectivity to 84% ee.  Preliminary 
investigation of scope showed that substitution around the aromatic ring was moderately 
tolerated, providing both p-Br-substituted 62 and p-Cl-substituted 63 with 79% ee in 88% 
yield and 92% yield, respectively.  A marked decrease in selectivity was seen in the case 
of ortho-substitution; MBH product 64 was obtained with 51% ee, although high yield 
was maintained (94% yield).  Heteroaromatic substitution was tolerated as well, with the 
MBH reaction providing thiophene analog 65 in 83% yield and with 74% ee.3 
                                                 
48  The products were not stable to silica gel chromatography as well as several other methods of 
purification such as fluorosil, neutral alumina, and basic alumina, all leading to the dehydrated product, 61. 
O
61  
49 As determined by TLC and 1H NMR analysis. 
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Figure 1.22: Substrate scope in the pipecolinic acid/NMI catalyzed MBH reaction. 
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1.5 Enhancement of Enantioselectivity: Kinetic Resolution 
As mentioned earlier, previous work from the Miller laboratory had uncovered a 
class of octapeptide catalysts that was highly effective for the kinetic resolution of 
secondary alcohols (Figure 1.23).22  Because the products from the intramolecular MBH 
reaction were indeed secondary alcohols, and possible substrates for asymmetric 
acylation, we were eager to determine if we could couple these two processes and 
effectively enhance the enantioselectivity of our MBH reaction. 
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Figure 1.23: Kinetic resolution of secondary alcohols catalyzed by peptide 30. 
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A variety of secondary alcohols had been demonstrated to undergo 
enantioselective acylation using peptide 30 with moderate to excellent levels of 
selectivity (krel = 4 to >50).50  The first question we had to answer was whether the 
products of the MBH reaction could be viable substrates for a similar kinetic resolution 
(Scheme 1.15).  Secondly, if we were able to efficiently catalyze the enantioselective 
acylation of racemic products, the analogous kinetic resolution with enantioenriched 
products from the MBH reaction could, in theory, provide enantiopure products in high 
yield.  For example, if the rate of acylation of the major enantiomer was slow while 
acylation of the minor enantiomer was fast, we could hypothetically obtain 90% yield and 
100% ee of the desired product when beginning with 80% enantiopure material. 
                                                 
50 krel = kfast/kslow 
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Scheme 1.15: Theoretical kinetic resolution of MBH products. 
peptide (2.5 mol %)
PhCH3, -65 °C
Ac2O
(±)
peptide (2.5 mol %)
PhCH3, -65 °C
Ac2O +
In Principle:
90% yield
100% ee
O
Ar
OH O
Ar
OH
90
kslow
10
kfast
O
Ar
OH O
Ar
OAc
+
O
Ar
OH O
Ar
OAcO
Ar
OH
+
 
Accordingly, initial examination of the kinetic resolution of MBH product 9 was 
promising; the racemic alcohol could be resolved with a krel of 8 using acylation catalyst 
peptide 30 (Scheme 1.16).  It was further demonstrated that the application of peptide 30 
to various MBH adducts afforded the desired products with up to 95% ee in moderate 
yields (<50%).31 
Scheme 1.16: Enantioselective acylation of racemic MBH product 9. 
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As previously discussed, we were once again interested in the possibility of 
obtaining a boost in enantioselectivity by way of an alanine scan of peptide 30.  After 
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testing peptides 33–39 for their efficiency in the kinetic resolution of MBH product 9 
(80% ee), it was determined that alanine scan peptide 37 was superior.  Peptide 30 
afforded 9 with 92% ee while peptide 37 afforded 9 with greater than 98% ee (under 
identical reaction conditions).   
 Once we had determined that the MBH products were viable substrates for 
asymmetric acylation using a peptide catalyst, and that peptide 37 was a highly efficient 
catalyst for this process, we were interested in pursuing a one-pot tandem sequence of the 
enantioselective MBH followed by an asymmetric acylation. Excitingly, this was 
accomplished via quench of the MBH reaction mixture with acetic anhydride and the 
addition of peptide-based asymmetric acylation catalyst 37.51  We found the initial MBH 
reaction could be carried out using pipecolinic acid/NMI (presumably affording product 9 
with 80% ee), which was then followed by the addition of acetic anhydride with peptide 
37, providing the desired product with >98% enantiomeric excess and in 50% isolated 
yield (after silica gel chromatography).  Thus we were able to effect an asymmetric MBH 
reaction coupled to a kinetic resolution of the nonracemic reaction mixture (Scheme 
1.17).  
                                                 
51 Jarvo, E. R.; Miller, S. J. Asymmetric Acylation. In Comprehensive Asymmetric Catalysis, Supplement 1; 
Jacobsen, E. N., Pfaltz, A., Yamamoto, H., Eds.; Springer-Verlag: Berlin Heidelberg, 2004; Chapter 43. 
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Scheme 1.17: Tandem one-pot MBH-kinetic resolution. 
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1.6 Conclusion 
The Morita-Baylis-Hillman reaction holds great promise of becoming a highly 
useful reaction.  Both the inter- and intramolecular variants have traditionally suffered 
from problems with reactivity and chemoselectivity, in addition to low stereoselectivity.  
However, with each successful advance in the reaction, it is possible that one day this 
reaction will be highly predictable and programmable.  Multiple parameters of the 
intramolecular MBH reaction were investigated and found to be crucial to reaction 
outcome (catalyst, co-catalyst, solvent, reaction concentration, and catalyst/co-catalyst 
loading and stoichiometry) and the fine-tuning of these parameters led to a set of 
optimized conditions that were amenable to the catalysis of several activated aromatic 
enone-aldehydes.  Moreover, building from previous work accomplished in our 
laboratory, we have been able to extend our peptide-catalyzed processes to include the 
most simplified variant, enantioselective catalysis using a single amino acid.  By coupling 
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the enantioselective MBH reaction with a secondary kinetic resolution, we were able to 
successfully combine the simple catalytic system with a peptide-based catalyst to afford 
enantiopure products. 
Moving forward, we are excited to extend the reaction scope to include a more 
expansive range of substrates as well as increase the enantioselectivity of the reaction 
even further.  Additionally, further investigation into the mechanism, through a kinetics 
study and isotopic labeling experiments, could shed light on the mechanism and enable 
the development of a superior catalytic system.  Importantly, our work has established 
that the enantioselective intramolecular MBH reaction can be performed rapidly and 
catalytically with high levels of stereoinduction in synthetically useful yields using a 
simple co-catalyst system and reaction conditions. 
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1.7 Experimental 
General Procedures.  Proton NMR spectra were recorded on a Varian 400 MHz 
spectrometer.  Proton chemical shifts are reported in ppm (δ) relative to internal 
tetramethylsilane (TMS, δ 0.0 ppm) or with the solvent reference relative to TMS 
employed as the internal standard (CDCl3, δ 7.26 ppm; d6-DMSO, δ 2.50 ppm; CD3OD, 
δ 3.31 ppm; D2O, δ 4.79 ppm).  Data are reported as follows: chemical shift (multiplicity 
[singlet (s), doublet (d), triplet (t), quartet (q), and multiplet (m)], coupling constants 
[Hz], integration).  Carbon NMR spectra were recorded on a Varian 400 (100 MHz) 
spectrometer with complete proton decoupling. Carbon chemical shifts are reported in 
ppm (δ) relative to TMS with the respective solvent resonance as the internal standard 
(CDCl3, δ 77.0 ppm).  Infrared spectra were obtained on a Perkin-Elmer Spectrum 1000 
spectrometer.  Analytical thin-layer chromatography (TLC) was performed using Silica 
Gel 60 Å F254 precoated plates (0.25 mm thickness).  TLC Rf values are reported. 
Visualization was accomplished by irradiation with a UV lamp and/or staining with 
KMnO4 or cerium ammonium molybdenate (CAM) solutions.  Flash column 
chromatography was performed using Silica Gel 60A (32-63 µm).52  Optical rotations 
were recorded on a Rudolf Research Analytical Autopol IV Automatic polarimeter at the 
sodium D line (path length 50 mm).  High resolution mass spectra were obtained at the 
Mass Spectrometry Facility of either Boston College (Chestnut Hill, MA) or the 
University of Illinois (Urbana-Champaign, IL).  The method of ionization is given in 
parentheses. 
                                                 
52 Still, W.C.; Kahn, M.; Mitra, J. J. Org. Chem. 1978, 43, 2923. 
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Analytical normal phase HPLC was performed on a Hewlett-Packard 1100 Series 
chromatograph equipped with a diode array detector (214 nm and 254 nm).  All reactions 
were carried out under an argon or nitrogen atmosphere employing oven- and flame-dried 
glassware. All solvents were distilled from appropriate drying agents prior to use. N-
methyl imidazole and acetic anhydride were distilled and stored in a Schlenk flask for no 
more than two weeks prior to use.  Intramolecular Baylis-Hillman substrate 7 was 
prepared as reported previously in the literature53 as well as by the general procedure 
described. 
 
Experimental Procedures 
 
Representative procedure for the preparation of intramolecular Morita-Baylis-
Hillman substrates (7, 63b, 62b, 64b and 65b). 
O O
 
(E)-7-oxo-7-phenylhept-5-enal (7).  2-(triphenylphosphanylidene)acetophenone54 (9.1 g, 
24 mmol) was added to a solution of 5,5-dimethoxypentanal55  (2.5 g, 17 mmol) in 
CH2Cl2 (43 mL).  After stirring for 24 h at ambient temperature, the reaction was 
                                                 
53 (a) Montgomery, J; Savchenko, A. V.; Zhao, Y. J. Org. Chem. 1995, 60, 5699-5701. (b) Richards, E. L.; 
Murphy, P. J.; Dinon, F.; Fratucello, S.; Brown, P. M.; Gelbrich, T.; Hursthouse, M. B. Tetrahedron 2001, 
57, 7771-7784. 
54 (a) Ramirez, F.; Dershowitz, S. J. Org. Chem. 1957, 22, 41-45.  (b) Denney, D. B.; Smith, L. C.; Song, 
J.; Rossi, C. J. J. Org. Chem. 1963, 28, 778-780. 
55 Schreiber, S. L.; Claus, R. E.; Reagan, J. Tetrahedron Lett. 1982, 23, 3867-3870. 
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concentrated under reduced pressure and purified via silica gel chromatography 
(hexane-EtOAc, 5:1) to afford the (E) Wittig product.  This material was then dissolved 
in THF (60 mL) and 1N HCl (20 mL) and stirred at 23 ºC.  After 2 h, THF was removed 
in vacuo from the yellow solution and the resultant residue was diluted with Et2O (100 
mL) and washed with water (50 mL), saturated aqueous NaHCO3 (50 ml), and saturated 
aqueous NaCl (50 mL).  The aqueous layers were extracted with ether (2 x 50 mL) and 
the combined organic layers were then dried over Na2SO4 and concentrated under 
reduced pressure.  Flash chromatography (toluene-EtOAc, 5:1) provided 7 as a pale 
yellow oil (960 mg, 4.7 mmol, 28%).  Compound 7, prepared in this manner, is identical 
to that prepared previously.53  Compounds 63b, 62b, 64b and 65b were prepared by 
analogous methodology. 
 
O O
Cl  
Compound 63b.  1H NMR (CDCl3, 400 MHz) δ 9.83 (s, 1H), 7.92 (d, J = 8.8 Hz, 2H), 
7.49 (d, J = 8.8 Hz, 2H), 7.08 (m, 1H), 6.92 (d, J = 15.6 Hz, 1H), 2.58 (t, J = 7.2 Hz, 2H), 
2.42 (q, J = 7.2 Hz, 2H), 1.92 (quintet, J = 7.6 Hz, 2H); 13C NMR (CDCl3, 100 MHz) δ 
201.6, 189.3, 148.7, 139.3, 136.2, 130.1, 129.0, 126.2, 43.1, 32.0, 20.6; IR (film, cm-1) 
2942, 2823, 2722, 1727, 1671, 1621, 1583, 1401, 1293, 1224, 1092, 1016; TLC Rf 0.31 
(3:1 toluene-EtOAc); HRMS (ESI) m/z 237.0693 (237.0682 calcd for C13H14O2Cl 
[M+H]+). 
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O O
Br  
Compound 62b.  1H NMR (CDCl3, 400 MHz) δ 9.83 (s, 1H), 7.83 (d, J = 8.8 Hz, 2H), 
7.64 (d, J = 8.8 Hz, 2H), 7.06 (dt, J = 15.2, 6.8 Hz, 1H), 6.89 (d, J = 15.2 Hz, 1H), 2.56 
(dt, J = 7.2 Hz, 1.2 Hz, 2H), 2.40 (q, J = 6.8 Hz, 2H), 1.91 (quintet, J = 7.2 Hz, 2H); 13C 
NMR (CDCl3, 100 MHz) δ 200.8, 188.7, 148.1, 136.0, 131.4, 129.6, 127.4, 125.6, 42.8, 
31.7, 20.2; IR (film, cm-1) 2949, 2886, 2829, 2722, 1721, 1671, 1620, 1583, 1400, 1073, 
1010; TLC Rf 0.36  (3:1 toluene-EtOAc); HRMS (ESI) m/z 281.0188 (281.0177 calcd for 
C13H14O2Br [M+H]+). 
 
 
O O
Me  
Compound 64b.  1H NMR (CDCl3, 400 MHz) δ 9.80 (s, 1H), 7.42-7.35 (m, 2H), 7.30-
7.24 (m, 2H), 6.71 (dt, J = 15.6, 6.8 Hz, 1H), 6.53 (d, J = 16.0 Hz, 1H), 2.55-2.53 (dt, J = 
7.2, 1.2 Hz, 2H), 2.42 (bs, 3H), 2.34 (q, J = 7.2 Hz, 2H), 1.85 (quintet, J = 7.6 Hz, 2H); 
13C NMR (CDCl3, 100 MHz) δ 201.1, 196.1, 149.2, 138.5, 136.6, 131.0, 130.2, 127.8, 
125.1, 43.0, 31.8, 20.4, 20.2; IR (film, cm-1) 2930, 2829, 2728, 1728, 1652, 1627; TLC Rf 
0.53 (3:1 toluene-EtOAc); HRMS (ESI) m/z 217.1238 (217.1229 calcd for C14H17O2 
[M+H]+). 
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O
S
O
 
Compound 65b.  1H NMR (CDCl3, 400 MHz) δ 9.82 (s, 1H), 7.77 (dd, J = 3.6, 0.8 Hz, 
1H), 7.66 (dd, J = 4.8, 0.8 Hz, 1H), 7.16 (dd, J = 4.8, 4.0 Hz, 1H), 7.07 (dt, J = 15.2, 7.2 
Hz, 1H), 6.83 (d, J = 15.2 Hz, 1H), 2.53 (dt, J = 7.2, 1.2 Hz, 2H), 2.37 (q, J = 6.8 Hz, 
2H), 1.88 (quintet, J = 7.2 Hz, 2H); 13C NMR (CDCl3, 100 MHz) δ 201.2, 181.7, 146.9, 
144.7, 133.6, 131.7, 128.0, 126.0, 43.0, 31.7, 20.5; IR (film, cm-1) 3094, 2936, 2829, 
2722, 1728, 1659, 1614, 1520, 1420; TLC Rf 0.46 (3:1 toluene-EtOAc); HRMS (ESI) m/z 
209.0634 (209.0636 calcd for C11H13O2S [M+H]+). 
 
 
Representative procedure for the catalytic intramolecular Morita-Baylis-Hillman 
reactions. 
O OH
Cl  
Compound 63.  Pipecolinic acid (14.2 mg, 0.11 mmol), water (233 µL), THF (659 µL), 
and NMI (1.37 M solution in THF, 41 µL) were added sequentially to a vessel containing 
aldehyde 63b (132 mg, 0.56 mmol).  The reaction was allowed to stir at room 
temperature for 48 h, whereupon the yellow solution was added to 30 mL of EtOAc and 
washed with saturated aqueous NH4Cl (20 mL), saturated aqueous NaHCO3 (20 mL), and 
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saturated aqueous NaCl (20 mL).  The organic layer was dried over Na2SO4, filtered, and 
concentrated under reduced pressure to afford 63 as a pale yellow oil (121 mg, 92%).  
The product isolated in this manner appears as a single compound with slight impurities 
manifested by low intensity peaks in the baseline of the 1H NMR spectrum (see figure A).  
This material may be purified further by silica gel chromatography using a gradient 
eluent (toluene-ethyl acetate 10:1 to 1:10) affording 63 (74 mg) as a clear oil in 56% 
isolated yield. 1H NMR (CDCl3, 400 MHz) δ 7.62 (d, J = 8.4 Hz, 2H), 7.42 (d, J = 8.8 
Hz, 2H), 6.70 (t, J = 4.4 Hz, 1H), 4.73 (br s, 1H), 3.38 (s, 1H), 2.39-2.27 (m, 2H), 1.97-
1.85 (m, 3H), 1.68-1.64 (m, 1H); 13C NMR (CDCl3, 100 MHz) δ 197.6, 146.7, 139.9, 
138.2, 135.9, 130.6, 128.4, 63.9, 29.9, 26.5, 17.5; IR (film, cm-1) 3440, 2936, 2867, 1646, 
1583; TLC Rf 0.37 (3:1 toluene-EtOAc); [α]D +18 (c 1.0, CHCl3, 79% ee); HRMS (ESI) 
m/z 259.0503 (259.0502 calcd for C13H13O2ClNa [M+Na]+); Assay of enantiomeric 
purity: Enantiomers of product were separated by chiral HPLC employing a Chiralcel OJ 
column (Daicel).  Conditions: 98:2 hexanes-ethanol; Flow rate 0.60 mL/min; 28.3 min 
(major ent), 32.7 min (minor ent). 
 
O OH
 
2-benzoyl-1-hydroxycyclohex-2-ene (9).  The characterization data for this compound 
matched that which has previously been reported.53 [α]D +30 (c 1.0, CHCl3, 80% ee); 
Assay of enantiomeric purity: Enantiomers of product were separated by chiral HPLC 
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employing a Chiralcel OD column (Daicel).  Conditions: 98:2 hexanes-ethanol; Flow rate 
0.75 mL/min; 18.8 min (major ent), 22.2 min (minor ent).  The absolute stereochemistry 
was assigned by Mosher analysis.56 
 
O OH
Br  
Compound 62.  1H NMR (CDCl3, 400 MHz) δ 7.59 (d, J = 8.8 Hz, 2H), 7.53 (d, J = 8.8 
Hz, 2H), 6.70 (t, J = 4.4 Hz, 1H), 4.73 (br s, 1H), 3.38 (s, 1H), 2.39-2.22 (m, 2H), 1.96-
1.83 (m, 3H), 1.69-1.62 (m, 1H); 13C NMR (CDCl3, 100 MHz) δ 197.7, 146.8, 139.9, 
136.4, 131.4, 130.7, 126.8, 63.9, 29.8, 26.5, 17.5; IR (film, cm-1) 3414, 2936, 2867, 1634; 
TLC Rf 0.36 (3:1 toluene-EtOAc); [α]D +15.4 (c 1.0, CHCl3, 79% ee); HRMS (ESI) m/z 
302.9996 (302.9997 calcd for C13H13O2BrNa [M+Na]+); Assay of enantiomeric purity: 
Enantiomers of product were separated by chiral HPLC employing a Chiralcel OJ column 
(Daicel).  Conditions: 98:2 hexanes-ethanol; Flow rate 0.60 mL/min; 30.8 min (major 
ent), 35.4 min (minor ent). 
 
 
 
                                                 
56 (a) Dale, J. A.; Dull, D. L.; Mosher, H. S J. Org. Chem. 1969, 34, 2543-2549. (b) Dale, J. A.; Mosher, H. 
S. J. Am. Chem. Soc. 1973, 95, 512-519. (c) Ward, D. E.; Rhee, C. K. Tetrahedron Lett. 1991, 32, 7165-
7166. (d) Ohtani, I.; Kusumi, T.; Kashman, Y.; Kakisawa, H. J. Org. Chem. 1991, 56, 1296-1298. 
- 56 - 
O OH
Me  
Compound 64.  1H NMR (CDCl3, 400 MHz) δ 7.32 (m, 1H), 7.21 (m, 3H), 6.65 (t, J = 
4.0 Hz, 1H), 4.78 (br s, 1H), 3.52 (br s, 1H), 2.30 (s, 3H), 2.34-2.15 (m, 2H), 1.93-1.78 
(m, 3H), 1.66-1.58 (m, 1H); 13C NMR (CDCl3, 100 MHz) δ 201.3, 148.8, 141.4, 138.2, 
135.8, 130.6, 129.6, 127.6, 124.9, 63.5, 29.9, 26.7, 19.7, 17.8; IR (film, cm-1) 3478, 2943, 
2867, 1633; TLC Rf 0.38 (3:1 toluene-EtOAc); [α]D +4.2 (c 1.0, CHCl3, 51% ee); HRMS 
(ESI) m/z 239.1045 (239.1048 calcd for C14H16O2Na [M+Na]+); Assay of enantiomeric 
purity: Enantiomers of product were separated by chiral HPLC employing a Chiralcel OD 
column (Daicel).  Conditions: 98:2 hexanes-ethanol; Flow rate 0.75 mL/min; 14.2 min 
(major ent), 27.6 min (minor ent). 
 
O
S
OH
 
Compound 65.  1H NMR (CDCl3, 400 MHz) δ 7.66 (dd, J = 4.8 Hz, 1.1 Hz, 1H), 7.62 
(dd, J = 4.0 Hz, 1.1 Hz, 1H), 7.12 (m, 1H), 6.95 (m, 1H), 4.68 (br s, 1H), 3.46 (br s, 1H). 
2.42-2.35 (m, 1H), 2.32-2.23 (m, 1H), 1.96-1.81 (m, 3H), 1.70-1.65 (m, 1H); 13C NMR 
(CDCl3, 100 MHz) δ 189.8, 143.2, 142.6, 139.9, 133.4, 133.3, 127.6, 64.1, 29.9, 26.2, 
17.4; IR (film, cm-1) 3440, 2936, 2867, 1621; TLC Rf 0.32 (3:1 toluene-EtOAc); [α]D 
+37 (c 1.0, CHCl3, 74% ee); HRMS (ESI) m/z 231.0459 (231.0456 calcd for 
C11H12O2NaS [M+Na]+); Assay of enantiomeric purity: Enantiomers of product were 
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separated by chiral HPLC employing a Chiralcel OD column (Daicel).  Conditions: 95:5 
hexanes-ethanol; Flow rate 0.60 mL/min; 25.7 min (major ent), 23.2 min (minor ent). 
 
 
Procedure for the tandem enantioselective intramolecular MBH reaction-
asymmetric acylation reaction 
Pipecolinic acid (2.6 mg, 0.02 mmol), water (41 µL), THF (94 µL), and NMI (30 µL of a 
0.33 M solution in THF) were added sequentially to a vessel containing aldehyde 7 (20 
mg, 0.1 mmol).  The reaction was stirred at room temperature for 48 hours, whereupon 
the yellow solution was concentrated, transferred to a round bottom flask, and azeotroped 
with toluene (5 x 10 mL).  The residue was then dissolved in toluene (16.8 mL) and 
peptide 30 (7 mg, 0.005 mmol) and acetic anhydride (37.4 µL, 0.4 mmol) were added.  
The solution was maintained at 23 ºC for 24 h and then quenched with methanol (2 mL).  
After concentration under reduced pressure, the residue was dissolved in EtOAc (30 mL), 
washed with saturated aqueous NH4Cl (20 mL), saturated aqueous NaHCO3 (20 mL), and 
saturated aqueous NaCl (20 mL), and dried (Na2SO4).  Purification via silica gel 
chromatography (toluene-ethyl acetate, 7:1) afforded 9 (9.9 mg, 50% yield, >98% ee) as 
a clear oil. 
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Compound ent-9-Ac.  1H NMR (CDCl3, 400 MHz) δ 7.70 (d, J = 7.0 Hz, 2H), 7.53 (t, 
J = 7.3 Hz, 1H), 7.43 (t, J = 7.3 Hz, 2H), 6.72 (m, 1H), 5.99 (m, 1H), 2.46-2.39 (m, 1H), 
2.24-2.15 (m, 1H), 2.05-1.98 (overlapping s and m, 4H), 1.86-1.70 (m, 3H); 13C NMR 
(CDCl3, 100 MHz) δ 195.3, 169.8, 146.0, 137.8, 136.7, 131.7, 129.0, 127.9, 65.0, 28.0, 
25.8, 21.3, 17.3; IR (film, cm-1) 2942, 2867, 1733, 1652; TLC Rf 0.51 (2:1 hexanes-
EtOAc); HRMS (ESI) m/z 267.0988 (267.0997 calcd for C15H16O3Na [M+Na]+); Assay 
of enantiomeric purity: Enantiomers of product were separated by chiral HPLC 
employing a Chiralcel OD column (Daicel).  Conditions: 98:2 hexanes-ethanol; Flow rate 
0.75 mL/min; 15.3 min (major ent), 16.6 min (minor ent). 
 
O O O
 
Aldol dimerization by-product (40).  1H NMR (CDCl3, 400 MHz) δ 9.42 (s, 1H), 7.92 
(t, J = 7.6 Hz, 4H), 7.58-7.52 (m, 2H), 7.49-7.43 (m, 4H), 7.08-6.84 (m, 4H), 6.54 (t, J = 
7.6 Hz, 1H), 2.51-2.34 (m, 8H), 1.75 (quintet, J = 7.6 Hz, 2H); 13C NMR (CDCl3, 100 
MHz) δ 194.3, 190.2, 154.4, 147.8, 147.6, 142.2, 137.6, 132.6, 128.4, 126.4, 32.4, 31.5, 
28.7, 27.3, 23.2; IR (film, cm-1) 3056, 2936, 2861, 2722, 1671, 1647, 1620, 1596, 1451, 
1287, 1224; TLC Rf 0.59 (3:1 toluene-EtOAc); HRMS (ESI) m/z 387.1943 (387.1960 
calcd for C26H27O3 [M+H]+). 
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Compound 45.  Boc-L-azetidine-2-carboxylic acid (440 mg, 2.20 mmol) was added to a 
solution of 10% H2SO4 (10 mL) and dioxane (10 mL).  The solution was allowed to stir 
for 12 h and then concentrated under reduced pressure.  The resulting residue was 
dissolved in aqueous H2SO4 (0.25 N, 10 mL) and DOWEX 50-2-200 cation exchange 
resin (2.0 g) was added.57  This mixture was allowed to stir for 12 h, then transferred to a 
column and washed with water (100 mL).  The desired product was then eluted with 5% 
NH4OH (200 mL) and concentrated under reduced pressure to afford 1 as a white solid.  
The characterization data for this compound matched that which has previously been 
reported. 1H NMR (CDCl3, 400 MHz) δ 4.64 (dd, J = 7.6 Hz, 9.6 Hz, 1H), 4.05-3.98 (m, 1H), 
3.90-3.85 (m, 1H), 2.80-2.71 (m, 1H), 2.57-2.47 (m, 1H); 13C NMR (CDCl3, 100 MHz) δ 
174.2, 60.7, 43.9, 25.1. 
 
 
 
 
 
 
 
                                                 
57 Kazlauskas, R. J. J. Org. Chem. 1994, 59, 2075-2078. 
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2 The Rauhut-Currier Reaction: A History and Its Synthetic 
Application  
2.1 Introduction 
Carbon–carbon bond formation is of fundamental importance in organic 
synthesis, with much attention directed towards controlling reaction efficiency, 
stereoselectivity, and chemoselectivity.58  Among the many methods established for the 
formation of a new C–C bond, carbon-based nucleophilic conjugate addition reactions 
constitute a significant and synthetically useful method, with the ability to build rings, set 
multiple stereocenters, and engage a wide variety of substrates. 59   Furthermore, for 
almost half a century, the use of enones as latent enolates has provided  a successful 
method for the regioselective alkylation of carbonyl compounds.60   
The Morita-Baylis-Hillman (MBH) and Rauhut-Currier (RC) reactions comprise a 
class of transformations that encompass the ability to generate a new C–C bond in an 
atom economical manner by combining the power of nucleophilic catalysis with the use 
of enones as latent enolates.  While the MBH reaction involves the coupling of an 
activated alkene with an aldehyde, the Rauhut-Currier reaction involves the reaction of 
two activated alkenes, creating a new C–C bond between the α-position of one activated 
                                                 
58 (a) Dalko, P. I.; Moisan, L. Angew. Chem., Int. Ed. 2004, 43, 5138-5175. (b) Dalko, P. I.; Moisan, L. 
Angew. Chem., Int. Ed. 2001, 40, 3726-3748. 
59 For selected reviews, please see: (a) Almaşi, D.; Alonso, D. A.; Nájera, C. Tetrahedron: Asymmetry 
2007, 18, 299-365. (b) Vicario, J. L.; Badía, D.; Carrillo, L. Synthesis 2007, 14, 2065-2092. (c) Krause, N.; 
Hoffmann-Röder, A. Synthesis 2001, 2, 171-196. (d) Sibi, M. P.; Manyem, S. Tetrahedron 2000, 56, 8033-
8061. 
60 Stork, G.; Rosen, P.; Goldman, N. L. J. Am. Chem. Soc. 1961, 83, 2965-2966. 
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alkene and the β-position of a second alkene under the influence of a nucleophilic catalyst 
(Figure 2.1). 
Figure 2.1: Comparison of the MBH and RC reactions. 
EWG
EWG
EWG
EWG
R
OH
EWG
RCHO
Morita-Bayl is-Hillman
N ucleophilic Catalyst
Rauhut-Currier
N ucleophilic Catalyst
 
A vast array of literature has been established regarding the MBH reaction, 
reflecting its impact on organic synthesis by providing densely functionalized products 
with a new stereogenic center that serve as substrates for a multitude of subsequent 
transformations.61  The Rauhut-Currier reaction, on the other hand, has received much 
less attention due, in part, to low reactivity and great difficulty in controlling the 
selectivity of the cross-coupling reaction.  While the development of the reaction has not 
been rapid, great advancement has been made in recent years, providing the synthetic 
community with new prospects for efficient C–C bond formation.62  Herein, the state-of-
the-art of the Rauhut-Currier reaction will be presented, from its inception to the present 
day.  Derivatives of this coupling reaction, such as alternative electrophilic and 
nucleophilic partners, will be discussed.  Finally, its application in the synthesis of 
                                                 
61 For selected reviews, please see: (a) Drewes, S. E.; Roos, G. H. P. Tetrahedron 1988, 44, 4653-4670. (b) 
Basavaiah, D.; Rao, P. D.; Hyma, R, S. Tetrahedron 1996, 52, 8001-8062. (c) Basavaiah, D.; Rao, A. J.; 
Satyanarayana, T. Chem. Rev. 2003, 103, 811-891. 
62 (a) Lee, K. Y.; Gowrisankar, S.; Kim, J. N. Bull. Kor. Chem. Soc. 2005, 26, 1481-1490. (b) Masson, G.; 
Housseman, C.; Zhu, J. Angew. Chem., Int. Ed. 2007, 46, 4614-4628. 
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representative natural products will be described, as this transformation has recently 
begun to impact complex molecule synthesis. 
2.2 Overview of the Intermolecular Rauhut-Currier Reaction 
In 1963, Rauhut and Currier63 reported the phosphine-catalyzed dimerization of 
electron-deficient alkenes, acrylonitrile and ethyl acrylate, in what has become known as 
the Rauhut-Currier reaction (RC) (Figure 2.2).  The transformation is believed to proceed 
via reversible conjugate addition of either trialkylphosphine or triarylphosphine to 
activated alkene I to generate zwitterionic species II.  A Michael reaction of the enolate 
with a second equivalent of activated alkene I generates zwitterionic intermediate III, 
which then undergoes a prototropic shift followed by extrusion of the phosphine catalyst 
to generate the RC coupling product (V). 
Figure 2.2: Proposed mechanism of the Rauhut-Currier reaction. 
EWG
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EWG
EWG = COOR, CN
P(alkyl)3 or P(Ar)3
EWG
EWG
R3P
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I
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V
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I
 
                                                 
63 Rauhut, M. M.; Currier, H. (American Cyanamid Co.), U.S. Patent 307499919630122, 1963; Chem. 
Abstr. 1963, 58, 11224a. 
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Two years later, McClure64 and Baizer and Anderson65 similarly described the 
successful dimerization of acrylonitrile in the presence of tributylphosphine.  The 
analogous triphenylphosphine-catalyzed dimerization was reported to be less efficient, 
producing a low yield of α-methyleneglutaronitrile (1, 60%) in addition to 1,4-dicyano-1-
butene (2, 40%), based on 9% conversion of acrylonitrile (Scheme 2.1).  The reaction 
was performed at 45 °C in the presence of t-butyl alcohol for 198 h. 
Scheme 2.1: Dimerization of acrylonitrile by Baizer and Anderson. 
CN
CN
CN
45 °C
t-butyl alcohol
9% conv, 198 h
1
60%
2
40%
PPh3
CN
NC
 
In 1969 Morita and Kobayashi66  reported the first cross-coupling reaction of 
activated alkenes (methyl acrylate and acrylonitrile) with fumaric/maleic esters (diethyl 
and dibutyl) in the presence of tricyclohexylphosphine (Scheme 2.2).  They achieved 
high yield (95.5%) in the coupling of methyl acrylate and diethyl fumarate, to provide 
addition product 3-butene-1,2,3-tricarboxylic acid 1,2-diethyl-3-methyl ester, 3.  The 
analogous reactions affording dibutyl (1-cyanovinyl)succinate and dibutyl 
(1-cyanoethylidene)succinate  were presented without yields. 
Scheme 2.2: Tricyclohexylphosphine-catalyzed coupling reported by Morita and Kobayashi.  
CO2MeEtO
O
EtO
O
+
EtO
O
EtO
O
CO2Me70-100 °C, 16 h
PCy3 (7 mol %)
3, 95.5%  
                                                 
64 McClure, J. D., U. S. Patent 3225083, 1965. 
65 Baizer, M. M., Anderson, J. D. J. Org. Chem. 1965, 30, 1357-1360. 
66 Morita, K.; Kobayashi, T. Bull. Chem. Soc. Jpn. 1969, 42, 2732. 
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McClure 67 presented a similar cross-coupling reaction of ethyl acrylate and 
acrylonitrile catalyzed by tributylphosphine in 1970 (Scheme 2.3).  In the presence of 
t-BuOH at 100 °C, only one of two possible cross-coupled products was obtained, 2-
ethoxycarbonyl-4-cyano-1-butene (4, 48%), in addition to the products corresponding to 
homodimerization of both reactants (5, 22%; 1, 25%). 
Scheme 2.3: Cross-Coupling in the RC reaction. 
CO2Et CN
CO2Et
CN
CO2Et
CO2Et
CN
CN
+
(1:1)
PBu3 (1 mol %)
100 °C
t-butyl alcohol
21% conv 4
48%
5
22%
1
25%
CN
CO2Et
8
not observed  
Homodimerization by-products 5 and 1 were isolated in similar amounts, 
suggesting that both intermediates, 6 and 7, were formed during the reaction (Scheme 
2.4). The absence of product 8 was thus rationalized by assuming that the subsequent 
reaction of the phosphonium zwitterions with ethyl acrylate (eq 1) was less favorable 
than reaction with acrylonitrile (eq 2).  The subsequent proton transfer step was also 
implicated in the selective product formation, with proton transfer being less favored in 
the case of intermediate 9 than 10.  Ultimate product formation was therefore dependent 
not on the relative ease of the initial conjugate addition (forming intermediates 6 and 7), 
but rather the ensuing steps in the transformation. 
                                                 
67 McClure, J. D. J. Org. Chem. 1970, 35, 3045-3048. 
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Scheme 2.4: Selective formation of cross-coupled product 4. 
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More than 15 years later, various reports of similar processes were established 
under the influence of amine-based catalysts.  In 1986 Amri and Villieras presented an 
amine-catalyzed variant of the Rauhut-Currier transformation.68  In an investigation of 
the related MBH reaction, researchers discovered that methyl vinyl ketone (MVK) 
underwent slow dimerization (7 days) in the presence of 1,4-diazabicyclo[2.2.2]octane 
(DABCO) to provide 3-methylene-2,6-heptadione. 
The DABCO-catalyzed dimerization was extended further by Basavaiah and co-
workers to include various α,β-unsaturated ketones and acrylonitrile (Scheme 2.5).69  A 
range of reaction times (0.25 h, phenyl vinyl ketone; 4 d, methyl vinyl ketone; 10 d, 
acrylonitrile) were reported with 15 mol % catalyst loading at 35 °C to provide the 
corresponding 2-methylene-1,5-diketones (11) and acrylonitrile dimer (12) in moderate to 
good yields (eq 3 and 4, Scheme 2.5).  
                                                 
68 Amri, H.; Villieras, J. Tetrahedron Lett. 1986, 27, 4307-4308. 
69 Basavaiah, D.; Gowriswari, V. V. L.; Bharathi, T. K. Tetrahedron Lett. 1987, 28, 4591-4592. 
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Scheme 2.5: Amine-catalyzed RC reaction. 
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Drewes and co-workers demonstrated that in the absence of an aldehyde coupling 
partner in the Morita-Baylis-Hillman reaction, acrylate esters will undergo self 
condensation under the Rauhut-Currier reaction to afford the corresponding dimers in 
nearly quantitative yield (89-100%, Scheme 2.6).70  The dimerization of a variety of aryl 
and alkyl functionalized acrylates was promoted by DABCO (20-40 mol %) to provide 
the homoesters of α-methyleneglutaric acid (13).  Under these conditions, methyl acrylate 
was unreactive, even after 30 days. 
Scheme 2.6: DABCO-catalyzed dimerization of acrylate esters. 
O
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Me
Me
13
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The utility of the dimerization of acrylates was highlighted in the efficient (4 step) 
synthesis of (±) sarkomycin ester 14 from ethyl acrylate by Amri and coworkers (Scheme 
                                                 
70 Drewes, S. E.; Emslie, N. D.; Karodia, N. Syn. Commun. 1990, 20, 1915-1921. 
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2.7).71  This large scale application of the RC reaction was performed under the influence 
of a phosphine-based catalyst, tris(dimethylamino)phosphine (TDAP), which promoted 
the dimerization of ethyl and tert-butyl acrylates in good yields (15, 61%; 16, 72%). 
Scheme 2.7: Tris(dimethylamino)phosphine (TDAP) catalyzed RC reaction in the synthesis of 
(±) sarkomycin esters. 
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N P
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O
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Hwu and co-workers introduced a related method for the α-alkylation of α,β-
unsaturated enones using the tertiary amine 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) 
with 1,3-dimethyl-2-imidazolidinone (DMI) as the solvent (Scheme 2.8). 72   Michael 
acceptors ethyl acrylate, acrylonitrile, and phenyl vinyl sulfone were employed in the 
cross-coupling reactions with 2-cyclohexen-1-one and 3-pentene-2-one, providing the 
corresponding α-substituted enones in good yields (17, 55-82%; 18, 60-76%).  This 
extension of the RC reaction to include β-substituted enones required elevated 
temperatures of 185 ºC for 24 h.  In the absence of alternative Michael acceptors, the 
dimerization of 2-cyclohexen-1-one was also possible, providing the corresponding 
product in 85% yield under identical conditions. 
                                                 
71 Amri, H.; Rambaud, M.; Villieras, J. Tetrahedron Lett. 1989, 30, 7381-7382. 
72 Hwu, J. R.; Hakimelahi, G. H.; Chou, C.-T. Tetrahedron Lett. 1992, 33, 6469-6472. 
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Scheme 2.8: α-Alkylation of α,β-unsaturated enones catalyzed by DBU. 
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Mechanistic work by Hwu and co-workers prompted them to propose that the 
DBU-catalyzed transformation proceeded via a different pathway than that previously 
presented for analogous MBH and RC reactions (Figure 2.3).  The reaction of 2-
cyclohexen-1-one with isobutyraldehyde in the presence of DBU generated the desired 
aldol adduct 19 in 50% yield, where as no reaction was detected in the presence of 
DABCO.  Additionally, while DABCO was reported by Amri and co-workers to catalyze 
the MBH reaction of methyl vinyl ketone and acetaldehyde to provide 20 (81% yield),68 
the analogous DBU-catalyzed reaction in the Hwu laboratory led only to the recovery of 
starting material.  It was therefore concluded that 2-cyclohexen-1-one, possessing acidic 
γ-protons, underwent deprotonation by DBU (vs. conjugate addition) to provide dienolate 
intermediate 21.  Subsequent Michael reaction with the desired activated alkene, and 
finally olefin migration, provided the observed α,β-unsaturated enones (17). 
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Figure 2.3: Mechanistic study by Hwu and co-workers. 
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Jenner and others presented the dimerization of acrylic esters, nitriles, and ketones 
under phosphine catalysis.73  In an early report, it was demonstrated that the dimerization 
of acrylonitrile and methyl acrylate could be promoted with DABCO (10 mol %) at 
elevated pressure (300 MPa).  Attempts to extend this methodology to include sluggish β-
substituted analogs, such as hindered crotonitrile, were unsuccessful with traditional 
tertiary amine-based catalysts used in the MBH reaction (DABCO and 3-quinuclidinol) at 
ambient or elevated pressure.  On the other hand, quantitative yield of the dimer was 
achieved using tri-n-butylphosphine at high pressure (300 MPa) or in slightly lower yield 
(87%) when using tris(dimethylamino)phosphine (TDAP) at ambient pressure (Figure 
2.4).  While the dimerization of β-substitited derivatives typically required higher 
pressures, cyclohex-2-en-1-one underwent quantitative dimerization using tri-n-
butylphosphine at ambient pressure (23). 
                                                 
73 (a) Jenner, G. High Press. Res. 1999, 16, 243-252. (b) Jenner, G. Tetrahedron Lett. 2000, 41, 3091-3094. 
(c) Su, W.; Mcleod, D.; Verkade, J. G. J. Org. Chem. 2003, 68, 9499-9501. (d) Hall, C. D.; Lowther, N.; 
Tweedy, B. R.; Hall, A. C.; Shaw, G. J. Chem. Soc., Perkin Trans. 2 1998, 2047-2054. 
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Figure 2.4: Phosphine-catalyzed dimerization of acrylic compounds. 
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In their study of the Morita-Baylis-Hillman reaction, Kaye and co-workers 
observed a competitive RC transformation leading to alkene dimerization products.74  
Accordingly, they presented a study of the direct dimerization reaction in the absence of 
an aldehyde coupling partner.  Various activated alkenes were examined in the presence 
of DABCO and DBU and shown to undergo coupling to the corresponding dimers (24) in 
low to moderate yield (5-65%; eq 5, Scheme 2.9)  They also reported the isolation of 
chromane 25 in the Morita-Baylis-Hillman reaction of salicylaldehyde and methyl 
acrylate.  Researchers proposed that 25 was the product of an in situ RC transformation 
of MBH product 26 and a second equivalent of methyl acrylate (eq 6). 
                                                 
74 (a) Kaye, P. T.; Nocanda, X. W. J. Chem. Soc., Perkin Trans. 1 2002, 1318-1323. (b) Kaye, P. T.; 
Robinson, R. S. Syn. Commun. 1996, 26, 2085-2097. 
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Scheme 2.9: (5) Dimerization of various activated alkenes with DABCO or DBU. (6) In situ RC 
reaction with MBH product 26. 
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The RC transformation has also been employed in the generation of bicyclic 
systems when followed by a subsequent enolization and aldol reaction.75  In the case of 
divinyl ketones, Schaus and co-workers have demonstrated divergent reactivity with 
differing α-substituted substrates to produce either traditional RC products or 
bicyclo[3.2.1]octenones with two bridgehead quaternary carbon centers (Figure 2.5).76  
When 1,4-diene-3-one 27 was employed in the cyclization reaction in the presence of 
triphenylphosphine (100 mol %), facile α-deprotonation of intermediate 28 (R = H) 
afforded RC product 29 in 53% yield.  Alternatively, in the absence of the requisite α-
proton (30, R = Me), the in situ generated enolate underwent intramolecular Michael 
addition followed by intramolecular Wittig olefination with the α,β-unsaturated ketone to 
generate bicycle 31 in good yield (76%). 
                                                 
75 Couturier, M.; Ménard, F.; Ragan, J. A.; Riou, M.; Dauphin, E.; Andersen, B. M.; Ghosh, A.; Dupont-
Gaudet, K.; Girardin, M. Org. Lett. 2004, 6, 1857-1860. 
76 McDougal, S. E.; Schaus, S. E. Angew. Chem., Int. Ed. 2006, 45, 3117-3119. 
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Figure 2.5: Divergent reactivity in phosphine-promoted RC reactions.  
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2.3 Intramolecular Rauhut-Currier Reaction 
Although the Rauhut-Currier transformation was first disclosed in 1963, the 
reaction remained relatively undeveloped due to lack of selectivity in cross-coupling 
reactions involving different activated alkenes.  In 1999, Moore and co-workers revealed 
a unique example of an intramolecular transannular RC reaction in the synthesis of 
natural product waihoensene (Section 2.6).77  Then, in 2002 the groups of Roush78 and 
Krische79 presented methodology studies where they resolved the issue of selectivity by 
tethering coupling partners of differing electrophilicity, thereby creating an 
intramolecular Rauhut-Currier (RC) reaction (Scheme 2.10). 
                                                 
77 Erguden, J. K.; Moore, H. W. Org Lett. 1999, 1, 375-377. 
78 Frank, S. A.; Mergott, D. J.; Roush, W. R. J. Am. Chem. Soc. 2002, 124, 2404-2405. 
79 Wang, L.-C.; Luis, A. L.; Agapiou, K., Jang, H.-Y.; Krische, M. J. J. Am. Chem. Soc. 2002, 124, 2402-
2403. 
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Scheme 2.10: Intramolecular RC reaction. 
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Both groups demonstrated that trialkylphosphines were able to catalyze the 
cycloisomerization of five- and six-membered symmetrical and unsymmetrical 
bis(enones) with high efficiency.  Amine-based nucleophiles commonly employed in the 
Morita-Baylis-Hillman reaction of activated alkenes and aldehydes, such as DABCO, 
DBU, Et2NH, and DMAP, were demonstrated to be much less efficient than phosphine-
based nucleophiles in the intramolecular RC reaction.  It was proposed that the lack of 
reactivity of amine-based nucleophiles was due to the softer character of phosphines 
being more suited to soft activated alkene substrates.  In addition, while 
trialkylphosphines (10 mol %) were sufficiently reactive to catalyze the transformation, 
triphenylphosphine (100 mol %) demonstrated inferior reactivity.  The relative order of 
reactivity of phosphine-based catalysts for the intramolecular RC reaction was 
empirically determined: Me3P > Bu3P >> Cy3P >>> PPh3.  Solvent effects were 
examined by both research groups, leading to similar conclusions; undesired by-product 
formation (oligomerization and aldol cyclization) could be minimized or eliminated by 
varying solvents, generally with polar protic solvents providing optimal results and the 
fastest reaction rates.  It is noteworthy that a single set of reaction conditions was not 
applicable to different substrate classes, and modifications were required for optimal 
results in each independent case. 
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The cyclization reaction of symmetrical bis(enones) was facile in the case of 5-
membered ring formation leading to the production of various substituted cyclopentenes 
(Scheme 2.11).  Cyclohexene formation was more difficult, providing slightly lower 
yields and requiring increased catalyst loading in some cases (25 mol %) to maintain 
useful reaction rates.  Roush and co-workers employed trimethylphosphine (eq 7) in 
methylene chloride at ambient temperature to provide products such as 32 (96%) and 33 
(64%).  Krische and co-workers used tributylphosphine in various solvents at ambient 
and elevated temperatures (23-50 ºC) in the analogous cyclization providing aromatic 
cyclopentene products (34, 86% and 35, 95%, eq 8) as well as a variety of aromatic and 
aliphatic cyclohexene products (36, 61-90%). 
Scheme 2.11: Cycloisomerization of 5- and 6-membered symmetrical bis(enones) by Roush (7) 
and Krische (8).    
O
Me
O Me
CH2Cl2, 23 °C
O
Me
Me
O
O
R
O R
PBu3 (10 mol %)
O
R
R
O
n = 1: R = Ph, 2-furyl
n = 2: R = Ph, 4-methoxyphenyl
4-trif luoromethylphenyl
3-naphthyl, 2-furyl
2-thiophene
CH3, CH2CH(CH3)2
(n = 1): 34 (86%), 35 (95%)
(n = 2): 36, 61-90%
32, 96%
33, 64%
(7)
(8)
n n
n = 1 (10 mol %)
n = 2 (25 mol %)
PMe3
n n
EtOAc, acetone, or t-BuOH
23-50 °C
 
The regioselectivity of the RC cycloisomerization of unsymmetric substrates was 
controlled through both electronic and steric differentiation.  For example, Krische and 
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co-workers demonstrated high regioselectivity in 5- and 6-membered ring formation with 
ratios of >95:5 for single isomeric cyclization products (Scheme 2.12).  In the case of 
enone-enoate 37, regioisomeric product 38 was isolated as the sole product in 87% yield.  
Cyclization to provide unsymmetric product 39 from 40 was catalyzed by 
tributylphosphine at elevated temperature (50 ºC) in EtOAc in good yield (75%) as a 
single regioisomeric product as well. 
Scheme 2.12: Electronic control of product distribution in the RC reaction of unsymmetric 
substrates by Krische and co-workers. 
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Roush and co-workers reported similar electronic effects, with the major product 
of cyclization reflecting chemoselective nucleophilic addition of the phosphine catalyst to 
the more electrophilic enone, followed by cyclization on the less reactive Michael 
acceptor (Figure 2.6).  Various substituted cyclopentenes and cyclohexenes were 
generated using either trimethylphosphine or tributylphosphine (20-100 mol %) in 
moderate to excellent yield (32-96%).  For example, facile conversion to compound 41 
was achieved in 95% yield, whereas enal-enoate 42 was more difficult (38%).  Enal-
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enone cyclization to afford cyclohexene product 43 was slightly more efficient (55% 
yield). 
Figure 2.6: RC cyclization of various unsymmetric substrates by Roush and co-workers. 
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In the comparison of five- and six-membered ring formation of unsymmetric 
aromatic-aliphatic bis(enones) 44 and 45, higher chemoselectivity was achieved in the 
case of cyclohexene formation (7:1 vs. 1:1, Scheme 2.13).  It was proposed that trapping 
of the kinetic phosphine Michael adducts in the rapid five-membered ring formation led 
to indiscriminate product formation (1:1).  Alternatively, the attenuated rate in 
homologous six-membered ring formation enabled the electronic effects of the different 
substituents to be reflected in the product distribution (7:1), with cyclization being the 
product- and rate-determining step. 
Scheme 2.13: Kinetic control of product distribution. 
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Furthermore, steric effects were demonstrated in the synthesis geminal dimethyl 
cyclohexene 46 by Krische and co-workers (eq 9, Scheme 2.14) and β,β-disubstituted 
enoate 47, establishing a quaternary center, by Roush and co-workers (eq 10).  In both 
cases, RC transformation proceeded through initial addition to the less hindered enone, 
with the more hindered site serving as the Michael acceptor in the ring-closing step. 
Scheme 2.14: Steric effects in the RC cyclization. 
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Finally, good diastereoselectivity was achieved (10:1) in the cyclization reaction 
of bis(enal) 48, providing desired cyclized product 49 in excellent yield (90%).  Optically 
pure xylose-derived substrate 50 underwent cyclization to provide pentasubstituted 51 as 
a single diastereomer (Scheme 2.15). 
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Scheme 2.15: Diastereoselectivity in the RC cycloisomerization reaction. 
CHO
CHO
TBSO
TBSO
CHO
CHO
TBSO
TBSO
49
dr 10:1
PBu3 (30 mol %)
MeCN, 14 h
90%
48
OBn
OBn
OBn
O
OEt
O
Me
Me
O OEt
O
OBn
OBn
OBn
PBu3 (20 mol %)
t-amyl-OH, 102 °C
71%, >95:5
50 51  
Following the work of the Roush and Krische laboratories, Murphy and co-
workers demonstrated a similar tandem Michael/Michael cyclization reaction. 80  
Symmetrical phenyl and methyl bis(enones) underwent cyclization catalyzed by n-Bu3P 
(20-60 mol %) at ambient temperature to provide the corresponding cyclopentene and 
cyclohexene derivatives in good yields (58-80%, Scheme 2.16).  The homologous 
bis(enone) that would generate a seven-membered ring was resistant to cyclization.  
Additionally, as was observed in the work of Roush78 and Krische,79 bis(enoates) were 
demonstrated to be unreactive under these reaction conditions, while a crossed enone-
enoate substrate was successfully cyclized to provide cyclohexene derivative 53 as the 
only product in good yield (77%). 
                                                 
80 (a) Brown, P. M.; Käppel, N.; Murphy, P. J. Tetrahedron Lett. 2002, 43, 8707-8710. (b) Brown, P. M.; 
Käppel, N.; Murphy, P. J.; Coles, S. J.; Hursthouse, M. B. Tetrahedron 2007, 63, 1100-1106. 
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Scheme 2.16: Tandem Michael/Michael reaction reported by Murphy and co-workers. 
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Murphy and co-workers also examined thiol-mediated catalysis of the identical 
transformations and discovered that upon exposure to both p-TolSH and p-TolSNa in 
refluxing THF, symmetrical bis(phenyl) enone 54 and unsymmetrical enone-enoate 55 
underwent cyclization (Scheme 2.17).  Although the reaction conditions did not enable 
the final catalyst elimination step in the RC reaction, affording products with the thiolate 
promoter covalently incorporated, they uncovered interesting stereochemical information 
regarding the corresponding intermediates in the transformation.  Substrate 54 afforded 
cyclized product 56 as a single stereoisomer, with an all-trans relationship of the three 
contiguous stereocenters.  Enone-enoate 55, on the other hand, provided the analogous 
product 57 with a syn-anti relationship of the ring substituents.  It was suggested that 
cyclization may be reversible in the case of the symmetrical bis(enone) and non-
reversible in the case of the enone-enoate substrate due to the lower acidity of the α-
protons of the resultant ester. 
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Scheme 2.17: Thiol-catalyzed RC transformation by Murphy and co-workers. 
TolSH (0.9 equiv )
TolSNa (0.2 equiv)
54
THF, 16 h, 65 °CPh
O
O
Ph
Ph
O
O
Ph
56, 59%
TolS
TolSH (0.9 equiv )
TolSNa (0.2 equiv)
55
THF, 16 h, 65 °CPh
O
O
OMe
Ph
O
O
OMe
TolS
57, 56%  
In 2005, Roush and co-workers presented a tandem intramolecular 
RC/aldolization reaction.81  The secondary aldol reaction was observed as a by-product in 
their initial study of the RC transformation and was further optimized in this study to 
provide products 58 in good yield (Scheme 2.18).  The high regioselectivity in the aldol 
reaction was attributed to an interaction between the phosphonium moiety and the 
adjacent carbonyl, increasing the acidity of the β-phosphonium-substituted methyl ketone 
leading to intermediate 59 and therefore regioselective deprotonation.  
Scheme 2.18: Tandem intramolecular RC/aldol reaction. 
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81 Thalji, R. K.; Roush, W. R. J. Am. Chem. Soc. 2005, 127, 16778-16779. 
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2.4 Enantioselective RC Reactions 
Although progress in the development of this forty-five year old reaction has been 
slow due to difficulties in controlling reactivity, it has recently become a potentially more 
useful reaction with the advent of an intramolecular variant.  In 2007, Miller and co-
workers82 were able to contribute to the further advancement of this transformation by 
establishing a method to perform an enantioselective Rauhut-Currier reaction in high 
yield and enantioselectivity using convenient reagents and conditions.  This report also 
documented the first use of a simple cysteine (Cys) derivative as an asymmetric catalyst. 
Aroyan and Miller discovered that Cys-based amino acid 60 was able to catalyze 
the cycloisomerization of symmetrical and unsymmetrical bis(enones) in the presence of 
potassium t-butoxide in acetonitrile with synthetically useful enantioselectivities and 
yields within 24 h (Figure 2.7).  Notably, the incorporation of a precise quantity of water 
(20 equiv) had a dramatic effect on enantioselectivity.  Systematic optimization of 
various reaction parameters, including solvent, concentration, base, and temperature, led 
to the optimal conditions which afforded cyclized product 61 in 95% ee and 70% yield.  
The cycloisomerization was extended to include electron-deficient (62, 70%, 93% ee; 63, 
71%, 84% ee) and electron-rich (64, 73%, 90% ee) aryl symmetrical bis(enones), as well 
as aliphatic (65, 55%, 90% ee) and heteroaromatic (66, 54%, 92% ee) bis(enones) while 
maintaining high enantioselectivity and good efficiency.  The reaction of unsymmetrical 
substrate 67 resulted in reduced enantioselectivity and yield.  Additionally, the use of 
substoichiometric catalyst loading (20 mol %) provided comparable results, with 
                                                 
82 Aroyan, C. E.; Miller, S. J. J. Am. Chem. Soc. 2007, 129, 256-257. 
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attenuated rate observed only when a further reduction in catalyst loading was utilized 
(10 mol %). 
Figure 2.7: Substrate scope in the enantioselective RC cyclization. 
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In order to provide a plausible mechanism of stereoinduction, two experiments 
were performed to guide in the formation of a transition state model.  First, when the 
cycloisomerization of bis(enone) 68 was run under optimized conditions in the presence 
of 18-crown-6, unconjugated by-product 69 (vs. 61) was isolated as the predominant 
product (26% yield, 84% ee) suggesting that potassium ion chelation was essential in the 
formation of desired RC product (Scheme 2.19). 
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Scheme 2.19: RC cyclization under optimized conditions with 18-C-6. 
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In the second experiment, the optimized cycloisomerization reaction was 
interrupted after 2 h, providing desired product 61 (29% yield, 95% ee) in addition to a 
mixture of five diastereomers of intermediate 70 (Scheme 2.20).  The mixture was then 
subjected to oxidation and elimination under irreversible conditions (i. mCPBA, ii. NaH), 
which afforded desired product 61 with reduced enantioselectivity of 40% ee.  It is 
therefore possible that carbon–carbon bond formation is reversible and that abstraction of 
the α-H atom and extrusion of the catalyst may be the first irreversible and 
stereochemical-determining step. 
Scheme 2.20: Elimination of Cys-based catalyst under irreversible conditions. 
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Based on these experiments, it was suggested that favored transition state 71 
benefits from a more stable potassium chelate between the enolate oxygen and the amide 
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carbonyl of the catalyst, leading to a faster rate of elimination and subsequent formation 
of 61 with high enantiomeric excess (Figure 2.8). 
Figure 2.8: Proposed transition state to explain the obtained enantioselectivity. 
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Later in the same year, Gladysz and co-workers presented a phosphine-catalyzed 
enantioselective intramolecular RC reaction of symmetrical bis(enone) 73 and 74 
(Scheme 2.21).83  It was proposed that the 18-electron rhenium fragment increased the 
Lewis basicity and nucleophilicity of the phosphorous donor atom (CH2PPh2) in the 
active catalyst (η5-C5H5)Re(NO)(PPh3)(CH2PPh2) (75).  Using catalyst 75 (10 mol %), 
cycloisomerization of the bis(phenyl)ketone and bis(thioester) provided compounds 76 
and 77, respectively, in good yield (67% and 81%) and with enantioselectivities of 56% 
and 52% ee. 
Scheme 2.21: Rhenium-containing phosphine-catalyzed enantioselective intramolecular RC 
reaction. 
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83 Seidel, F.; Gladysz, J. A. Synlett 2007, 6, 986-988. 
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2.5 Extension to Include Alternative Electrophilic Partners 
Exciting advances have also been made in the extension of the traditional RC 
transformation to include alternative non-classical electrophilic partners.  In 2001, 
Basavaiah and co-workers incorporated the use of (Z)-allyl halides (chlorides and 
bromides) as coupling partners in the synthesis of 3-substituted 2,4-functionalized 1,4-
pentadienes (Scheme 2.22).84  Researchers proposed generation of the desired products 
(78) via unique reactivity in the RC transformation.  They suggested that DABCO 
underwent reaction with both acrylonitrile and the requisite allyl halide to provide 
intermediates 79 and 80.  Subsequently, 80 underwent SN2’ displacement of DABCO by 
zwitterionic species 79.  Finally, elimination of a second equivalent of DABCO provided 
the desired 1,4-pentadienes in moderate to good yields (78, 36-67%).  Simple allyl 
bromides, such as 3-bromoprop-1-ene, were unreactive under analogous conditions (23 
ºC, 7 d).  No further studies were presented in support of the proposed mechanism. 
Scheme 2.22: Extension of the RC reaction to include allyl halides as electrophilic partners. 
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In another report, Basavaiah and co-workers expanded the scope to produce 2,4-
functionalized 1,4-pentadienes without substitution at the 3-position (Scheme 2.23).85  In 
the presence of a tertiary amine (DABCO or DBU), they illustrated the coupling alkyl 2-
                                                 
84 Basavaiah, D.; Kumaragurubaran, N.; Sharada, D. S. Tetrahedron Lett. 2001, 42, 85-87. 
85 Basavaiah, D.; Sharada, D. S.; Kumaragurubaran, N.; Reddy, R. M. J. Org. Chem. 2002, 67, 7135-7137. 
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(bromomethyl)prop-2-enoates with various activated alkenes, including methyl vinyl 
ketone, acrylonitrile, alkyl acrylates, and cyclohex-2-en-1-one.  DABCO was also 
employed successfully by Lee and Lee in the coupling of dihalonaphthoquinones with 
methyl vinyl ketone and methyl acrylate to form α-vinylquinones.86 
Scheme 2.23: Synthesis of 2,4-functionalized 1,4-pentadienes. 
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Krische and co-workers have presented a two-component catalyst system to 
combine the nucleophilic features of the MBH-type reaction with the electrophilic 
features of the Trost-Tsuji reaction to effect a catalytic enone cycloallyation (Figure 
2.9).87  In this derivative of the RC reaction, an allylic carbonate activated by palladium-
π–allyl formation has been employed as a latent electrophilic partner, with an enone 
activated by phosphine addition as the latent nucleophilic partner.   A variety of enone-
allylic carbonates, including aromatic, heteroaromatic, and aliphatic enones, were 
subjected to stoichiometric tributylphosphine and catalytic quantities of (Ph3P)4Pd (1 mol 
%) to afford the corresponding five- or six-membered ring cycloallylated products in 
good to excellent yields (82, 64-92%).  Although enoates were found to be unreactive in 
this system, the related thioenoates were viable substrates (73% yield).88 
                                                 
86 Lee, C. H.; Lee, K.-J. Synthesis 2004, 12, 1941-1946. 
87 Jellerichs, B. G., Kong, J.-R.; Krische, M. J. J. Am. Chem. Soc. 2003, 125, 7758-7759. 
88 Keck and co-workers pioneered the use of thioenoates in the MBH reaction, see: Keck, G. E.; Welch, D. 
S. Org. Lett. 2002, 4, 3687-3690. 
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Figure 2.9: Cycloallylation of enones using the two-component catalyst system of phosphine and 
palladium. 
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Another interesting variant reported by Krische and co-workers involved the use 
of p-nitrophenyl substituted vinylsulfones as the electrophilic coupling partner with a 
variety of enones and thioenoates (Scheme 2.24). 89  Cyclopentene and cyclohexene 
products 83 were afforded in good to excellent yield (74-97%) using 10-20 mol % 
tributylphosphine.  Reaction temperature and solvent were substrate dependent and 
required individual optimization.  
Scheme 2.24: Extension of the RC reaction to include vinylsulfone coupling partners. 
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In work similar to Basavaiah’s, Krafft and Haxell have demonstrated the direct 
use of allyl halides as electrophiles in the intramolecular RC reaction (Scheme 2.25).90  
Tributylphosphine (100 mol %) was used to promote the cyclization of various enones 
                                                 
89 Luis, A. L.; Krische, M. J. Synthesis 2004, 15, 2579-2585. 
90 Krafft, M. E.; Haxell, T. F. N. J. Am. Chem. Soc. 2005, 127, 10168-10169. 
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with primary and secondary allylic chlorides in t-BuOH under phase transfer conditions 
(KOH, BnEt3NCl) to afford both mono- and disubstituted alkenes 84 in good to excellent 
yields (74-94%).  In analogy to the work presented by the groups of Roush and Krische 
in the intramolecular RC reaction, amine-based catalysts (DABCO, quinuclidine, DBU, 
and DMAP) were found to be inefficient catalysts.  The use of allylic mesylates and 
tosylates was inferior to allylic chlorides, which were generated in situ from the 
corresponding enone-allylic alcohols using thionyl chloride. 
Scheme 2.25: Intramolecular RC cycloisomerization of enones and allylic leaving groups.  
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Thus far, the Morita-Baylis-Hillman and Rauhut-Currier transformations have 
involved the coupling of activated alkenes with highly reactive sp2 hybridized carbon 
electrophiles, including aldehydes, α-keto esters, 1,2-diketones, enones, enoates, vinyl 
sulfones, allylic carbonates, and allylic halides.  In 2005, Krafft and co-workers 
incorporated a new class of electrophiles into the expanding list of viable coupling 
partners; 91  researchers successfully promoted the phosphine-catalyzed RC 
cycloisomerization reaction of activated alkenes with sp3 hybridized electrophiles 
(Scheme 2.26).  The formation of both five- and six-membered enone cycloalkylation 
products 85 was performed in a stepwise procedure in excellent yields (79-99%) using 
                                                 
91 Krafft, M. E.; Seibert, K. A.; Haxell, T. F. N.; Hirosawa, C. Chem. Commun. 2005, 5772-5774. 
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stoichiometric tributylphosphine in t-BuOH followed by the addition of aqueous base 
under phase transfer conditions.  In a related report, researchers were able to perform the 
reaction using substoichiometric phospine (20 mol %) by demonstrating that all the 
required components of the transformation were compatible, enabling a one-step 
procedure under similar conditions (KOH, BnEt3NCl, t-BuOH-CH2Cl2).92  Comparable 
results were obtained under lower catalyst loading, with PBu3 as the optimal catalyst for 
five-membered ring formation and PMe3 optimal for six-membered ring formation.  The 
direct reaction of phosphine with the alkyl halide to generate a phosphonium salt was 
discounted through control experiments. 
Scheme 2.26: Direct intramolecular α-alkylation of enones. 
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Intermediate ketophosphonium salt 86 was isolated in a later study by the same 
authors, lending credence to the proposed MBH/RC reaction mechanism.93  Potential 
transition state conformations leading to the observed trans-configuration of the 
intermediate did not include the potentially beneficial oxygen-phosphorous electrostatic 
interaction.  The authors suggested that this interaction, which has been involved in many 
MBH mechanistic discussions, may not be the overriding influence in defining the 
stereochemical outcome of the cyclization and may not be necessary for a successful 
transformation. 
                                                 
92 Krafft, M. E.; Seibert, K. A. Synlett 2006, 3334-3336. 
93 Krafft, M. E.; Haxell, T. F. N.; Seibert, K. A.; Abboud, K. A. J. Am. Chem. Soc. 2006, 128, 4174-4175. 
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Expanding upon the use of sp3 hybridized electrophiles, Krafft and Wright 
reported the incorporation of an epoxide as the electrophilic partner in the intramolecular 
RC transformation, giving rise to homologous aldol adducts.94  As illustrated in Figure 
2.10, RC cyclization of the epoxy enone could proceed to generate either alcohol 87 
(from exo ring opening of the epoxide) or alcohol 88 (from endo ring opening).  
Investigation of several phenyl and methyl enones demonstrated that substitution on the 
epoxide or the tether was required for high endo/exo selectivity in the cyclization step, 
providing various cyclopentene and cyclohexene derivatives in good yield (43-92%).  A 
control experiment confirmed that phosphine was not reacting directly with the epoxide 
and that the transformation proceeded through the traditional RC mechanistic pathway 
where conjugate addition of trimethylphosphine generated a zwitterionic enolate 
followed by epoxide opening.  The final deprotonation/elimination of the catalyst was 
proposed to be promoted by the resultant alkoxide. 
Figure 2.10: Intramolecular RC cyclization via epoxide ring opening 
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94 Krafft, M. E.; Wright, J. A. Chem. Commun. 2006, 2977-2979. 
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A further extension of the RC reaction to include an alternative latent nucleophile 
(vs. the original α,β-unsaturated enone) was presented by Miller and co-workers. 95  
Divergent reactivity was demonstrated such that the phosphine-catalyzed reaction of 
enone 89 and allenic ester 90 afforded the corresponding [3+2]-cycloadduct. 96  
Alternatively, the amine-catalyzed coupling (quinuclidine, 10 mol %) of various α,β-
unsaturated carbonyls with allenoate 90 in toluene at ambient temperature underwent a 
traditional RC pathway, providing α,α’-disubstituted allenoates (91) in good to excellent 
yields (50-96%; Figure 2.11).  A three-component coupling reaction was demonstrated 
with several aldehydes 92, acrylate 93, and allenoate 90, affecting a MBH-RC tandem 
reaction sequence with good yields (94, 60-88%). 
Figure 2.11: Coupling of allenic esters and various α,β-unsaturated carbonyl compounds. 
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This methodology was expanded to include the coupling of α-amino acid derived 
vinyl ketones with allenic esters to provide a diverse range of α,α’-disustituted allenoates 
                                                 
95 Evans, C. A.; Miller, S. J. J. Am. Chem. Soc. 2003, 125, 12394-12395. 
96 Du, Y.; Lu, X.; Yu, Y. J. Org. Chem. 2002, 67, 8901-8905. 
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95 (76-86%, Scheme 2.27).97  Allenic ester products were then elaborated to provide 
synthetically interesting chiral azacycles (96, 82-97%) through a deprotection/7-endo-dig 
cyclization-isomerization reaction sequence. 
Scheme 2.27: Synthesis of azepines from allenoate-enone coupling products. 
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2.6 Application in Total Synthesis 
The Rauhut-Currier reaction and its derivatives have the ability to establish 
complex ring systems with multiple stereogenic centers.  While the development of this 
transformation has been slow due to highly substrate dependent yields and low reaction 
rates, the introduction of an intramolecular variant had a great affect on the utility of the 
reaction, as illustrated by its use in the synthesis of several natural products. 
As noted above, in 1999, Moore and co-workers98 demonstrated an interesting 
and unique application of the first intramolecular RC reaction in the synthesis of a fused 
tetraquinane ring system en route to the synthesis of natural product waihoensene 
(Scheme 2.28).  The cycloisomerization of tricyclic bis(enone) 97 catalyzed by 
thiophenol and sodium thiophenolate provided angularly fused tetraquinane 98 was in 
excellent yield (93%Scheme 2.28).  The transformation was believed to proceed through 
a tandem sequence of reactions, including initial conjugate addition of the thiolate 
                                                 
97 Evans, C. A.; Cowen, B. J.; Miller, S. J. Tetrahedron 2005, 61, 6309-63. 
98 Erguden, J. K.; Moore, H. W. Org Lett. 1999, 1, 375-377. 
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followed by transannular Michael reaction to provide intermediate 99, and finally an 
intramolecular E2 trans-diaxial elimination reaction to produce desired product 98 and 
regenerate the thiophenolate catalyst. 
Scheme 2.28: Synthesis of the tetraquinane ring system of waihoensene. 
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Interestingly, in a very similar transformation involving homolog 100 (containing 
a five-membered ring versus a six-membered ring), the requisite intermediate was no 
longer in proper alignment for the elimination reaction and product 101 was isolated 
when a stoichiometric quantity of thiophenol was employed (Scheme 2.29).  The covalent 
trapping of the catalyst is more representative of general thiol-based catalysis in 
MBH/RC-type transformations.99 
Scheme 2.29: Synthesis of tetraquinane ring system without elimination of the catalyst. 
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99 Basavaiah, D.; Rao, A. J.; Satyanarayana, T. Chem. Rev. 2003, 103, 811-891. 
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Krische and Agapiou demonstrated the use of highly reactive and chemoselective 
thioenoates in the RC transformation in the synthesis of the furanosequiterpene lactone 
(±)-ricciocarpin A (Scheme 2.30). 100   While the phosphine-catalyzed cross Michael 
reaction of enoate-enone 102 was unreactive, the analogous thioenoate-enone substrate 
(103) demonstrated heightened reactivity, as well as exquisite chemoselectivity, to 
provide desired cyclized product 105 in 81% yield.  Cyclohexene 105 was elaborated to 
the natural product in 3 steps. 
Scheme 2.30: Synthesis of (±)-ricciocarpin A by Krische and co-workers.  
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In 2004, Roush and co-workers reported the total synthesis of (-)-spinosyn A 
featuring a diastereoselective transannular Rauhut-Currier reaction (Scheme 2.31).101  An 
intramolecular Horner-Wadsworth-Emmons macrocyclization reaction followed by a 
transannular Diels-Alder reaction generated the RC substrate, 106.  The RC ring 
contraction was effected with trimethylphosphine (8 equiv) in tert-amyl-alcohol and 
proceeded with excellent diastereoselectivity in the generation of the C3-C14 carbon–
carbon bond.  Desired product 107 was provided with only minimal amounts of the C(3) 
epimer of 107 and olefin migration product 108 (88:5:7). 
                                                 
100 Agapiou, K.; Krische, M. J. Org. Lett. 2003, 5, 1737-1740. 
101 (a) Mergott, D. J.; Frank, S. A.; Roush, W. R. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 11955-11959. (b) 
Methot, J. L.; Roush, W. R. Adv. Synth. Catal. 2004, 346, 1035-1050. 
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Scheme 2.31: Synthesis of (-)-spinosyn A by Roush and co-workers. 
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In studies leading up to the successful synthesis of (-)-spinosyn A, Roush and co-
workers presented various studies of the transannular RC reaction in the generation of the 
as-indacene core.102  For example, olefin geometry had a critical effect on the product 
distribution in the phosphine-catalyzed cyclization of enone-enoate 109 (Table 2.1).  
Cyclization of the (E)-enoate bicyclic precursor in CH2Cl2 provided approximately a 2:1 
mixture of desired tricycle 110 and olefin migration by-product 111, in addition to 
regioisomeric tricycle 112.  Excitingly, when the alternative (Z)-enoate precursor was 
employed in the cyclization with trimethylphosphine in tert-amyl alcohol, researchers 
were able to obtain the desired cyclization product in good yield (86%) and excellent 
chemoselectivity (96:4), with only trace amounts of the olefin migration by-product.  
Cycloisomerization of the (E)-enoate was examined in various solvents, with CH2Cl2 
providing the best results.  It was proposed that the change in olefin geometry to the (Z)-
                                                 
102 Mergott, D. J.; Frank, S. A.; Roush, W. R. Org. Lett. 2002, 4, 3157-3160. 
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enoate resulted in restricted orbital alignment, which suppressed γ-deprotonation and 
therefore minimized formation of the olefin migration by-product. 
Table 2.1: RC cyclization with (Z)- and (E)-enoates.  
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In an effort to synthesize antimitotic agent FR182877, Roush and co-workers 
illustrated the use of an intramolecular RC cycloisomerization to generate the 
as-indacene ring of this natural product.103  RC cyclization of enone-enoate 113 under 
previously optimized conditions (t-amyl-OH) was unsuccessful and underscored the 
substrate dependence of this transformation (Table 2.2).  Optimization of the reaction 
conditions revealed a dramatic solvent effect.  Poor selectivity was obtained among the 
desired cyclization product (114), the olefin migration product (115), and regioisomeric 
product 116 when the reaction was performed in t-amyl alcohol (58:8:34).  On the other 
hand, exquisite selectivity was obtained when the reaction was performed in THF-H2O 
(3:1) with 2 equiv tributylphosphine providing exclusively desired product 114.  
Interestingly, when the reaction was performed in 2,2,2-trifluoroethanol under otherwise 
identical reaction conditions, exclusive formation of regioisomeric product 116 was 
                                                 
103 Methot, J. L.; Roush, W. R. Org. Lett. 2003, 5, 4223-4226. 
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observed.  Additionally, in hexamethylphosphoramide (HMPA) olefin migration product 
115 was isolated as the major product. 
Table 2.2: Studies of the intramolecular RC reaction in the synthesis of FR182877. 
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The optimal reaction conditions (THF-H2O) were amenable to the more advanced 
model system, 117, in the synthetic studies toward FR182877, providing desired 
cyclization product 118 in 84% yield with 6:1 diastereomeric ratio (118:119) (Scheme 
2.32). 
Scheme 2.32: Advanced model system in the synthetic studies of FR182877. 
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Sorensen and co-workers demonstrated the use of a tertiary amine-catalyzed RC 
transformation in the successful synthesis of (+)-harziphilone (Figure 2.12).104  Under 
mild catalysis with DABCO (10 mol %), they were able to promote the selective 
cyclization reaction to generate the bicyclic natural product.  The mechanism of the 
bicycloisomerization was proposed to proceed via reversible conjugate addition of 
DABCO to the unsubstituted enone system of 120 followed by intramolecular Michael 
addition to afford zwitterion 122 after a proton transfer of the generated allenolate ion.  
The reaction could proceed through a traditional MBH-RC mechanism, such that β-
elimination would provide 123 with regeneration of the catalyst, enabling a subsequent 
6π-electrocyclization to provide the natural product.  Alternatively, an intramolecular 
displacement of DABCO from intermediate 122 could be envisioned to lead directly to 
(+)-harziphilone. 
                                                 
104 Stark, L. M.; Pekari, K.; Sorensen, E. J. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 12064-12066. 
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Figure 2.12: Synthesis of (+)-harziphilone by Sorensen and co-workers. 
O
CH3
O
HO
HO
H3C
O
HO
HO
H3C
O
O
HO
HO
H3C
O
DABCO (10 mol %)
CHCl3, rt, 24 h, 70%
N
N
CH3 CH3
O
CH3
O
HO
HO
H3C
N
N
intermolecular
1,4-addition
intramolecular
1,4-addition
proton transfer
(+)-harziphilone
O
CH3
O
HO
HO
H3C
123
β-elimination
Intramolecular
substitution
6π-electrocyclization
120 121 122
 
2.7 Conclusion 
The Rauhut-Currier reaction predates the Morita-Baylis-Hillman reaction by five 
years, however, with the great difficulty in controlling the selectivity of this reaction its 
widespread application has been limited.  Successful dimerization of various enones and 
enoates has been achieved, yet with great potential to improve upon reactivity and 
breadth of viable substrates.  The last five years has seen substantial growth in the RC 
methodology with the advent of the intramolecular variant, dramatically improving the 
utility of this transformation.  Moreover, the development of an enantioselective variant 
has further enhanced the utility of this reaction and presented many possibilities in the 
realm of stereoselective carbon–carbon bond formation.  Looking to the future, many 
opportunities persist for multidimensional growth in the development of an 
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enantioselective intermolecular version and continued expansion of substrate class in the 
enantioselective intramolecular version.  Finally, the extended application of the RC 
reaction in complex molecule synthesis will remain the final frontier and serve as 
inspiration in the design of new substrate classes. 
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3 Development of the Enantioselective Rauhut-Currier 
Reaction 
3.1 Introduction 
Research efforts in our laboratory have taken place in the proverbial classroom of 
nature, as we glean inspiration from the ability of enzymes to exert exquisite control over 
a multitude of transformations critical to everyday function.  As introduced in Chapter 1, 
we have been greatly interested in harnessing the power of biosynthetic tools in the form 
of small peptide-based nucleophilic catalysts for synthetic organic transformations.105  
Through the development of the enantioselective Morita-Baylis-Hillman reaction we 
were able to expand our synthetic tool box further to include not only a new co-catalytic 
system (pipecolinic acid/N-methylimidazole (NMI)), but a new class of transformations 
as well, namely the formation of a carbon–carbon bond. 
Although our progress in the intramolecular MBH reaction led to state-of-the-art 
levels of enantioselectivity, the reaction is still in its infancy.  Inspired by our findings 
and our initial success, we sought to expand this methodology even further to aid in the 
development of this class of C–C bond forming reactions.  Specifically, we sought to 
create an enantioselective variant of the Rauhut-Currier (RC) reaction with the goal of 
providing a method to access highly functionalized enantiopure ring systems.106  The 
                                                 
105 For a review of the use of peptides as asymmetric catalysts, see: (a) Davie, E. A. C.; Mennen, S. M.; Xu, 
Y.; Miller, S. J. Chem. Rev. 2007, 107, 5759-5812. (b) Miller, S. J. Acc. Chem. Res. 2004, 37, 601-610 and 
references therein. 
106 For selected reviews, please see: (a) Drewes, S. E.; Roos, G. H. P. Tetrahedron 1988, 44, 4653-4670. (b) 
Basavaiah, D.; Rao, P. D.; Hyma, R, S. Tetrahedron 1996, 52, 8001-8062. (c) Basavaiah, D.; Rao, A. J.; 
Satyanarayana, T. Chem. Rev. 2003, 103, 811-891. 
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Rauhut-Currier reaction, also known as the vinylogous MBH reaction,107 involves the 
coupling of two activated alkenes compared to the coupling of an activated alkene and an 
aldehyde, as in the MBH reaction (Figure 3.1). 
Figure 3.1: Morita-Baylis-Hillman and Rauhut-Currier Reactions. 
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The development of methods for the formation of new carbon–carbon bonds as 
well as functional group transformations is central to the successful synthesis of target 
molecules.  For this reason, both of these transformations hold great potential of 
becoming indispensable reactions in organic synthesis.  Furthermore, the Morita-Baylis-
Hillman and Rauhut-Currier reactions are of specific interest due to their ability to 
generate a new C–C bond in an atom economical manner, while generating a new 
stereogenic center and densely functionalized products that have served as substrates for 
                                                 
107  Fuson, R. C. Chem. Rev. 1935, 16, 1-27. The definition of vinylogy is the transmission of 
stereoelectronic effects through conjugation. “The influence of a functional group may be felt at a distant 
point in the molecule when this position is connected by conjugated double bond linkages to the 
group...this concept allows the extension of the electrophilic or nucleophilic character of a functional group 
through the π-system of a carbon–carbon double bond.”  Although the term “vinylogous Morita-Baylis-
Hillman” reaction has been used interchangeably with Rauhut-Currier in the literature, we have chosen to 
refer specifically to the coupling of two activated olefins through 1,4-addition as the Rauhut-Currier 
reaction, whereas the MBH reaction involves 1,2-addition.  We make this distinction to emphasize the 
multidimensional differences between the two reactions 
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a multitude of subsequent transformations.108  Although this class of reactions has been 
known in the scientific community for over four decades, these reactions still present 
many opportunities for multidimensional growth (Figure 3.2).109  The development of a 
robust asymmetric version will require the design of highly efficient chiral catalysts, able 
to promote the coupling reaction of many diverse partners.  Progress in the intramolecular 
(as well as asymmetric intramolecular) variant of both reactions will provide 
opportunities for the design of novel substrates leading to complex products with multiple 
stereogenic centers.  Finally, the dense functionality present in the MBH and RC products 
offers many possibilities for further elaboration and the synthesis of natural products as 
well as nonnatural target molecules. 
Figure 3.2: Opportunities for advancement in the MBH and RC reactions. 
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108 (a) Lee, K. Y.; Gowrisankar, S.; Kim, J. N. Bull. Kor. Chem. Soc. 2005, 26, 1481-1490. (b) Masson, G.; 
Housseman, C.; Zhu, J. Angew. Chem., Int. Ed. 2007, 46, 4614-4628. 
109 Basavaiah, D.; Rao, K. V.; Reddy, R. J. Chem. Soc. Rev. 2007, 36, 1581-1588. 
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Importantly, until our report in 2007, the asymmetric Rauhut-Currier reaction was 
unknown. 110   Herein, we present the natural extension of the intramolecular MBH 
reaction to allow the use of vinylogous reaction partners in the Rauhut-Currier reaction 
and demonstrate the use of a single amino acid derivative of cysteine as a highly selective 
catalyst to provide cyclized products in up to 70% yield and 95% ee.111 
3.2 Development of the Enantioselective Intramolecular RC 
Reaction 
3.2.1 Nitrogen-Based Nucleophiles 
Our study of the intramolecular Rauhut-Currier reaction commenced with the 
investigation of the cycloisomerization shown in Scheme 3.1.  In analogy to our findings 
in the Morita-Baylis-Hillman reaction,112 we were intrigued with the possibility of using 
our optimized co-catalytic system (pipecolinic acid/N-methylimidazole (NMI)) and protic 
reaction conditions (THF-H2O) to extend the MBH methodology to include a vinylogous 
reaction partner. 
Scheme 3.1: Intramolecular Rauhut-Currier reaction. 
Ph
O
O
Ph
Ph
O ∗
O
Ph
1 2
N ucleophilic Catalyst
 
                                                 
110 Gladysz and co-workers reported a moderately enantioselective intramolecular RC reaction later in the 
same year: Seidel, F.; Gladysz, J. A. Synlett 2007, 6, 986-988.  Please refer to Chapter 2 for a full 
discussion. 
111 Aroyan, C. E.; Miller, S. J. J. Am. Chem. Soc. 2007, 129, 256-257. 
112 Please refer to Chapter 1 for a detailed discussion of our development of an enantioselective MBH 
reaction. 
  
- 115 - 
 
From previous reports in the literature, we began our investigation with the 
knowledge that the RC cycloisomerization differs in reactivity when compared to its 
MBH counterpart.106  For example, trialkylphosphines were reported to be sufficiently 
reactive to catalyze the cycloisomerization of bis(enone) 1 to 2.  On the other hand, 
triarylphosphines were unreactive.  Additionally, nitrogen-based nucleophiles, which 
were traditionally successful catalysts of the MBH reaction, were incapable of catalyzing 
the analogous RC cyclization reaction (Scheme 3.2).113 
Scheme 3.2: Phosphine- and nitrogen-based catalysis of the RC reaction. 
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Despite reports that amine-based nucleophiles were ineffective at catalyzing this 
vinylogous reaction, we had previously displayed an impressive enhancement of 
reactivity in the MBH reaction by employing combination catalysis.  Therefore, we were 
prompted to examine co-catalytic amines once again with the hope that the RC 
cyclization would benefit from a similar heightened reactivity.  Accordingly, bis(enone) 1 
                                                 
113 (a) Frank, S. A.; Mergott, D. J.; Roush, W. R. J. Am. Chem. Soc. 2002, 124, 2404-2405. (b) Wang, L.-
C.; Luis, A. L.; Agapiou, K., Jang, H.-Y.; Krische, M. J. J. Am. Chem. Soc. 2002, 124, 2402-2403. 
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was subjected to the previously optimized reaction conditions (THF-H2O, 3:1) employing 
N-methylimidazole (NMI) (entry a, Figure 3.3), pipecolinic acid (entry b), and the co-
catalytic combination of NMI/pipecolinic acid (entry c).  Unfortunately, we were not able 
to successfully promote the cycloisomerization reaction employing these conditions, and 
under forcing conditions (65 °C, 48 h) we obtained significant decomposition of the 
starting material.  The co-catalytic combination of NMI/proline114 was examined as well, 
however, it provided similar results with no reaction at room temperature and 
decomposition upon heating (entry d). 
Figure 3.3: Investigation of co-catalysis in the RC cyclization. 
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3.2.2 Phosphorous-Based Nucleophiles 
Undaunted by the ineffectiveness of our amine-based catalysts, we turned to the 
more reactive phosphine-based catalysts, mindful that the steric and electronic 
environment would play a critical role in reactivity.  In analogy to previous work in our 
laboratory, where a nucleophilic moiety (NMI) was incorporated into small peptide-based 
                                                 
114 For the use of NMI/proline in the MBH reaction, please refer to Chapter 1 and the references therein. 
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catalysts (as a modified histidine residue) to confer high levels of enantioselectivity,105 
we were intrigued with the possibility of employing a similar chiral phosphine-based 
catalyst in the RC reaction.  In this sense, we were interested in determining if we could 
use a phosphine-containing amino acid or peptide catalyst to promote an enantioselective 
variant of the Rauhut-Currier reaction by taking advantage of the chiral environment 
provided by the amino acid or peptide secondary structure (Scheme 3.3). 
Scheme 3.3: Chiral phosphine catalyst to promote an enantioselective RC reaction? 
Chiral Phosphine-containing
amino acid or peptide catalyst?
Reactivity, Enantioselectivity?
Ph
O
O
Ph
Ph
O
∗
O
Ph
1 2
 
We began our study by focusing on diaryl phosphine-containing peptides due to 
their relative stability (compared with trialkylphosphines).  Specifically, we were 
interested in using the known chiral phosphine-based amino acid 
diphenylphosphinoserine (Pps, 7) which contains a β-stereogenic center.  Gilbertson and 
co-workers have pioneered the use of Pps by incorporating the amino acid into peptides 
used as phosphorous-based metal ligands for various transformations such as 
hydrogenation and alkylation.115  Following Gilbertson’s work, Pps was synthesized in 
four steps from commercially available Boc-Ser.  Protection of the amino acid as the 
corresponding methyl ester (4, quantitative), was followed by conversion to Boc-
                                                 
115  (a) Gilbertson, S. R.; Chen, G.; McLoughlin, M. J. Am. Chem. Soc. 1994, 116, 4481-4482. (b) 
Greenfield, S. J.; Gibertson, S. R. Synthesis 2001, 15, 2337-2340. (c) Agarkov, A.; Greenfield, S. J.; Xie, 
D.; Pawlick, R.; Starkey, G.; Gilbertson, S. R. Biopolymers: Pept. Sci. 2006, 84, 48-73. 
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protected 3-iodo-alanine methyl ester 5 (68%).  Subsequently, 5 was converted to the 
zinc iodide with activated zinc and then treated with a stoichiometric amount of 
CuCN·2LiCl to create a reactive zinc/copper species.  Addition of 
chlorodiphenylphosphine and protection of the phosphine as the sulfide provided 
enantiomerically pure Pps(sulfide) 6 in 64% yield.  The less stable, desired Pps amino 
acid (7) was liberated prior to use by reaction with Raney nickel (Scheme 3.4).116 
Scheme 3.4: Chiral phosphine-containing amino acid (Pps) preparation. 
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Prior to testing the chiral amino acid (7), it was imperative to establish the level of 
reactivity of phosphines in the RC reaction.  As previously described, trialkylphosphines 
have been reported to catalyze the cycloisomerization of bis(enone) 1 to 2, while 
triarylphosphines were not reactive enough and provided only recovered starting material 
(Scheme 3.2).  Therefore, methyldiphenylphosphine (MePh2P), the achiral counterpart to 
Pps, was tested as a model catalyst to provide insight into the relative reactivity of 
various substituted phosphines.  Bis(enone) 1 was thus subjected to MePh2P 
                                                 
116 Pps is not as air-sensitive as trialkylphosphines, however, it was found that Pps will oxidize completely 
to the corresponding diphenylphosphinoserine-oxide within 24 h when exposed to air. 
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(100 mol %), providing promising results in various solvents (acetone, THF-H2O, or 
ethanol); the RC reaction underwent full conversion to the desired product within 12 
hours (Figure 3.4).  Encouraged by this initial data, we briefly investigated the possibility 
of employing combination catalysis with this new phosphine-based nucleophilic moiety.  
Therefore, bis(enone) 1 was subjected to MePh2P in combination with pipecolinic acid 
(as in the MBH reaction), however preliminary experimentation suggested the presence 
of pipecolinic acid was deleterious to the phosphine-promoted RC reaction and resulted 
in less than 50% conversion to 2.  
Figure 3.4: Catalysis of 1 to 2 with achiral MePh2P. 
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Having established sufficient catalysis of the desired cyclization reaction with the 
model catalyst, methyldiphenylphosphine, we next examined catalysis employing the 
chiral variant, amino acid 7 (Figure 3.5).  Unfortunately, the reactivity of MePh2P did not 
translate to the amino acid and upon exposure of bis(enone) 1 to Pps at room temperature, 
only 5% conversion to 2 was obtained.  We hypothesized that steric demand near the 
phosphorous center, and the inductive electron-withdrawing affect of the amino acid 
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functionality, interfered with productive enone addition.  Thus, the less hindered and 
electronically more reactive homo-Pps (8) was synthesized and tested.117  However, this 
single amino acid catalyst was only modestly more reactive (30% conversion) and, not 
surprisingly, did not induce enantioselectivity.  Consequently, we determined the relative 
order of reactivity of phosphine nucleophiles in this RC cyclization to increase with the 
number of aliphatic substituents, with the amino acid of interest being unreactive in the 
Rauhut-Currier reaction: Bu3P > MePh2P >>> homo-Pps >> Pps > Ph3P.  
Figure 3.5: Catalysis of the RC reaction with catalysts 7 and 8. 
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3.3 Chalcogenides 
3.3.1 Overview of Chalcogenides in MBH-Type Reactions 
During our initial investigation into the RC reaction, it became clear that the 
development of a powerful catalyst would require an entirely new methodology, and that 
our previous work in the Morita-Baylis-Hillman reaction would not be applicable here.  
Hence, during the study of nitrogen and phosphorous-based catalysts, we simultaneously 
                                                 
117 homo-Pps 8 was synthesized in analogy to Pps (7) from commercially available Boc-L-homoserine. 
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investigated the possibility of a thiolate-promoted cycloisomerization.  Various 
chalcogenides have been reported as catalysts in MBH-type reactions; however, dialkyl 
chalcogenides require Lewis acid activation to overcome their low reactivity106 and 
reactions catalyzed by monoalkyl chalcogenides terminate without elimination of the 
catalyst (Scheme 3.5). 118   For example, the intermolecular MBH reaction can be 
promoted with catalytic dimethyl sulfide or thioanisole by employing stoichiometric 
amounts of titanium tetrachloride to provide the desired products in up to 88% yield.  
Additionally, Murphy and co-workers demonstrated the cyclization of bis(enone) 1 
catalyzed by thiophenol and sodium thiophenolate, however they obtained cyclized 
addition product 9 instead of the desired Rauhut-Currier product, 2. 
Scheme 3.5: Chalcogenide catalysis of MBH-type reactions. 
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In a unique example by Moore and co-workers, 119  they demonstrated the 
cycloisomerization of tricyclic bis(enone) 10 catalyzed by thiophenol and sodium 
                                                 
118  (a) Dinon, F.; Richards, E.; Murphy, P. J.; Hibbs, D. E.; Hursthouse, M. B.; Malik, K. M. A. 
Tetrahedron Lett. 1999, 40, 3279-3282. (b) Brown, P. M.; Käppel, N.; Murphy, P. J. Tetrahedron Lett. 
2002, 43, 8707-8710. 
119 Erguden, J. K.; Moore, H. W. Org Lett. 1999, 1, 375-377. 
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thiophenolate (Figure 3.6).  This unusual transformation was believed to proceed through 
the conjugate addition of thiolate to substrate 10 which then underwent a transannular 
Michael reaction to provide intermediate 11.  From molecular modeling, these authors 
determined that the three-dimensional conformation of the molecule placed the generated 
enolate in close proximity to the β–proton of the thiophenolate leaving group.  Thus, the 
enolate was able to induce an intramolecular E2 trans-diaxial elimination to produce 
desired product 12 and regenerate the thiophenolate catalyst.  Interestingly, and more 
representative of general thiol catalysis, in a very similar transformation involving 
homolog 13 (containing a five-membered ring versus a six-membered ring), the requisite 
intermediate was no longer in proper alignment for the elimination reaction and product 
14 was isolated when a stoichiometric quantity of thiophenol was employed. 
Figure 3.6: Catalysis of the RC reaction with thiophenol and thiophenolate. 
Me
O
O
H
H
O
H
Me
O
H
PhSH (0.1 equiv)
PhSNa (0.1 equiv)
THF, ref lux, 12 h
O
H
Me
O
H
SPh
Intramolecular
E2 trans-diaxial
elimination
Michael addition/
transannular ring
closure
PhS
Me
O
O
H
H
H
Me
O
H
PhSH (1 equiv)
PhSNa (0.1 equiv)
THF, ref lux, 2 h
SPh
O
10 12, 93%
13 14, 76%
11
H
 
  
- 123 - 
 
3.3.2 Examination of Cysteine-Based Catalysis 
We began our study of the thiolate-promoted RC cycloisomerization with 
derivatives of cysteine (Cys) in the hope that upon demonstration of sufficient reactivity, 
the amino acid could be embedded into a peptide in order to achieve substantial 
enantioselectivity.  However, unlike catalysis with nitrogen- or phosphorous-based 
catalysts, our new study began with many basic questions.  Would cysteine be reactive 
enough to catalyze the desired RC transformation without the use of a Lewis acid?  If we 
could catalyze the initial conjugate addition and cyclization steps, would our system be 
capable of promoting the final elimination step to regenerate the catalyst and deliver the 
desired cyclization products?  And finally, would we be able to catalyze the 
transformation with discernable levels of stereoinduction using a cysteine nucleophile 
embedded into a peptide, effectively adding a new nucleophile to our catalytic tool 
box?120  
Beginning with the cyclization illustrated in Figure 3.7 (entry a), we were 
encouraged to find that the simple protected amino acid, 15, was able to catalyze the 
reaction.  However, as anticipated, catalyst elimination was a problem and intermediate 
16 was isolated in addition to recovered starting material.  Furthermore, Boc-Cys-OMe 
(15) in combination with various amine bases (such as triethyl amine, Hünig’s base, 
diaza(1,3)bicyclo[5.4.0]undecane (DBU), and 2,6-lutidine) was not able to promote the 
elimination reaction in order to generate desired product 2 (entry b, Figure 3.7).  
Excitingly, we determined that by incorporating a stronger base, NaH, in combination 
                                                 
120 Please refer to Chapter 1 for a discussion of alternative nucleophilic moieties embedded in small 
peptide-based catalysts to promote various selective processes. 
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with the Cys-based catalyst, we were able to promote the full transformation of 
bis(enone) 1 to provide 2.  Most importantly, not only were we able to catalyze the 
cyclization, we determined that this simple protected amino acid was able to promote the 
desired transformation with stereoinduction, 20% ee.  Although the enantioselectivity 
was modest, we were nonetheless surprised to find that a more elaborate secondary 
structure was not needed to separate the energetics of diastereomeric transition states.  
Thus, we decided to proceed in our study with the investigation of diverse reaction 
parameters using a single amino acid derivative as the catalyst. 
Figure 3.7: Catalysis of the RC reaction with catalyst 15. 
Ph
O
O
Ph
Ph
O
∗
O
PhO
S
NHBocMeO
O
O
+
1 216
1 + 161 + 16 2, 20% ee
(toluene)
23 °C, 5 h
various solvents
O
NHBoc
MeO
SH
catalyst (1 equiv)
O
NHBoc
MeO
SH
O
NHBoc
MeO
SH
amine
bases NaH+ +
(a) (b) (c)
15 15 15
reaction outcome:
catalyst:
 
Realizing that the choice of base was critical to product distribution, we first 
performed a base screen in the RC reaction promoted by the Boc-protected Cys-based 
catalyst (15).  In addition to the amine bases already tested in combination with 15, 
sodium carbonate and sodium hydroxide were examined in the cyclization of bis(enone) 
1 (Table 3.1).  The results were similar to those obtained when using amine bases, such 
that we obtained a mixture of starting material and cyclized addition product 16, without 
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production of the desired product.  Importantly, NaH, KH, and t-BuOK provided the 
cleanest transformation while the stronger bases, LDA and n-BuLi (thiolate was 
preformed to avoid conjugate addition), led mainly to decomposition.  It is interesting to 
note that 16 can be converted to 2 upon isolation and subjection to NaH, suggesting that 
it is indeed an intermediate en route to desired product 2.  This proved to be important in 
the following studies, as it required the fine-tuning of reaction conditions to promote the 
full reaction pathway of the cyclization followed by final elimination of the catalyst. 
Table 3.1: Base screen in the RC reaction. 
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As in the case of the intramolecular MBH reaction, solvent was found to affect 
the vinylogous reaction.  Catalysis of the RC reaction with Cys derivative 15 (1 equiv) 
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and sodium hydride (1 equiv) in various solvents (THF, ether, acetonitrile, N,N-
dimethylformamide, hexanes, toluene, CH2Cl2, and acetone) all produced the desired 
product with varying degrees of enantioselectivity and by-product formation.  Notably, 
acetonitrile and acetone provided the cleanest reactions with the highest levels of 
stereoinduction (39% and 38% ee, respectively) (Table 3.2). 
Table 3.2: Solvent screen in the RC cyclization of 1 to 2 promoted by 15. 
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Through careful optimization of solvent and base, we began to reveal a new 
catalytic system for the promotion of an enantioselective variant of the RC reaction.  Due 
to inconsistencies in results when employing NaH, we decided to proceed in our 
optimization studies using t-BuOK, which provided indistinguishable results from those 
obtained when using NaH.  Accordingly, further investigation of reaction conditions 
revealed that the stoichiometry of catalyst and base was extremely critical to product 
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distribution and levels of stereoinduction in the cyclization.   As illustrated in Table 3.3, 
the optimal ratio of catalyst/base was found to be 1:1.5.  Under catalysis using fewer 
equivalents of base, the reaction terminated prematurely, leading to intermediate 16 as 
well as unidentifiable by-products.  Alternatively, an excess in the amount of base 
employed furnished the desired product with varying degrees of decomposition.  
Additionally, greater dilution of the reaction concentration (0.1 M versus 0.9 M) provided 
the cleanest transformation of 1 to 2 with the highest levels of enantioselectivity.  
Therefore, the initial optimization of base, solvent, stoichiometry, and reaction 
concentration led to an exciting entry into enantioselective catalysis of the RC reaction, 
addressing our first two questions of (1) sufficient reactivity employing a Cys-based 
catalyst and (2) control of product formation through final elimination and regeneration 
of the catalyst.  Exposure of bis(enone) 1 to catalyst 15 along with t-BuOK (1.5 equiv) in 
acetonitrile (0.1 M) at room temperature afforded the desired product 2 with 36% 
enantioselectivity (Table 3.3). 
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Table 3.3: Effects of base stoichiometry and reaction concentration. 
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0.5
1.0
1.5
2.0
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2: 35% ee
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0.1
0.3
0.6
0.9
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O
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2
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(equiv) reaction outcome
a conc (M) reaction outcomeb
a reaction performed at 0.1 M.
b reaction performed with 1.5 equiv t-BuOK.  
3.3.3 Cystine Catalysis 
Our next goal was to address the third question that we initially posed: would we 
be able to catalyze the desired transformation with discernable levels of stereoinduction 
using a cysteine-based nucleophile embedded in a peptide?  In our attempts to answer this 
question and investigate optimization of the cysteine moiety, we remained enthusiastic 
that such a simple catalyst (15) was able to show measurable levels of stereoinduction 
and we were therefore optimistic that an elaborate secondary structure may not ultimately 
be required to achieve high levels of enantioselectivity. 
Although cysteine is stable, it is known that dipeptides containing a cysteine 
residue are readily oxidized to the corresponding disulfide dimer.  Therefore, before 
synthesizing various dipeptides to examine the Cys amino acid embedded into more 
complex secondary structures, we were interested in the possibility of catalyzing the 
transformation with the corresponding dimer of the protected cysteine catalyst, 17.  To 
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our surprise, employment of the Boc-protected cystine catalyst (17) promoted cyclization 
of bis(enone) 1 to 2 with comparable enantioselectivity (17% ee) to that of monomeric 
Boc-protected cysteine (15, 23% ee), using sub-stoichiometric catalyst loading (Figure 
3.8).  One dipeptide (18) was synthesized using solution phase peptide synthesis and 
tested in the analogous reaction.  Although stereoinduction was similar (20% ee), the 
reaction suffered from poor chemoselectivity compared to that of catalyst 15 or 17, and 
led to the formation of multiple by-products. 
Figure 3.8: Catalysis of the RC reaction with cystine derivatives. 
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3.3.4 Development of Cysteine Derivatives 
While the incorporation of Cys into an oligopeptide was just beginning, we were 
very interested in maintaining the simplicity of our catalyst.  Therefore, we 
simultaneously began an optimization study of the cysteine component by considering 
moderate changes.  The exploration of simple SAR (structure-activity relationship) 
around the mono-amino acid led to an intriguing result.  Changing the nitrogen protecting 
group from a carbamate to an amide caused a complete reversal in the sense of 
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asymmetric induction (Figure 3.9).  Under the optimized conditions, Boc-protected (15) 
and Fmoc-protected (19) cysteine promoted the cyclization of 1, providing 2 with 32% 
and 28% enantiomeric excess, respectively.  Amide-protected compounds 20 and 21 led 
to similar levels of stereoselectivity (-32%, -31% ee), however provided the opposite 
enantiomer in excess. 
Figure 3.9: Simple SAR of the nitrogen protecting group of catalyst 15. 
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3.3.5 Protic Additives in the RC Reaction 
Research efforts in Morita-Baylis-Hillman-type reactions from other groups have 
demonstrated the potential of protic additives to accelerate the reaction and affect product 
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distribution.121  In our investigation of the Morita-Baylis-Hillman reaction, we learned 
that protic additives had a dramatic effect not only on the reaction rate and on product 
distribution, but importantly on the enantioselectivity of the desired transformation as 
well.122  Although, the MBH reaction and Rauhut-Currier reaction have proven to be 
highly distinct from one another in our laboratory, we were nonetheless interested in 
exploring the possibility of employing protic additives in this transformation as well. 
Interestingly, we discovered that the incorporation of a protic additive did indeed 
have a dramatic effect on enantioselectivity in the Rauhut-Currier reaction, with the 
outcome strictly dependent upon the catalyst employed (Figure 3.10).  For example, in 
the catalysis of 1 to 2 employing carbamate-protected catalysts 15 and 19, the 
incorporation of water (9 equiv) was completely deleterious to stereoinduction and 
provided only racemic product.  Most excitingly, when water was incorporated in the 
reaction with amide-protected catalyst 20, we observed a dramatic increase in 
enantioselectivity to 70% ee.  Hence, we discovered that we could promote the RC 
reaction with good levels of stereoinduction using a single amino acid catalyst, lending 
credence to our hypothesis that a more complex secondary structure would not be critical 
to obtaining a highly stereoselective reaction. 
                                                 
121 (a) Methot, J. L.; Roush, W. R. Org. Lett. 2003, 5, 4223-4226. (b) Aggarwal, V. K.; Dean, D. K.; Mereu, 
A.; Williams, R. J. Org. Chem. 2002, 67, 510-514. (c) Keck, G. E.; Welch, D. S. Org. Lett. 2002, 4, 3687-
3690 and references therein.  
122 (a) Methot, J. L.; Roush, W. R. Org. Lett. 2003, 5, 4223-4226. (b) Aggarwal, V. K.; Dean, D. K.; Mereu, 
A.; Williams, R. J. Org. Chem. 2002, 67, 510-514. (c) Keck, G. E.; Welch, D. S. Org. Lett. 2002, 4, 3687-
3690 and references therein. 
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Figure 3.10: Effects of a protic additive in the cyclization of 1 to 2 promoted by various Cys-
protected derivatives. 
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To determine if this effect was unique to water, we were prompted to examine 
various alternative hydroxylic additives in the transformation of 1 to 2 catalyzed by 
acetate-protected Cys-derivative 20.  As illustrated in Table 3.4, the addition of methanol, 
ethanol, and 2-propanol (9 equiv) led to a modest enhancement in selectivity, providing 
product 2 with approximately a 10% increase in ee over the analogous reaction with no 
additive (entries 1-3, 40%, 37%, and 36% ee, respectively; cf. 32% ee with no protic 
additive).  The addition of 2,2,2-trifluoroethanol provided a further enhancement in 
enantioselectivity (45% ee), while incorporation of t-butanol led to a slight decrease in 
enantioselectivity (26% versus 32% ee). 
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Table 3.4: Effect of various additives in the RC reaction catalyzed by 20. 
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% eeentry
1
2
3
4
5
6 water is the best
protic additive  
With water leading to the most dramatic effect as a protic additive, we next 
explored the exact requirements of the system.  Indeed, we determined that a precise 
quantity of water was required.  Notably, increased selectivity from 42% ee (1 equiv of 
water, entry 2, Table 3.5) to 81% ee was achieved with the addition of 20 equiv of water 
to the acetonitrile solvent.  A further increase in equivalents of water was deleterious, 
with a 2:1 mixture of MeCN-H2O providing the desired product with only 10% 
enantiomeric excess (entry 11). 
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Table 3.5: Effects of water additive in the RC reaction catalyzed by 20.  
Ph
O
O
Ph
O
NHAc
MeO
SH
t-BuOK (1.5 equiv), MeCN (0.1 M)
5 h, rt
(1 equiv)
Ph
O ∗
O
Ph
-
1
3
9
20
25
30
40
50
100
275
water (equiv)
32
42
57
70
81
81
74
69
72
33
10
% eeentry
1
2
3
4
5
6
7
8
9
10
11
1 2
20
 
3.3.6 Optimization of Cysteine-Based Catalysis 
Once we uncovered the dramatic effects of water on enantioselectivity in the RC 
cyclization, we looked further at the possibility of optimizing the cysteine-based catalyst.  
With the new reaction conditions in hand (20 equiv of water in bulk acetonitrile), we 
examined a series of N-amide-protected cysteine derivatives.  As shown in Figure 3.11, 
when N-benzoyl-protected catalyst 21 was employed in the cyclization of 1 to 2, a 
considerable decrease in enantioselectivity was seen (41% ee) as compared with catalyst 
20 (81% ee).    N-isobutyryl catalyst 22 provided comparable results (78% ee), whereas a 
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further increase in steric bulk of the protecting group led to a significant decrease in 
enantioselectivity (N-pivaloyl catalyst 23, 43% ee). 
Figure 3.11: Effects of various amide protecting groups on cysteine in the RC cyclization.  
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O
O
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A minor study of solvent effects was revisited under the optimized aqueous 
reaction conditions (20 equiv H2O in MeCN) in the cyclization reaction promoted by the 
optimal catalyst, 20, which mainly led to eroded product enantioselectivity and resulted 
in the formation of by-products (Figure 3.12).  Propionitrile led to a modest decrease in 
enantioselectivity (77% ee, entry 2), while deleterious results with THF were more 
pronounced (55% ee, entry 1).   
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Figure 3.12: Solvent effects with water additive in the RC cyclization of 1 to 2 promoted by 20. 
THF
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Importantly, because we were able to develop a highly reactive catalytic system, 
able to promote the conversion of 1 to 2 within 5 hours at 23 °C, we believed there was 
an opportunity to use temperature control to further enhance the enantioselectivity.  In 
beginning our investigation of temperature effects, we quickly learned there was a 
delicate balance required between the stoichiometry of the base, the reaction 
concentration, and the temperature of the reaction.  For example, in cooling the reaction 
to -20 °C, we observed an increase in the level of stereoinduction (92% ee, entry 1, Table 
3.6), albeit with a major decrease in the isolated yield (15%).  At this reduced 
temperature, the final elimination step was prohibitive and the major isolated product was 
intermediate 16.  By fine-tuning the stoichiometry of the base and overall concentration, 
we were able to obtain excellent results.  Consequently, increasing the quantity of t-
BuOK led to higher conversions and thus higher isolated yields (4 equiv, 47%, entry 2; 6 
equiv, 57%, entry 3).  This was demonstrated previously (Table 3.1) in the independent 
conversion of intermediate 16 to desired product 2 by isolation and subjection to the 
appropriate base.  However, this also led to a simultaneous decrease in the 
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enantioselectivity of the reaction (84% and 77% ee, respectively).  An explanation of the 
observed decrease in enantioselectivity in the presence of excess base will be proposed in 
the following discussion of mechanistic details.  Nevertheless, by lowering the reaction 
concentration while maintaining a moderate quantity of base, we were able to preserve 
the enantioselectivity while obtaining good yield.  This trend continued as we decreased 
the temperature further.  For example, in going from -20 °C to -30 °C (entries 5 and 6) 
and finally to -40 °C (entries 7-10), we observed a continual improvement in 
enantioselectivity to 95% ee, however with a reduced yield of 39% (6 equiv t-BuOK, 
entry 7).  Increasing the amount of base to 9 equiv provided good conversion to product 2 
(74% yield, entry 9), again at the cost of selectivity (83% ee).  Excitingly, by simply 
running the reaction for a longer amount of time, 24 h versus 5 h, we were delighted to 
find that we were able to catalyze the Rauhut-Currier reaction with high levels of 
enantioselectivity (95% ee) and synthetically useful yields (70%, entry 10). 
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Table 3.6: Optimization of reaction conditions in the RC cyclization reaction. 
entry % yield % eeconcentration(M)
t-BuOK
(equiv)
temperature
(°C)
1
2
3
4
-20
-20
-20
-20
0.1
0.1
0.1
0.07
1.5
4
6
4
15
47
57
70
92
84
77
85
5
5
5
5
time
(h)
7
8
9
-40
-40
-40
0.05
0.05
0.05
6
8
9
5
5
5
39
54
74
95
92
83
10 -40 0.05 6 24 70 95
Ph
O
O
Ph
t-BuOK, H2O (20 equiv)
MeCN
5
6
-30
-30
0.07
0.07
4
5
27
67
94
91
5
5
Ph
O ∗
O
Ph
1 2
O
NHAc
MeO
SH (1 equiv)20
 
3.3.7 Determination of Absolute Stereochemistry 
The absolute configuration of cyclization product 24 from the intramolecular RC 
reaction was determined by X-ray diffraction analysis of crystalline hydrazone derivative 
25 following Brady’s method.123  As illustrated in Scheme 3.6, optically enriched para-
bromo-substituted compound 24 (93% ee) was treated with a solution of 2,4-
dinitrophenylhydrazine in ethanol and sulfuric acid to provide hydrazone 25 (45% yield), 
followed by recrystallization of the orange precipitate from diethyl ether and ethyl acetate 
to provide X-ray quality crystals. 
                                                 
123 (a) Behforouz, M.; Bolan, J. L.; Flynt, M. S. J. Org. Chem. 1985, 50, 1186-1189. (b) Brady, O. L. J. 
Chem. Soc. 1931, 756-759. 
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Scheme 3.6: Formation of hydrazone 25 for crystallization. 
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3.4 Mechanistic Studies 
Excitingly, we have been able to use a single amino acid derivative to catalyze the 
first enantioselective Rauhut-Currier reaction.  Although the simplicity of our catalytic 
system was empirically determined, it was initially unexpected, as we believed 
incorporation of the cysteine moiety into a more elaborate secondary structure would be 
necessary.  Therefore, in order to provide a plausible mechanism of stereoinduction, two 
key experiments were performed. 
First, the cycloisomerization of bis(enone) 1 was run under optimized conditions 
in the presence of 18-crown-6 in order to sequester the potassium ion and determine its 
role in the reaction (Scheme 3.7).  Expected product 2 was not observed; however, 
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unconjugated cyclized product 26 was found to be the predominant product, albeit in low 
yield (26%) and with attenuated enantioselectivity (84% ee).  Therefore, these results 
suggest that potassium ion chelation was essential to both product distribution and 
stereoselectivity.   
Scheme 3.7: RC reaction under optimized reaction conditions with 18-crown-6.  
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O
O
Ph
O
NHAc
MeO
SH (1 equiv)
Ph
O
O
Ph
t-BuOK, H2O (20 equiv)
18-C-6, MeCN
-40 °C, 24 h
26%, 84% ee
1 26
20
 
In support of this hypothesis, the RC cycloisomerization was performed with 
catalyst 20 in the presence of sodium tert-butoxide versus the optimized conditions 
including potassium tert-butoxide (Scheme 3.8).  Under otherwise identical reaction 
conditions, substitution of potassium with sodium afforded product 2 with attenuated 
yield (55%) as well as enantioselectivity (85% ee), further demonstrating the importance 
of the potassium counterion in promoting a highly efficient transformation. 
Scheme 3.8: Use of sodium tert-butoxide versus potassium tert-butoxide in the RC cyclization. 
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In the second experiment, bis(enone) 1 was subjected to the optimized 
cycloisomerization reaction conditions, however, the reaction was stopped after only two 
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hours instead of twenty-four hours (Scheme 3.9).  As expected, we obtained the desired 
product (2) with high enantioselectivity (95% ee) and in reduced yield (29%) due to the 
short reaction time.  Additionally, a mixture of five diastereomers of intermediate 27 was 
isolated, as determined by 1H NMR.  We then subjected intermediate 27 to oxidation and 
elimination under irreversible conditions (i. mCPBA, ii. NaH) to determine the 
enantioselectivity of the desired stereogenic center prior to any potential equilibration.  
Unlike the outcome under our optimized conditions, product 2 was isolated with reduced 
enantioselectivity of only 40% ee, which suggested that carbon–carbon bond formation 
was reversible under the optimized conditions and that abstraction of the α-H atom and 
extrusion of the catalyst that was the stereochemistry-determining step.  These data are in 
agreement with the most recent mechanistic studies of MBH-type processes by the 
groups of Aggarwal and McQuade who have also proposed proton transfer/catalyst 
elimination to be rate-determining.124 
                                                 
124 For mechanistic studies regarding the MBH reaction, see: (a) Aggarwal, V. K.; Fulford, S.; Lloyd-Jones, 
G. C. Angew. Chem., Int. Ed. 2005, 44, 1706-1708. (b) Price, K. E.; Broadwater, S. J.; Walker; B. J.; 
McQuade, D. T. J. Org. Chem. 2005, 70, 3980-3987. (c) Price, K. E.; Broadwater, S. J.; Jung, H. M.; 
McQuade, D. T. Org. Lett. 2005, 7, 147-150.  For mechanistic studies regarding the related aza-MBH 
reaction, please see: (d) Buskens, P.; Klankermayer, J.; Leitner, W. J. Am. Chem. Soc. 2005, 127, 16762-
16763. (e) Raheem, I. T.; Jacobsen, E. N. Adv. Synth. Catal. 2005, 347, 1701-1708. 
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Scheme 3.9: Isolation of intermediate 27 and subjection to irreversible elimination. 
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As in our studies of the MBH reaction, the mechanism of the RC reaction is not 
definitively known.  However, based on these experiments and in analogy to the 
phosphine-catalyzed reactions, 125  we proposed that the mechanism of the reaction 
involved conjugate addition of the cysteine-based thiolate to bis(enone) 1 to form enolate 
28 (Figure 3.13).  Reversible intramolecular Michael addition would then afford cyclized 
intermediate 29, followed by irreversible proton transfer and extrusion of the catalyst to 
generate the RC cyclization product 2 with regeneration of the catalyst.  The final step, 
proceeding from intermediate 29 to desired product 2, would therefore be the rate-
determining and stereo-determining step. 
                                                 
125 Methot, J. L.; Roush, W. R. Adv. Synth. Catal. 2004, 346, 1035-1050.  
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Figure 3.13: Proposed mechanism of the Cys-catalyzed RC reaction. 
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As previously disclosed (3.3.6), a significant decrease in enantioselectivity was 
observed in the cyclization reaction when excess base was employed.  We have 
determined that the integrity of product ee was not diminished by resubjection of the 
product to reaction conditions.  Therefore, the decrease in enantioselectivity was not due 
to racemization of the product, but possibly due to an alternative mechanism, as shown in 
Scheme 3.10.   In the presence of excess base, γ-deprotonation could lead to intermediate 
30 which in turn would undergo cyclization and olefin isomerization to provide 2 (+/-).126 
Scheme 3.10: Possible base promoted cyclization to provide racemic product. 
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126 Hwu, J. R.; Hakimelahi, G. H.; Chou, C.-T. Tetrahedron Lett. 1992, 33, 6469-6472. 
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In order to explain the formation of the observed enantiomer, we have proposed 
favored (31) and disfavored (32) transition state models (Figure 3.14).  We speculate that 
the configuration allowing for a more stable potassium chelate between the enolate 
oxygen and the amide carbonyl on the catalyst would be favored (31), versus the 
analogous ester chelation,127 32.  The greater stability of structure 31 would then lead to a 
faster rate of elimination with subsequent formation of 2 in high enantiomeric excess. 
Figure 3.14: Transition state models to explain formation of the observed enantiomer. 
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3.5 Reaction Scope 
Traditionally, Morita-Baylis-Hillman and Rauhut-Currier-type reactions have 
been plagued with reactivity and selectivity issues, only to be resolved or partially solved 
for specific cases and narrow substrate scope.  Therefore, it was our desire to not only 
develop a reactive system that was able to produce a highly enantiomerically enriched 
product, but also a set of conditions that were amenable to a broad class of substrates 
providing structurally complex products.  Thus, with our set of optimized reaction 
conditions, we were eager to explore the full scope of this developed methodology. 
All the studies presented thus far have included stoichiometric loading of the 
cysteine-based catalyst.  An examination of catalyst loading effects is presented in Table 
                                                 
127 Cho, J.-Y.; Iverson, C. N.; Smith, M. R., III J. Am. Chem. Soc. 2000, 122, 12868-12869. 
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3.7, and as demonstrated, a substoichiometric amount of catalyst was well tolerated.  The 
cyclization of bis(enone) 1 underwent efficient cyclization with 20 mol % of catalyst 20 
to provide 2 with 92% enantiomeric excess in 75% yield after 24 h (entry 2).  While 
lowering the catalyst loading further to 10 mol % maintained high enantioselectivity in 
the transformation, providing 2 with 91% ee, the efficiency of the reaction was 
dramatically sacrificed, as the isolated yield was only 41% within the same timeframe.  In 
light of the rate reduction from decreased catalyst loading, and because our Cys-based 
catalyst was simple and commercially available, we decided to perform the following 
study of reaction scope employing a full equivalent of 20 to ensure high efficiency and 
enantioselectivity within a useful timeframe. 
Table 3.7: Effect of catalyst loading on the RC reaction of 1 to 2 promoted by 20. 
Ph
O
O
Ph
O
NHAc
MeO
SH
Ph
O
O
Ph
t-BuOK (6 equiv), H2O (20 equiv)
MeCN, -40 °C, 24 h
100
20
10
70
75
41
catalyst
(mol %)
1 2
95
92
91
yield eeentry
1
2
3
20
 
Thus, we set out to synthesize various substrates for investigation of the scope of 
the enantioselective intramolecular Rauhut-Currier reaction.  Following previous work of 
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Murphy and co-workers 128  which documented a synthetic route to accessing the 
bis(phenyl)-substituted ketone 1, the substrates were prepared by reaction of a dialdehyde 
with the requisite phosphorus ylide.  As illustrated in Scheme 3.11, ozonolysis of 
cyclopentene generated the desired dialdehyde which was followed by in situ Wittig 
olefination with the stabilized phosphorane, 33.  The stabilized Wittig reagents were 
prepared by subjection of the corresponding α–chloro or bromo halides to 
triphenylphosphine, followed by elimination under basic conditions.129   A variety of 
symmetrical bis(enones) were therefore prepared via subjection of the desired stabilized 
Wittig reagents to the ozonolysis reaction.  Synthesis of unsymmetrical bis(enone) 
substrate 34 was achieved by utilizing a procedure disclosed by Schrieber and co-workers 
for the generation of protected dialdehyde 35.130  Subjection of 35 to stabilized Wittig 
reagent 33 provided the MBH enone-aldehyde substrate (36) after acid deprotection of 
the methyl acetal.  A second Wittig olefination reaction with the desired phosphorane 
(37) afforded unsymmetrical bis(enone) substrate 34. 
                                                 
128 Brown, P. M.; Käppel, N.; Murphy, P. J. Tetrahedron Lett. 2002, 43, 8707-8710. 
129 For the preparation of stabilized Wittig salts, please see: (a) Ramirez, F.; Dershowitz, S. J. Org. Chem. 
1957, 22, 41-45. (b) Denney, D. B.; Smith, L. C.; Song, J.; Rossi, C. J.; Hall, C. D. J. Org. Chem. 1963, 28, 
778-780. 
130 Schreiber, S. L.; Kelly, S. E.; Porco, J. A.; Sammakia, T.; Suh, E. M. J. Am. Chem. Soc. 1988, 110, 
6210-6218. 
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Scheme 3.11: Synthesis of symmetrical and unsymmetrical RC substrates. 
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Excitingly, we determined that the RC cycloisomerization could be extended to 
include electron-deficient and electron-rich aryl symmetrical bis(enones) as well as 
aliphatic and heteroaromatic bis(enones) while maintaining high levels of 
enantioselectivity.111  As previously demonstrated (3.3.6) and reiterated in the following 
discussion, a delicate balance existed between the amount of base and the concentration 
of the reaction.  Rauhut-Currier cyclization leading to para-bromo-substituted compound 
24 was performed using 5 equiv of t-BuOK at a slightly higher dilution (0.03 M) to 
provide 70% yield and 93% enantiomeric excess (Table 3.8).  Unlike the case with 
bis(phenyl) compound 1, a decrease in catalyst loading (20 mol %) was deleterious to 
enantioselectivity, providing 24 with 74% ee and 81% yield in the same timeframe.  
Analogous para-methoxy substitution of symmetrical bis(phenyl) compound 1 was also 
well tolerated, producing compound 38 with 90% ee in 73% yield (7 equiv t-BuOK, 0.01 
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M).  Performing this cyclization with lowered catalyst loading (20 mol %) provided 
comparable enantioselectivity (90% ee), yet with reduced efficiency (57% yield).  A 
slight decrease in stereoinduction was observed in the cyclization leading to para-NO2-
substituted compound 39 with 84% ee and 71% yield within 4 h (2 equiv t-BuOK, 0.01 
M).  Heteroaromatic furan-substituted 40 was delivered with high enantiomeric excess 
(92%) and modest yield (54%) in 48 h.  Fine-tuning of the reaction conditions provided 
aliphatic bis(methylketone) 41 with high selectivity and moderate yield (90% ee, 55% 
yield) or slightly decreased enantioselectivity (81% ee) and higher yield (68%).  Finally, 
unsymmetrical keto ester 42 showed a decrease in enantioselectivity (67% ee).  We are 
optimistic that unsymmetrical substrates will not be a limitation and with further 
optimization of catalyst and reaction conditions this will be a viable class of substrates.  
  
- 149 - 
 
Table 3.8: Substrate scope in the enantioselective Rauhut-Currier reaction promoted by catalyst 
20. 
O
O
O
O
NO2
NO2
O
OO
O
O
O
MeO
OMe
O
O
Br
Br
70%, 95% ee
(6 equiv, 0.05 M, 24 h)
70%, 93% ee
(5 equiv, 0.03 M, 24 h)
73%, 90% ee
(7 equiv, 0.01 M, 24 h)
71%, 84% ee
(2 equiv, 0.01M, 4 h)
55%, 90% ee
(4 equiv, 0.008 M, 40 h)
54%, 92% ee
(6 equiv, 0.05 M, 48 h)
Ph
O
O
OEt 66%, 67% ee
(6 equiv, 0.05 M, 24 h)
2
24
39
38
40
42
O
O
41
producta yield, ee(t-BuOK, conc, time) product
a yield, ee
(t-BuOK, conc, time)
a Reactions were conducted at -40 °C with 20 equiv H2O in MeCN (see Experimental section for details).
68%, 81% ee
(4 equiv, 0.01 M, 40 h)
57%, 90% ee
(20 mol % 20)
81%, 74% ee
(20 mol % 20)
 
3.6 Conclusion 
The Rauhut-Currier reaction is a powerful transformation with the capability of 
providing structurally complex enantiopure compounds through the generation of a new 
carbon–carbon bond.  Although progress in the development of this forty five year old 
reaction has been slow due to difficulties in controlling reactivity, it has recently become 
a more prominent reaction with the development of the intramolecular version.  We have 
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been able to contribute to the further advancement of this transformation by establishing 
a method to perform the first enantioselective intramolecular Rauhut-Currier reaction in 
high yield and enantioselectivity using convenient reagents and conditions.  Moreover, 
our report documents the first use of a simple cysteine derivative as an asymmetric 
catalyst.  An initial substrate scope was examined and we determined that electron-
deficient and electron-rich aryl symmetrical bis(enones) as well as aliphatic and 
heteroaromatic bis(enones) were viable substrates under this catalytic system.  
Unsymmetrical substrates proved to be more difficult and will be the subject of further 
explorations. 
Many opportunities for growth persist in the development of both the MBH and 
RC reactions.  Further expansion of the substrate scope to include more complex 
substrates will involve the design of novel molecules, hopefully amenable to catalysis 
under our Cys-based catalyst.  For example, a relay system of RC transformations is 
possible in a substrate such as compound A where the latent enolate from one RC 
reaction would be trapped by a second such cyclization.  
Y
X Y
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H
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Additionally, opportunities exist in the development of orthogonal conditions in 
the promotion of the MBH and RC reactions; the MBH reaction is promoted by nitrogen-
based catalysis, while the RC reaction is promoted by sulfur-based catalysis and not 
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nitrogen.  If the MBH reaction was inert to specific Cys-based catalytic conditions, we 
would be able to access interesting scaffolds in a tandem one-pot transformation 
including sequential MBH/RC reactions (represented by compound B).  Finally, the 
facile and widespread application of this methodology to the synthesis of natural products 
and non-natural target molecules will be the next frontier. 
 
 
 
 
 
 
 
 
 
 
 
 
  
- 152 - 
 
3.7 Experimental 
General.  Proton NMR spectra were recorded on a 500 or 400 MHz spectrometer.  
Proton chemical shifts are reported in ppm (δ) relative to internal tetramethylsilane 
(TMS, δ 0.0 ppm) or with the solvent reference relative to TMS employed as the internal 
standard (CDCl3, δ 7.26 ppm; d6-DMSO, δ 2.50 ppm; CD3OD, δ 3.31 ppm; D2O, δ 4.79 
ppm).  Data are reported as follows: chemical shift (multiplicity [singlet (s), doublet (d), 
triplet (t), quartet (q), and multiplet (m)], coupling constants [Hz], integration).  Carbon 
NMR spectra were recorded at 125 or 100 MHz with complete proton decoupling. 
Carbon chemical shifts are reported in ppm (δ) relative to TMS with the respective 
solvent resonance as the internal standard (CDCl3, δ 77.0 ppm).  Infrared spectra were 
obtained on a Perkin-Elmer Spectrum 1000 spectrometer.  Analytical thin-layer 
chromatography (TLC) was performed using Silica Gel 60 Å F254 precoated plates (0.25 
mm thickness).  TLC Rf values are reported. Visualization was accomplished by 
irradiation with a UV lamp and/or staining with KMnO4 or cerium ammonium 
molybdenate (CAM) solutions.  Flash column chromatography was performed using 
Silica Gel 60 Å (32-63 µm).131 Optical rotations were recorded on a Rudolf Research 
Analytical Autopol IV Automatic polarimeter at the sodium D line (path length 100 mm).  
High resolution mass spectra were obtained at the Mass Spectrometry Facility of either 
Boston College (Chestnut Hill, MA) or the University of Illinois (Urbana-Champaign, 
IL).  The method of ionization is given in parentheses.  Analytical normal phase HPLC 
was performed on a Hewlett-Packard 1100 Series chromatograph equipped with a diode 
                                                 
131 Still, W.C.; Kahn, M.; Mitra, J. J. Org. Chem. 1978, 43, 2923. 
  
- 153 - 
 
array detector (214 nm and 254 nm).  All reactions were carried out under an argon or 
nitrogen atmosphere employing oven- and flame-dried glassware. All solvents were 
purified using a Seca Solvent Purification System by GlassContour.  t-BuOK was freshly 
sublimed prior to use. 
 
Experimental Procedures 
 
General procedure A: preparation of intramolecular Rauhut-Currier substrates (1, 
38b, 24b, 39b, 40b, 41b, and 42b). 
O
O
O
O
 
Compound 40b. Cyclopentene (0.52 mL, 5.9 mmol) was dissolved in CH2Cl2 (8.7 mL), 
cooled to –78 °C, and ozone was bubbled through the reaction until the clear solution 
turned blue.  Nitrogen was then bubbled through the solution until the blue color 
disappeared to remove excess ozone.  Triphenylphosphine (2.3 g, 8.9 mmol) was added 
and the reaction was allowed to stir for 1 h at -78 °C.  1-(2-furanyl)-2-
(triphenylphosphoranylidene)-ethanone 132 (4.6 g, 12.4 mmol) was added at room 
temperature and the pale yellow solution was allowed to stir for 24 h and then 
concentrated under reduced pressure.  Flash chromatography (hexanes-EtOAc, 5:1) 
                                                 
132 (a) Ramirez, F.; Dershowitz, S. J. Org. Chem. 1957, 22, 41-45. (b) Denney, D. B.; Smith, L. C.; Song, 
J.; Rossi, C. J. J. Org. Chem. 1963, 28, 778-780. 
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provided 40b as a pale yellow oil (790 mg, 2.8 mmol, 47%). 1H NMR (CDCl3, 400 MHz) 
δ 7.63-7.62 (m, 2H), 7.27-7.24 (m, 2H), 7.15 (dt, J = 15.4, 7.2 Hz, 2H), 6.84 (d, J = 15.6 
Hz, 2H), 6.56 (dd, J = 3.5, 1.8 Hz, 2H), 2.38 (q, J = 6.8 Hz, 4H), 1.78 (quintet, J = 7.5 
Hz, 2H); 13C NMR (CDCl3, 125 MHz) δ 178.3, 153.7, 148.1, 146.9, 125.9, 118.0, 112.7, 
32.4, 26.9; IR (film, cm-1) 3124, 2933, 1664, 1620, 1564, 1465, 1392, 1297, 1010; TLC 
Rf 0.25 (2:1 hexanes-EtOAc); HRMS (ESI) m/z 285.1137 (285.1127 calcd for C17H17O4 
[M+H]+).  Compounds 1, 38b, 24b, 39b, 41b, and 42b were prepared by analogous 
methodology. 
 
O
O
 
Compound 1.  1H NMR (CDCl3, 500 MHz) δ 7.93 (dd, J = 8.2, 1.2 Hz, 4H), 7.55 (t, J = 
7.5 Hz, 2H), 7.46 (t, J = 7.6 Hz, 4H), 7.06 (dt, J = 15.4, 6.9 Hz, 2H), 6.92 (d, J = 15.4 Hz, 
2H), 2.39 (q, J = 6.8 Hz, 4H), 1.83-1.75 (m, 2H); 13C NMR (CDCl3, 125 MHz) δ 190.6, 
148.5, 137.8, 132.7, 128.5, 128.4, 126.4, 32.1, 26.7; IR (film, cm-1)3056, 2929, 2856, 
1671, 1621, 1577, 1446, 1344, 1291, 1221, 1009, 968; TLC Rf 0.46 (3:1 hexanes-
EtOAc); HRMS (ESI) m/z 305.1546 (305.1542 calcd for C21H21O2 [M+H]+). 
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Compound 38b.  1H NMR (CDCl3, 400 MHz) δ 7.95 (d, J = 8.7 Hz, 4H), 7.05 (dt, J = 
15.2, 6.9 Hz, 2H), 6.97-6.90 (m, 6H), 3.88 (s, 6H), 2.39 (q, J = 7.1 Hz, 4H), 1.78 (quintet, 
J = 7.4 Hz, 2H); 13C NMR (CDCl3, 100 MHz) δ 188.8, 163.4, 147.5, 130.8, 130.7, 126.2, 
113.8, 55.5, 32.1, 26.8; IR (film, cm-1) 3010, 2930, 2835, 1662, 1621, 1594, 1570, 1506, 
1302, 1259, 1235, 1167; TLC Rf 0.26 (2:1 hexanes-EtOAc); HRMS (ESI) m/z 365.1764 
(365.1753 calcd for C23H25O4 [M+H]+). 
 
O
O
Br
Br
 
Compound 24b.  1H NMR (CDCl3, 500 MHz) δ 7.79 (d, J = 8.5 Hz, 4H), 7.61 (d, J = 
8.5 Hz, 4H), 7.07 (dt, J = 15.1, 7.1 Hz, 2H), 6.82 (d, J = 15.1 Hz, 2H), 2.40 (q, J = 6.8 
Hz, 4H), 1.78 (quintet, J = 7.5 Hz, 2H); 13C NMR (CDCl3, 125 MHz) δ 189.3, 149.0, 
136.5, 131.9, 130.0, 127.9, 126.0, 32.2, 26.6; IR (film, cm-1) 2949, 2886, 2829, 2722, 
1721, 1671, 1620, 1583, 1400, 1073, 1010; TLC Rf 0.42 (1:1 hexanes-Et2O); HRMS 
(ESI) m/z 460.9771 (460.9752 calcd for C21H19O2Br2 [M+H]+). 
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Compound 39b.  1H NMR (CDCl3, 500 MHz) δ 8.32 (d, J = 8.8 Hz, 4H), 8.06 (d, J = 
8.8 Hz, 4H), 7.13 (dt, J = 15.4, 6.9 Hz, 2H), 6.91 (d, J = 15.4 Hz, 2H), 2.45 (q, J = 6.9 
Hz, 4H), 1.83 (quintet, J = 7.5 Hz, 2H); 13C NMR (CDCl3, 125 MHz) δ 189.0, 150.6, 
150.1, 142.6, 129.4, 126.1, 123.8, 32.3, 26.6; IR (film, cm-1) 3109, 2934, 2856, 1671, 
1617, 1601, 1524, 1344, 1213; TLC Rf 0.32 (2:1 hexanes-EtOAc); HRMS (ESI) m/z 
395.1246 (395.1243 calcd for C21H19N2O6 [M+H]+). 
 
O
O
 
Compound 41b.  1H NMR (CDCl3, 400 MHz) δ 6.78 (dt, J = 15.9, 6.9 Hz, 2H), 6.10 (d, 
J = 16.0 Hz, 2H), 2.31-2.24 (m, 10H), 2.39 (q, J = 7.1 Hz, 2H), 1.68 (quintet, J = 7.4 Hz, 
2H); 13C NMR (CDCl3, 100 MHz) δ 198.5, 147.0, 131.8, 31.8, 27.0, 26.4; IR (film, cm-1) 
3001, 2933, 2856, 1697, 1673, 1620, 1427, 1359, 1254, 1182, 972; TLC Rf 0.29 (2:1 
hexanes-EtOAc); HRMS (ESI) m/z 203.1054 (203.1048 calcd for C11H16O2Na [M+Na]+). 
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Compound 42b.  1H NMR (CDCl3, 500 MHz) δ 7.93 (d, J = 7.0 Hz, 2H), 7.56 (t, J = 7.3 
Hz, 1H), 7.47 (t, J = 7.6 Hz, 2H), 7.07-6.89 (m, 3H), 5.85 (dt, J = 15.8, 1.5 Hz, 1H), 4.19 
(q, J = 7.1 Hz, 2H), 2.36 (q, J = 6.9 Hz, 2H), 2.28 (q, J = 6.9 Hz, 2H), 1.72 (quintet, J = 
7.3 Hz, 2H), 1.29 (t, J = 7.1 Hz, 3H); 13C NMR (CDCl3, 125 MHz) δ 191.0, 166.9, 148.9, 
148.4, 138.2, 133.1, 128.9, 128.9, 126.8, 122.4, 60.6, 32.4, 31.9, 26.9, 14.6; IR (film, 
cm-1) 2980, 2936, 1715, 1672, 1652, 1616, 1442, 1264, 1178; TLC Rf 0.28 (3:1 hexanes-
EtOAc); HRMS (ESI) m/z 295.1310 (295.1310 calcd for C17H20O3Na [M+Na]+). 
 
General procedure B: catalytic intramolecular Rauhut-Currier reactions. 
O
O
 
Compound 2.  Bisenone 1 (30.0 mg, 0.10 mmol) was dissolved in acetonitrile (2.0 mL) 
and water (36 µL, 2.0 mmol) and cooled to –40 °C.  AcCysOMe (20) (17.6 mg, 0.10 
mmol) and t-BuOK (67.0 mg, 0.59 mmol) were added sequentially and the reaction was 
allowed to stir for 24 h at –40 °C.  The reaction mixture was then filtered through a short 
plug of silica (hexanes-EtOAc, 1:1), concentrated under reduced pressure, and purified by 
silica gel chromatography (hexanes-EtOAc, 5:1) to afford 2 as a pale yellow oil (21 mg, 
0.069 mmol, 70%).  The characterization data for this compound matched that which has 
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previously been reported.133  [α]D –38.6 (c 0.76, CHCl3, 95% ee); Assay of enantiomeric 
purity: Enantiomers of product were separated by chiral HPLC employing a Chiralcel AD 
column (Daicel).  Conditions: 96:4 hexanes-isopropanol; Flow rate 0.75 mL/min; 15.1 
min (major ent), 20.5 min (minor ent).  Compounds 38, 24, 39, 40, 41, and 42 were 
prepared by analogous methodology.  NOTE: In order to ensure high efficiency and 
enantioselectivity, the reaction concentration and equivalents of t-BuOK must be as 
described for each respective substrate.  For runs employing less than 100 mol% catalyst, 
reaction parameters other than catalyst loading remain constant. 
 
O
O
MeO
OMe
 
Compound 38.  General procedure B was followed, except that bisenone 38b (20.0 mg, 
0.055 mmol) was employed as starting material with t-BuOK (43.2 mg, 0.39 mmol) in 
acetonitrile (5.5 mL).  Yield: 73% (12.8 mg, 0.035 mmol); 1H NMR (CDCl3, 500 MHz) δ 
8.05 (d, J = 8.9 Hz, 2H), 7.74 (d, J = 8.8 Hz, 2H), 6.96-9.92 (m, 4H), 6.53 (td, J = 3.9, 1.1 
Hz, 1H), 3.87 (s, 3H), 3.85 (s, 3H), 3.47-3.45 (m, 1H), 3.34 (dd, J = 14.4, 3.2 Hz, 1H), 
2.69 (dd, J = 14.4, 10.8 Hz, 1H), 2.38-2.29 (m, 1H), 2.23-2.15 (m, 1H), 1.81-1.57 (m, 
4H); 13C NMR (CDCl3, 125 MHz) δ 198.7, 197.5, 163.8, 163.2, 142.7, 142.0, 132.1, 
131.6, 131.2, 130.3, 114.1, 113.8, 55.9, 55.8, 42.8, 31.6, 27.0, 26.4, 18.8; IR (film, cm-1) 
                                                 
133 (a) Wang, L.-C.; Luis, A. L.; Agapiou, K.; Jang, H.-Y.; Krische, M. J. J. Am. Chem. Soc. 2002, 124, 
2402-2403. (b) Frank, S. A.; Mergott, D. J.; Roush, W. R. J. Am. Chem. Soc. 2002, 124, 2404-2405. 
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2925, 2840, 1671, 1630, 1597, 1569, 1507, 1254, 1172, 1029; TLC Rf 0.36 (2:1 hexanes-
EtOAc); [α]D +7.0 (c 0.77, CHCl3, 90% ee); HRMS (ESI) m/z 365.1766 (365.1753 calcd 
for C23H25O4 [M+H]+); Assay of enantiomeric purity: Enantiomers of product were 
separated by chiral HPLC employing a Chiralcel AD column (Daicel).  Conditions: 80:20 
hexanes-isopropanol; Flow rate 0.75 mL/min; 19.3 min (major ent), 28.0 min (minor ent). 
 
O
O
Br
Br
 
Compound 24.  General procedure B was followed, except that bisenone 24b (30.0 mg, 
0.065 mmol) was employed as starting material with t-BuOK (36.0 mg, 0.33 mmol) in 
acetonitrile (2.2 mL).  Yield: 70% (21 mg, 0.045 mmol); 1H NMR (CDCl3, 500 MHz) δ 
7.93 (d, J = 8.6 Hz, 2H), 7.62-7.53 (m, 6H), 6.62 (t, J = 3.6 Hz, 1H), 3.43-3.41 (m, 1H), 
3.33 (dd, J = 14.8, 3.5 Hz, 1H), 2.80 (dd, J = 14.8, 10.2 Hz, 1H), 2.38-2.31 (m, 1H), 2.25-
2.19 (m, 1H), 1.79-1.61 (m, 4H); 13C NMR (CDCl3, 125 MHz) δ 198.9, 197.2, 145.8, 
141.6, 137.8, 135.8, 132.3, 131.8, 131.2, 130.4, 128.6, 126.9, 42.8, 30.7, 26.9, 26.5, 18.4; 
IR (film, cm-1) 2932, 2861, 1679, 1640, 1585, 1393, 1263, 1067, 1008; TLC Rf 0.64 (3:1 
hexanes-EtOAc); [α]D +9.7 (c 1.0, CHCl3, 93% ee); HRMS (ESI) m/z 460.9751 
(460.9752 calcd for C21H19O2Br2 [M+H]+); Assay of enantiomeric purity: Enantiomers of 
product were separated by chiral HPLC employing a Chiralcel AD column (Daicel).  
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Conditions: 96:4 hexanes-isopropanol; Flow rate 0.75 mL/min; 26.3 min (major ent), 
32.8 min (minor ent). 
 
O
O
NO2
NO2
 
Compound 39.  General procedure B was followed, except that bisenone 39b (20.0 mg, 
0.051 mmol) was employed as starting material with t-BuOK (11.4 mg, 0.10 mmol) in 
acetonitrile (5.1 mL) and the reaction was allowed to stir for 4 h.  Yield: 71% (14.2 mg, 
0.036 mmol); 1H NMR (CDCl3, 400 MHz) δ 8.33 (d, J = 8.9 Hz, 2H), 8.30 (d, J = 8.8 
Hz, 2H), 8.23 (d, J = 8.9 Hz, 2H), 7.78 (d, J = 8.8 Hz, 2H), 6.69 (t, J = 3.6 Hz, 1H), 3.49-
3.40 (m, 2H), 2.99 (dd, J = 15.0, 9.4 Hz, 1H), 2.45-2.37 (m, 1H), 2.33-2.23 (m, 1H), 
1.81-1.69 (m, 4H); 13C NMR (CDCl3, 100 MHz) δ 197.9, 195.9, 150.3, 149.4, 148.1, 
144.2, 141.1, 141.0, 129.9, 129.4, 123.9, 123.4, 42.8, 29.8, 26.5, 26.4, 17.8; IR (film, 
cm-1) 2937, 2864, 1689, 1643, 1599, 1522, 1345, 1265; TLC Rf 0.32 (3:1 hexanes-
EtOAc); [α]D +15.0 (c 1.0, CHCl3, 84% ee); HRMS (ESI) m/z 395.1259 (395.1243 calcd 
for C21H19N2O6 [M+H]+); Assay of enantiomeric purity: Enantiomers of product were 
separated by chiral HPLC employing a Chiralcel AD column (Daicel).  Conditions: 80:20 
hexanes-isopropanol; Flow rate 0.75 mL/min; 42.9 min (major ent), 39.0 min (minor ent). 
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Compound 40.  General procedure B was followed, except that bisenone 40b (30.0 mg, 
0.11 mmol) was employed as starting material with t-BuOK (74.0 mg, 0.66 mmol) in 
acetonitrile (2.2 mL) and the reaction was allowed to stir for 40 h.  Yield: 54% (13.7 mg, 
0.048 mmol); 1H NMR (CDCl3, 500 MHz) δ 7.62 (dd, J = 1.7, 0.7 Hz, 1H), 7.57 (dd, J = 
1.7, 0.6 Hz, 1H), 7.41 (d, J = 3.7 Hz, 1H), 7.11 (dd, J = 3.6, 0.6 Hz, 1H), 7.00 (td, J = 3.9, 
1.0 Hz, 1H), 6.53-6.51 (m, 2H), 3.48-3.45 (m, 1H), 3.11 (dd, J = 14.6, 3.2 Hz, 1H), 2.66 
(dd, J = 14.6, 10.6 Hz, 1H), 2.39-2.21 (m, 2H), 1.78-1.63 (m, 4H); 13C NMR (CDCl3, 
125 MHz) δ 188.2, 183.7, 152.4, 152.3, 146.5, 146.4, 142.1, 140.9, 119.1, 118.2, 112.1, 
111.7, 42.3, 30.6, 26.3, 26.1, 18.0; IR (film, cm-1) 3130, 2934, 2860, 1673, 1628, 1564, 
1463, 1390, 1285; TLC Rf 0.32 (2:1 hexanes-EtOAc); [α]D +14 (c 0.88, CHCl3, 92% ee); 
HRMS (ESI) m/z 285.1133 (285.1127 calcd for C17H17O4 [M+H]+); Assay of 
enantiomeric purity: Enantiomers of product were separated by chiral HPLC employing a 
Chiralcel AD column (Daicel).  Conditions: 80:20 hexanes-isopropanol; Flow rate 0.75 
mL/min; 10.2 min (major ent), 14.0 min (minor ent). 
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Compound 41.  General procedure B was followed, except that bisenone 41b (20.0 mg, 
0.11 mmol) was employed as starting material with t-BuOK (37.0 mg, 0.33 mmol) in 
acetonitrile (5.5 mL) and the reaction was allowed to stir for 40 h.  Yield: 55% (7.2 mg, 
0.040 mmol); 1H NMR (CDCl3, 500 MHz) δ 6.95 (t, J = 3.9 Hz, 1H), 3.20-3.15 (m, 1H), 
2.60 (dd, J = 15.6, 3.2 Hz, 1H), 2.31-2.26 (m, 5H), 2.17 (s, 3H), 1.66-1.52 (m, 5H); 13C 
NMR (CDCl3, 125 MHz) δ 208.7, 199.2, 142.9, 142.5, 48.0, 30.1, 28.2, 26.6, 26.4, 25.9, 
17.4; IR (film, cm-1) 2923, 2854, 1717, 1660, 1635, 1351, 1233, 1160; TLC Rf 0.39 (2:1 
hexanes-EtOAc); [α]D –43 (c 0.42, CHCl3, 90% ee); HRMS (ESI) m/z 203.1056 
(203.1048 calcd for C11H16O2Na [M+Na]+); Assay of enantiomeric purity: Enantiomers 
of product were separated by chiral HPLC employing a Chiralcel AD column (Daicel).  
Conditions: 97:3 hexanes-isopropanol; Flow rate 0.60 mL/min; 14.9 min (major ent), 
16.0 min (minor ent). 
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Compound 42.  General procedure B was followed, except that bisenone 42b (20.0 mg, 
0.073 mmol) was employed as starting material with t-BuOK (49.4 mg, 0.44 mmol) in 
acetonitrile (1.5 mL).  Yield: 66% (13.4 mg, 0.049 mmol); 1H NMR (CDCl3, 500 MHz) 
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δ 7.67 (d, J = 6.9 Hz, 2H), 7.51 (t, J = 7.4 Hz, 1H), 7.42 (t, J = 7.4 Hz, 2H), 6.54 (t, J = 
3.9 Hz, 1H), 4.09 (q, J = 7.1 Hz, 2H), 3.40-3.33 (m, 1H), 2.59 (dd, J = 14.9, 4.4 Hz, 1H), 
2.40 (dd, J = 15.1, 9.1 Hz, 1H), 2.35-2.26 (m, 1H), 2.23-2.14 (m, 1H), 1.85-1.61 (m, 4H), 
1.22 (t, J = 7.1 Hz, 3H); 13C NMR (CDCl3, 125 MHz) δ 197.6, 172.4, 143.9, 141.2, 
138.6, 131.6, 129.3, 128.0, 60.2, 38.1, 30.1, 27.1, 26.0, 18.3, 14.2; IR (film, cm-1) 2927, 
2851, 1728, 1641, 1593, 1443, 1368, 1265, 1249, 1173; TLC Rf 0.52 (3:1 hexanes-
EtOAc); [α]D –62 (c 0.5, CHCl3, 67% ee); HRMS (ESI) m/z 295.1320 (295.1310 calcd 
for C17H20O3Na [M+Na]+); Assay of enantiomeric purity: Enantiomers of product were 
separated by chiral HPLC employing a Chiralcel AD column (Daicel).  Conditions: 96:4 
hexanes-isopropanol; Flow rate 0.75 mL/min; 11.7 min (major ent), 14.6 min (minor ent). 
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Compound 26.  1H NMR (CDCl3, 500 MHz) δ 7.94 (dd, J = 8.2, 1.2 Hz, 2H), 7.78 (dd, J 
= 8.2, 1.1 Hz, 2H), 7.54 (t, J = 7.25 Hz, 1H), 7.51-7.42 (m, 3H), 7.35 (t, 7.8 Hz, 2H), 
5.96-5.92 (m, 1H), 5.80-5.75 (m, 1H), 4.43 (bs, 1H), 3.06 (dd, J = 17.0, 7.9 Hz, 1H), 2.95 
(dd, J = 17.3, 6.0 Hz, 1H), 2.85-2.78 (m, 1H), 2.20-2.07 (m, 3H), 1.80-1.72 (m, 1H); 13C 
NMR (CDCl3, 125 MHz) δ 201.3, 199.7, 137.2, 137.1, 133.1, 132.9, 129.9, 128.7, 128.5, 
128.3, 127.9, 124.1, 45.8, 39.6, 31.9, 25.2, 23.6; IR (film, cm-1) 3060, 3025, 2922, 1682, 
1595, 1578, 1446, 1372, 1323, 1283, 1211, 999; TLC Rf 0.52 (3:1 hexanes-EtOAc); [α]D 
+54.3 (c 0.23, CHCl3, 84% ee); HRMS (ESI) m/z 305.1552 (305.1542 calcd for C21H21O2 
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[M+H]+); Assay of enantiomeric purity: Enantiomers of product were separated by chiral 
HPLC employing a Chiralcel AD column (Daicel).  Conditions: 96:4 hexanes-
isopropanol; Flow rate 0.75 mL/min; 26.1 min (major ent), 27.9 min (minor ent). 
 
General procedure C: preparation of Rauhut-Currier catalysts. 
O
NHAc
MeO
SH  
Compound 20.  A white heterogeneous mixture of CysOMe·HCl (1.00 g, 5.82 mmol) in 
acetonitrile (58 mL) was cooled to 0 °C.  N,N-Diisopropylethylamine (935 µL, 5.24 
mmol) and acetyl chloride (374 µL, 5.24 mmol) were added and the reaction was allowed 
to stir for 20 min.  Saturated aqueous NH4Cl (50 mL) was added at 0 °C and the reaction 
mixture was extracted with EtOAc (2 x 100 mL).  The combined organic layers were 
washed with saturated aqueous NaHCO3 (100 ml), saturated aqueous NaCl (100 mL), 
dried over Na2SO4, and concentrated under reduced pressure.  Flash chromatography on 
silica gel (hexanes-EtOAc, 1:2) yielded 20 as a white fluffy solid (422 mg, 2.38 mmol, 
41%). 1H NMR (CDCl3, 500 MHz) δ 6.41-6.33 (bs, 1H), 4.90 (dt, J = 7.9, 3.8 Hz, 1H), 
3.80 (s, 3H), 3.07-2.98 (m, 2H), 2.08 (s, 3H), 1.34 (t, J = 8.9 Hz, 1H); 13C NMR (CDCl3, 
125 MHz) δ 171.0, 170.1, 53.9, 53.2, 27.2, 23.5; IR (film, cm-1) 3276, 2952, 1748, 1652, 
1532, 1437, 1369, 1213; TLC Rf 0.21 (1:2 hexanes-EtOAc); [α]D +71 (c 1.0, CHCl3); 
HRMS (ESI) m/z 200.0363 (200.0357 calcd for C6H11NO3SNa [M+Na]+). 
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Compound 22.  General procedure C was followed, except that CysOMe·HCl (100 mg, 
0.58 mmol) was used with isobutyryl chloride (55 µL, 0.52 mmol) and N,N-
diisopropylethylamine (94 µL, 0.52 mmol) in acetonitrile (5.8 mL).  Yield: 39% (47 mg, 
0.23 mmol). 1H NMR (CDCl3, 500 MHz) δ 6.40-6.33 (bs, 1H), 4.89 (dt, J = 7.7, 3.7 Hz, 
1H), 3.80 (s, 3H), 3.03 (dd, J = 8.8, 4.1 Hz, 2H), 2.47 (quintet, J = 6.9 Hz, 1H), 1.31 (t, J 
= 8.9 Hz, 1H), 1.20 (d, J = 4.1 Hz, 3H), 1.19 (d, J = 4.1 Hz, 3H); 13C NMR (CDCl3, 125 
MHz) δ 177.1, 171.2, 53.6, 53.2, 35.9, 27.3, 20.0, 19.7; IR (film, cm-1) 3322, 2962, 2921, 
1749, 1744, 1650, 1528, 1430, 1340, 1319, 1213; TLC Rf 0.64 (1:2 hexanes-EtOAc); 
[α]D +59 (c 1.0, CHCl3); HRMS (ESI) m/z 206.0858 (206.0851 calcd for C8H16NO3S 
[M+H]+). 
 
O H
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Compound 23.  General procedure C was followed, except that CysOMe·HCl (200 mg, 
1.2 mmol) was used with pivaloyl chloride (123 µL, 1.0 mmol) and N,N-
diisopropylethylamine (174 µL, 1.0 mmol) in acetonitrile (11.6 mL).  Yield: 42% (107 
mg, 0.49 mmol); 1H NMR (CDCl3, 500 MHz) δ 6.58-6.48 (bs, 1H), 4.85 (dt, J = 7.9, 3.9 
Hz, 1H), 3.80 (s, 3H), 3.03 (dd, J = 8.8, 4.1 Hz, 2H), 1.29 (t, J = 9.0 Hz, 1H), 1.25 (s, 
9H); 13C NMR (CDCl3, 125 MHz) δ 178.7, 171.3, 53.7, 53.2, 39.2, 27.8, 27.2; IR (film, 
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cm-1) 3349, 2953, 1747, 1653, 1648, 1513, 1438, 1207; TLC Rf 0.73 (1:2 hexanes-
EtOAc); [α]D +55 (c 1.0, CHCl3); HRMS (ESI) m/z 220.1004 (220.1007 calcd for 
C9H18NO3S [M+H]+). 
 
Determination of absolute configuration. 
O N
Br
H
N
Br
NO2
NO2
 
Compound 25.  2,4-dinitrophenylhydrazine (5.4 mg, 0.022 mmol) and 0.5 N H2SO4 
(22 µL, 0.011 mmol) were added to a solution of 24 (10 mg, 0.022 mmol) in ethanol 
(100 µL).  The red heterogeneous mixture was heated to reflux for 12 h, at which point 
excess 2,4-dinitrophenylhydrazine (10.8 mg, 0.044 mmol) was added and refluxed for an 
additional 12 h until the starting material was consumed as indicated by TLC.  The solid 
material was collected and purified by silica gel chromatography (hexanes-EtOAc, 10:1) 
to afford 25 as an orange solid (6.3 mg, 0.010 mmol, 45%).  X-ray quality crystals were 
prepared by recrystallizing 25 from an Et2O-ethyl acetate solution affording bright orange 
plate crystals. 1H NMR (CDCl3, 500 MHz) δ 11.6 (s, 1H), 9.17 (d, J = 2.5 Hz, 1H), 8.36 
(dd, J = 9.6, 2.5 Hz, 1H), 8.08 (d, J = 9.6 Hz, 1H),  7.87 (d, J = 8.6 Hz, 2H), 7.59 (d, J = 
8.6 Hz, 2H), 7.53 (d, J = 8.6 Hz, 2H), 7.42 (d, J = 8.6 Hz, 2H), 6.69 (t, J = 3.8 Hz, 1H), 
3.39-3.30 (m, 1H), 3.24 (dd, J = 14.4, 5.6 Hz, 1H), 2.79 (dd, J = 14.4, 9.6 Hz, 1H), 2.49-
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2.39 (m, 1H), 2.29-2.17 (m, 1H), 1.90-1.59 (m, 4H); 13C NMR (CDCl3, 125 MHz) δ 
196.6, 154.5, 146.9, 145.4, 140.6, 138.8, 137.1, 135.6, 132.3, 131.9, 131.0, 130.6, 130.2, 
129.1, 127.2, 125.1, 123.8, 117.3, 31.5, 31.2, 27.3, 26.6, 18.5; IR (film, cm-1) 3317, 2927, 
2856, 1645, 1617, 1586, 1514, 1502, 1486, 1331, 1307, 1263; TLC Rf 0.53 (3:1 hexanes-
EtOAc); [α]D + 50 (c 0.45, CHCl3); HRMS (ESI) m/z 641.0034 (641.0035 calcd for 
C27H23Br2N4O5 [M+H]+). 
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3.7.1 NMR Spectra 
Compound 1. 
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Compound 38b. 
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Compound 24b. 
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Compound 39b. 
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Compound 40b. 
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Compound 41b. 
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Compound 42b. 
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Compound 38. 
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Compound 24. 
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Compound 39. 
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Compound 40. 
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Compound 41. 
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Compound 42. 
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Compound 26. 
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Compound 25. 
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Compound 20. 
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Compound 22. 
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Compound 23. 
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3.7.2 Appendix: Crystallographic Data for Compound 25 
 
YALE CHEMICAL INSTRUMENTATION CENTER 
 
X-Ray Structure Report 
Reference Number:  MILLER_CA01 
 
September 29, 2006 
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YALE CHEMICAL INSTRUMENTATION CENTER 
 
X-Ray Structure Report 
Reference Number:  MILLER_CA01 
 
September 29, 2006 
 
 
Data Collection 
 
 An orange plate crystal of C27H22Br2N4O5 having approximate dimensions of 0.20 
x 0.20 x 0.10 mm3 was mounted with epoxy cement on the tip of a fine glass fiber.  All 
measurements were made on a Nonius KappaCCD diffractometer with graphite 
monochromated Mo-Kα radiation. 
 
 Cell constants and an orientation matrix for data collection corresponded to a 
primitive orthorhombic cell with dimensions: 
           a = 7.3503(15) Å α = 90 o 
           b = 11.878(2) Å β = 90 o 
           c = 33.132(7) Å γ = 90 o 
           V = 2892.6(10) Å
3
 
 
For Z = 4 and F.W. = 642.31, the calculated density is 1.475 g/cm3.  Based on a 
statistical analysis of intensity distribution, and the successful solution and refinement of 
the structure, the space group was determined to be P212121 (#19).  
 
 The data were collected at a temperature of 173(2) K to a maximum 2θ value of 
58.22 °.   Three omega scans consisting of 108, 108, and 87 data frames, respectively, 
were collected with a frame width of 0.7 ° and a detector-to-crystal distance, Dx, of 43.0 
mm.  Each frame was exposed twice (for the purpose of de-zingering) for a total of 21 s.  
The data frames were processed and scaled using the DENZO software package.134 
 
Data Reduction 
 
 A total of 7386 reflections were collected of which 7386 were unique and 
observed (Rint = 0.000, Friedel pairs not mergerd).  The linear absorption coefficient, µ, 
for Mo-Kα radiation is 28.44 cm-1, and no absorption correction was applied.  The data 
were corrected for Lorentz and polarization effects.  
 
                                                 
134 Z. Otwinowski and W. Minor, "Processing of X-Ray Diffraction Data Collected in Oscillation Mode," 
Methods in Enzymology, vol. 276: Macromolecular Crystallography, part A, 307-326, 1997, C.W. Carter, 
Jr. & R.M. Sweet, Eds., Academic Press. 
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Structure Solution and Refinement 
 
 The structure was solved by direct methods and expanded using Fourier 
techniques. 135   The non-hydrogen atoms were refined anisotropically, and hydrogen 
atoms, with exceptions noted, were treated as idealized contributions. The final cycle of 
full-matrix least-squares refinement136 on F was based on 7386 observed reflections (I > 
2.00σ(I)) and 347 variable parameters and converged with unweighted and weighted 
agreement factors of:  
 
R = Σ ||Fo| - |Fc|| / Σ |Fo| = 0.0521 
Rw = {Σ[w (Fo2 – Fc2)2] / Σ[w(Fo2)2]}1/2 = 0.1252 
 
 The maximum and minimum peaks on the final difference Fourier map 
corresponded to 0.990 and –0.442 e-/Å3 respectively.  
 
 
 
Structural Description 
 
 The compound crystallized in the chiral orthorhombic space group P212121 with 
one molecule in the asymmetric unit and four molecules in the unit cell.   
H(2) was located from the residual electron difference map and freely refined 
with isotropic displacement parameters.  No geometric restraints were applied to the 
N(2)-H(2) bond, which refined to a distance of 0.76(5) Å.  As illustrated in Figure 3, H(2) 
is hydrogen bonded to O(2) of the adjacent nitro-group.  Interatomic distances are 2.03 Å 
for H(2)···O(2) and  2.60 Å for N(2)···O(2).  The N(2)-H(2)···O angle is 131.3 °. 
Extensive π-stacking is present in the crystal lattice.  As illustrated in Figures 4 
and 5, the π-stacking is present between the dinitro-substituted phenyl ring, C(22-27) and 
                                                 
135 SHELXTL, v.6.12, Bruker-AXS, Madison, WI, 2001. 
136 Least Squares function minimized: Σw(Fo2 – Fc2)2 
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one of the bromo-substituted phenyl rings, C(16-21).  Interplane separations are 
approximately 3.6 Å and the stacking propagates along the crystallographic a-axis. 
The absolute molecular configuration was unambiguously determined [Flack 
= - 0.013(10)].  ORTEPs, packing diagrams and full crystallographic tables follow. 
 
 
 
 
 
Figure 1 
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Figure 3 
 
 
Figure 4 
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Figure 5 
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Packing diagram – View down the a-axis 
 
Packing diagram – View down the b-axis 
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Packing diagram – View down the c-axis 
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Table 1.  Crystal data and structure refinement for miller_ca01. 
Identification code  miller_ca01 
Empirical formula  C27 H22 Br2 N4 O5 
Formula weight  642.31 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P2(1)2(1)2(1) 
Unit cell dimensions a = 7.3503(15) Å α= 90°. 
 b = 11.878(2) Å β= 90°. 
 c = 33.132(7) Å γ = 90°. 
Volume 2892.6(10) Å3 
Z 4 
Density (calculated) 1.475 g/cm3 
Absorption coefficient 28.44 cm-1 
F(000) 1288 
Crystal size 0.20 x 0.20 x 0.10 mm3 
Theta range for data collection 2.84 to 29.11°. 
Index ranges -10<=h<=10, -16<=k<=16, -44<=l<=45 
Reflections collected 7386 
Independent reflections 7386 [R(int) = 0.0000] 
Completeness to theta = 29.11° 98.9 %  
Absorption correction None 
Max. and min. transmission 0.7641 and 0.6001 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7386 / 0 / 347 
Goodness-of-fit on F2 1.008 
Final R indices [I>2sigma(I)] R1 = 0.0521, wR2 = 0.1252 
R indices (all data) R1 = 0.0891, wR2 = 0.1417 
Absolute structure parameter -0.013(10) 
Largest diff. peak and hole 0.990 and -0.442 e.Å-3 
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Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (Å2x 103) 
for miller_ca01.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
Br(1) 8864(1) 7359(1) 4467(1) 48(1) 
Br(2) 8544(1) 9560(1) 8834(1) 45(1) 
O(1) 8632(5) 8496(2) 6489(1) 35(1) 
O(2) 6852(5) 13348(3) 6016(1) 43(1) 
O(3) 6366(6) 14939(3) 5730(1) 51(1) 
O(4) 5269(5) 18273(3) 7107(1) 41(1) 
O(5) 4519(5) 18139(3) 6476(1) 43(1) 
N(1) 7735(5) 12705(3) 7152(1) 25(1) 
N(2) 7469(5) 13253(3) 6786(1) 27(1) 
N(3) 6577(5) 14366(3) 6033(1) 34(1) 
N(4) 5157(5) 17751(3) 6790(1) 31(1) 
C(1) 9217(6) 9414(4) 5471(1) 33(1) 
C(2) 9104(7) 9028(4) 5076(1) 41(1) 
C(3) 8932(7) 7886(4) 5006(1) 36(1) 
C(4) 8799(7) 7122(4) 5316(1) 36(1) 
C(5) 8912(6) 7516(4) 5710(1) 29(1) 
C(6) 9196(6) 8653(3) 5790(1) 25(1) 
C(7) 9431(5) 9019(3) 6222(1) 26(1) 
C(8) 10658(6) 9946(3) 6327(1) 25(1) 
C(9) 12158(6) 10147(4) 6107(1) 30(1) 
C(10) 13724(7) 10880(4) 6227(2) 42(1) 
C(11) 13630(6) 11154(4) 6676(2) 36(1) 
C(12) 11688(5) 11489(4) 6788(1) 29(1) 
C(13) 10377(5) 10513(4) 6731(1) 24(1) 
C(14) 8394(6) 10936(3) 6768(1) 25(1) 
C(15) 8133(5) 11655(3) 7142(1) 24(1) 
C(16) 8366(5) 11131(3) 7545(1) 24(1) 
C(17) 8016(6) 9992(3) 7603(1) 30(1) 
C(18) 8097(6) 9535(4) 7982(2) 35(1) 
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C(19) 8511(6) 10187(4) 8307(1) 30(1) 
C(20) 8901(6) 11328(4) 8260(1) 31(1) 
C(21) 8825(6) 11791(3) 7877(1) 28(1) 
C(22) 6924(5) 14348(3) 6788(1) 22(1) 
C(23) 6490(6) 14924(3) 6423(1) 27(1) 
C(24) 5916(6) 16034(3) 6422(1) 27(1) 
C(25) 5797(5) 16587(3) 6785(1) 26(1) 
C(26) 6232(7) 16069(3) 7147(1) 28(1) 
C(27) 6772(6) 14956(3) 7149(1) 26(1) 
________________________________________________________________________________ 
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Table 3.   Bond lengths [Å] and angles [°] for  miller_ca01. 
_____________________________________________________  
Br(1)-C(3)  1.895(4) 
Br(2)-C(19)  1.900(4) 
O(1)-C(7)  1.230(5) 
O(2)-N(3)  1.228(5) 
O(3)-N(3)  1.223(5) 
O(4)-N(4)  1.225(5) 
O(5)-N(4)  1.230(5) 
N(1)-C(15)  1.282(5) 
N(1)-N(2)  1.388(5) 
N(2)-H(2)  0.76(5) 
N(2)-C(22)  1.361(5) 
N(3)-C(23)  1.452(5) 
N(4)-C(25)  1.460(5) 
C(1)-C(2)  1.389(6) 
C(1)-C(6)  1.391(6) 
C(2)-C(3)  1.382(7) 
C(3)-C(4)  1.372(7) 
C(4)-C(5)  1.390(6) 
C(5)-C(6)  1.392(6) 
C(6)-C(7)  1.507(6) 
C(7)-C(8)  1.465(6) 
C(8)-C(9)  1.344(6) 
C(8)-C(13)  1.513(6) 
C(9)-C(10)  1.497(6) 
C(10)-C(11)  1.524(7) 
C(11)-C(12)  1.528(6) 
C(12)-C(13)  1.520(6) 
C(13)-C(14)  1.546(6) 
C(14)-C(15)  1.516(6) 
C(15)-C(16)  1.482(6) 
C(16)-C(17)  1.391(6) 
C(16)-C(21)  1.393(6) 
C(17)-C(18)  1.367(6) 
C(18)-C(19)  1.360(7) 
C(19)-C(20)  1.394(6) 
C(20)-C(21)  1.383(6) 
C(22)-C(27)  1.402(6) 
C(22)-C(23)  1.426(6) 
C(23)-C(24)  1.385(6) 
C(24)-C(25)  1.372(6) 
C(25)-C(26)  1.386(6) 
C(26)-C(27)  1.381(6) 
 
C(15)-N(1)-N(2) 117.8(4) 
H(2)-N(2)-C(22) 119(4) 
H(2)-N(2)-N(1) 121(4) 
C(22)-N(2)-N(1) 119.0(4) 
O(3)-N(3)-O(2) 122.0(4) 
O(3)-N(3)-C(23) 118.1(4) 
O(2)-N(3)-C(23) 119.8(4) 
O(4)-N(4)-O(5) 124.2(4) 
O(4)-N(4)-C(25) 117.9(4) 
O(5)-N(4)-C(25) 117.9(4) 
C(2)-C(1)-C(6) 120.1(4) 
C(3)-C(2)-C(1) 119.1(5) 
C(4)-C(3)-C(2) 122.0(4) 
C(4)-C(3)-Br(1) 119.0(3) 
C(2)-C(3)-Br(1) 118.9(4) 
C(3)-C(4)-C(5) 118.4(4) 
C(4)-C(5)-C(6) 120.9(4) 
C(5)-C(6)-C(1) 119.2(4) 
C(5)-C(6)-C(7) 118.5(4) 
C(1)-C(6)-C(7) 122.2(4) 
O(1)-C(7)-C(8) 120.2(4) 
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O(1)-C(7)-C(6) 118.8(4) 
C(8)-C(7)-C(6) 120.9(4) 
C(9)-C(8)-C(7) 120.7(4) 
C(9)-C(8)-C(13) 120.9(4) 
C(7)-C(8)-C(13) 117.4(4) 
C(8)-C(9)-C(10) 126.2(4) 
C(9)-C(10)-C(11) 110.4(4) 
C(10)-C(11)-C(12) 109.7(4) 
C(13)-C(12)-C(11) 111.3(3) 
C(8)-C(13)-C(12) 111.3(3) 
C(8)-C(13)-C(14) 110.1(3) 
C(12)-C(13)-C(14) 109.9(3) 
C(15)-C(14)-C(13) 111.5(3) 
N(1)-C(15)-C(16) 114.3(4) 
N(1)-C(15)-C(14) 126.7(4) 
C(16)-C(15)-C(14) 118.9(3) 
C(17)-C(16)-C(21) 118.8(4) 
C(17)-C(16)-C(15) 120.9(4) 
C(21)-C(16)-C(15) 120.2(4) 
C(18)-C(17)-C(16) 120.4(4) 
C(19)-C(18)-C(17) 120.7(4) 
C(18)-C(19)-C(20) 120.7(4) 
C(18)-C(19)-Br(2) 120.5(3) 
C(20)-C(19)-Br(2) 118.8(3) 
C(21)-C(20)-C(19) 118.7(4) 
C(20)-C(21)-C(16) 120.7(4) 
N(2)-C(22)-C(27) 121.3(4) 
N(2)-C(22)-C(23) 121.4(4) 
C(27)-C(22)-C(23) 117.3(4) 
C(24)-C(23)-C(22) 121.8(4) 
C(24)-C(23)-N(3) 116.4(4) 
C(22)-C(23)-N(3) 121.7(4) 
C(25)-C(24)-C(23) 118.2(4) 
C(24)-C(25)-C(26) 122.1(4) 
C(24)-C(25)-N(4) 118.9(4) 
C(26)-C(25)-N(4) 119.0(4) 
C(27)-C(26)-C(25) 119.8(4) 
C(26)-C(27)-C(22) 120.8(4) 
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_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
  
 
Table 4.   Anisotropic displacement parameters  (Å2x 103) for miller_ca01.  The anisotropic 
displacement factor exponent takes the form:  -2π2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
Br(1) 48(1)  67(1) 31(1)  -16(1) 5(1)  -21(1) 
Br(2) 52(1)  47(1) 35(1)  13(1) 0(1)  7(1) 
O(1) 49(2)  28(2) 29(2)  0(1) 7(2)  -6(2) 
O(2) 68(3)  29(2) 33(2)  -4(1) -2(2)  6(2) 
O(3) 86(3)  41(2) 25(2)  3(1) -1(2)  14(2) 
O(4) 55(2)  24(2) 45(2)  -9(2) 1(2)  3(2) 
O(5) 55(2)  28(2) 45(2)  5(2) -10(2)  12(2) 
N(1) 29(2)  20(2) 27(2)  2(2) -2(1)  2(2) 
N(2) 38(2)  21(2) 22(2)  -1(2) 2(2)  2(2) 
N(3) 38(2)  37(2) 26(2)  2(2) 1(2)  5(2) 
N(4) 32(2)  20(2) 42(2)  -1(2) 3(2)  -1(2) 
C(1) 43(2)  25(2) 30(2)  -3(2) -3(2)  -2(2) 
C(2) 49(3)  45(3) 30(2)  2(2) 0(2)  -6(2) 
C(3) 38(3)  41(3) 29(2)  -12(2) 2(2)  -7(2) 
C(4) 41(3)  32(2) 36(2)  -10(2) -1(2)  -10(2) 
C(5) 25(2)  27(2) 34(2)  -5(2) 3(2)  -4(2) 
C(6) 27(2)  25(2) 23(2)  -6(2) -1(2)  -2(2) 
C(7) 26(2)  22(2) 31(2)  -2(2) 3(2)  2(2) 
C(8) 27(2)  20(2) 27(2)  2(2) -1(2)  4(2) 
C(9) 30(2)  25(2) 34(3)  -4(2) 6(2)  -4(2) 
C(10) 32(2)  48(3) 45(3)  -14(2) 10(2)  -9(2) 
C(11) 24(2)  43(3) 43(3)  -9(2) 0(2)  -3(2) 
C(12) 22(2)  29(2) 37(2)  -6(2) 0(2)  3(2) 
C(13) 24(2)  23(2) 26(2)  -3(2) -1(2)  4(2) 
C(14) 26(2)  22(2) 26(2)  -6(2) -3(2)  2(2) 
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C(15) 19(2)  26(2) 29(2)  1(2) 0(2)  -4(2) 
C(16) 19(2)  22(2) 31(2)  -3(2) -2(2)  3(2) 
C(17) 32(2)  20(2) 39(3)  -2(2) -4(2)  1(2) 
C(18) 38(2)  22(2) 45(3)  4(2) 0(2)  5(2) 
C(19) 27(2)  34(2) 29(2)  7(2) -2(2)  8(2) 
C(20) 34(2)  30(2) 30(2)  -3(2) 0(2)  0(2) 
C(21) 30(2)  22(2) 31(2)  -1(2) -3(2)  -1(2) 
C(22) 22(2)  21(2) 24(2)  2(2) 1(2)  -1(2) 
C(23) 29(2)  26(2) 27(2)  -2(2) 3(2)  -3(2) 
C(24) 30(2)  25(2) 25(2)  4(2) 2(2)  1(2) 
C(25) 21(2)  24(2) 32(2)  1(2) 0(2)  2(2) 
C(26) 34(2)  24(2) 26(2)  -3(2) 2(2)  -3(2) 
C(27) 34(2)  23(2) 21(2)  1(2) -3(2)  3(2) 
______________________________________________________________________________ 
  
- 201 - 
Table 5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 3) 
for miller_ca01. 
________________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________________  
  
H(2) 7640(70) 12960(40) 6587(15) 30(14) 
H(1A) 9309 10198 5523 39 
H(2A) 9146 9542 4857 50 
H(4A) 8633 6344 5262 44 
H(5A) 8794 7001 5928 35 
H(9A) 12230 9791 5851 36 
H(10A) 13693 11587 6068 50 
H(10B) 14882 10489 6167 50 
H(11A) 14474 11779 6739 44 
H(11B) 14004 10488 6835 44 
H(12A) 11658 11737 7074 35 
H(12B) 11298 12130 6618 35 
H(13A) 10603 9948 6949 29 
H(14A) 8077 11382 6526 30 
H(14B) 7562 10281 6781 30 
H(17A) 7720 9528 7379 36 
H(18A) 7861 8756 8018 42 
H(20A) 9213 11779 8486 37 
H(21A) 9088 12567 7840 33 
H(24A) 5613 16403 6177 32 
H(26A) 6159 16479 7392 34 
H(27A) 7043 14598 7398 32 
________________________________________________________________________________   
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4 Synthetic Studies Toward the Synthesis of (+)-Sch 642305 
via Selective Transannular Rauhut-Currier Reaction 
4.1 Introduction 
An ongoing question in our research group has been concerned with the issue of 
utilizing catalyst control to override substrate control.  It is well established that the 
conformational rigidity of macrocycles can be employed as a controlling element for 
various stereospecific transformations. 137   Transannular reactions have the ability to 
incorporate high degrees of both stereo and architectural complexity in a single step, 
traditionally directed by the conformational properties of the reacting macrocycle.138  The 
ability to control the outcome of these reactions through the use of a chiral catalyst would 
enable the efficient synthesis of not only desired complex molecules, but analogs of these 
products as well. 
In 2004, Roush and coworkers reported the synthesis of Spinosyn A in which they 
effectively used trimethylphosphine to catalyze a diastereoselective transannular 
Rauhut-Currier (RC) reaction (Figure 4.1). 139   They utilized the predefined 
conformational preference of the macrocycle in order to achieve high diastereoselectivity 
and set the C3 stereocenter.  The stereochemical issues were dependent upon the intrinsic 
properties of the macrocycle, and not of the achiral catalyst.  However, an alternative 
approach would be necessary if the inherent reactivity provided the opposite diastereomer 
                                                 
137 Still, W. C.; Galynker, I. Tetrahedron 1981, 37, 3981-3996. 
138 For a recent example, please see: Scheerer, J. R.; Lawrence, J. F.; Wang, G. C.; Evans, D. A. J. Am. 
Chem. Soc. 2007, 129, 8968-8969 and references therein. 
139 (a) Mergott, D. J.; Frank, S. A.; Roush, W. R.  Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 11955-11959. 
(b) Winbush, S. M.; Mergott, D. J.; Roush, W. R. J. Org. Chem. 2008, 73, 1818-1829. 
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from that desired, or to obtain an unnatural epimer of the natural product.  We are 
intrigued with the prospect of using chiral catalysts to override the inherent selectivity 
dictated by macromolecular conformation, thereby granting access to otherwise difficult 
to obtain stereoisomers.   
Figure 4.1: Use of macrocyclic control of the Rauhut-Currier Reaction in the synthesis of 
Spinosyn A by Roush and co-workers. 
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Inspired by the synthesis of Spinosyn A, we sought a molecule that would provide 
a forum in which we could explore this challenge.  As illustrated in Scheme 4.1, the 
application of our enantioselective Rauhut-Currier methodology140 to the stereoselective 
synthesis of (+)-Sch 642305 (1) will allow the us to address three major challenges: 1) 
the ability of our catalyst to dictate the stereoselectivity of the key step (catalyst control) 
and allow the synthesis of the natural product and unnatural stereoisomeric analogs, 2) 
the application of our newly developed RC methodology in a complex reaction setting, 
further demonstrating the utility of the transformation, and 3) the demonstration that this 
new methodology for generating a carbon–carbon bond with exquisite control of 
stereochemistry will provide an expedient synthesis of natural product 1. 
Herein we present the initial investigations into addressing each of these 
challenges in the synthesis of (+)-Sch 642305.  Crucially, we have synthesized the key 
                                                 
140 Please refer to Chapter 3 for an in-depth discussion of our methodology study. 
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Rauhut-Currier substrate in both pathways and have begun preliminary studies in that 
context.  The findings that will be discussed lay the groundwork for an ongoing in-depth 
study.   
Scheme 4.1:  Application of our developed enantioselective Rauhut-Currier reaction to the 
synthesis of (+)-Sch 642305 (1). 
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4.2 Biological Significance: Anti-bacterial and Anti-HIV 
In 2003, scientists at Schering-Plough reported the isolation of 10-membered 
macrolide (+)-Sch642305 (1) from Penicillium verrucosum. 141   The compound was 
shown to inhibit bacterial DNA primase (Dna G), a novel target for the discovery of new 
antibiotics, with an EC50 value of 70 µM. 142   Dna G is a DNA-dependent RNA 
polymerase which is required for chromosomal DNA replication in Gram-positive and 
Gram-negative bacteria.  With the emergence of multiple drug resistant organisms, the 
                                                 
141 Chu, M.; Mierzwa, R.; Xu, L.; He, L.; Terracciano, J.; Patel, M.; Gullo, V.; Black, T.; Zhao, W. J.; 
Chan, T. M.; McPhail, A.T.  J. Nat. Prod. 2003, 66, 1527-1530. 
142 Agarwal, A.; Louise-May, S.; Thanassi, J. A.; Podos, S. D.; Cheng, J.; Thoma, C.; Liu, C.; Wiles, J. A.; 
Nelson, D. M.; Phadke, A. S.; Bradbury, B. J.; Deshpande, M. S.; Pucci, M. J. Bioorg. Med. Chem. Lett. 
2007, 17, 2807-2810. 
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identification and development of new targets to address the challenge of antibacterial 
resistance is of great interest worldwide. 
The 10-membered macrolide was also isolated from the fungus Septofusidium sp. 
in 2005 by a group at Merck. 143   It was shown to inhibit HIV-1 Tat-dependent 
transactivation with an IC50 value of 1.0 µM.  Human immunodeficiency virus-1 tat 
(HIV-tat) is a proinflammatory cytokine and one of six regulatory proteins encoded by 
HIV that are essential for viral replication.  The Tat protein is known to affect various 
cellular responses, playing a critical role in the pathogenesis of AIDS, and therefore 
represents an attractive target for the development of a new class of therapeutics in the 
treatment of HIV infections.  
4.3 Previous Synthesis of (+)-Sch 642305 
In addition to its interesting biological activities, (+)-Sch 642305 (1) is 
structurally novel with a decalactone ring trans-fused to a 4-hydroxycyclohexenone ring 
and includes four stereogenic centers, three of which are contiguous.  Accordingly, the 
synthesis of 1 presents interesting challenges and has been the subject of attention of 
various research groups, leading to six total syntheses reported in the five years since its 
discovery in 2003.144-149 
As illustrated in Figure 4.2 (eq 1), Mehta and Shinde 144  reported the first 
enantioselective total synthesis of compound 1 in 2005.  The key steps of their synthesis 
                                                 
143 Jayasuriya, H.; Zink, D. L.; Polishook, J. D.; Bills, G. F.; Dombrowski, A. W.; Genilloud, O.; Pelaez, F. 
F.; Herranz, L.; Quamina, D.; Lingham, R. B.; Danzeizen, R.; Graham, P. L.; Tomassini, J. E.; Singh, S. B. 
Chem. Biodiversity 2005, 2, 112-122. 
144 Mehta, G.; Shinde, H. M.  J. Chem. Soc., Chem. Commun. 2005, 3703-3705. 
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included ring-closing metathesis (RCM) to construct the decalactone ring along the 
C8-C9 bond as well as a lipase-mediated enzymatic desymmetrization to generate the 
enantiopure substituted cyclohexenone.  Watanabe and co-workers145 reported a synthesis 
in 2006 that featured a highly functionalized enantiopure cyclohexanone derivative 
obtained through two stereoselective enzymatic reductions (baker’s yeast), 
stereoselective dianion alkylation of a β-keto-sulfoxide, and finally Yamaguchi 
macrolactonization (Figure 4.2, eq 2).  An enantioselective synthesis by Trauner and co-
workers employed a Mukaiyama-Michael addition/allylation sequence to establish the 
syn-anti relationship of the three contiguous stereocenters followed by RCM to form the 
10-memberd lactone.146 
Figure 4.2: Synthesis of compound 1 by the groups of (1) Mehta, (2) Watanabe, and (3) Trauner.  
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145 Ishigami, K.; Katsuta, R.; Watanabe, H. Tetrahedron 2006, 62, 2224-2230. 
146 Wilson, E. M.; Trauner, D. Org Lett. 2007, 9, 1327-1329. 
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More recently, Carda and co-workers 147  have presented a stereoselective 
synthesis relying on a similar Mukaiyama-Michael addition/allylation sequence, as 
employed by the Trauner laboratory, as well as a macrolactonization via the Mitsunobu 
procedure (Figure 4.3, eq 4).  The strategy of employing a single chiral auxiliary to set 
multiple stereocenters was employed by Fujioka and co-workers to promote both regio- 
and stereoselective transformations while serving as a protecting group (Figure 4.3, eq 5). 
148 
Figure 4.3: Synthesis of compound 1 by the groups of (4) Carda and (5) Fujioka.  
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Finally, Snider and coworkers presented a biomimetic synthesis of 1 where they 
utilized macrocyclic conformational control in a transannular Michael reaction (Scheme 
4.2).149  It was proposed that the cyclization reaction may be diastereoselective, providing 
only one of four possible stereoisomers, due to the rigid conformation of the macrocycle 
                                                 
147 Garcia-Fortanet, J.; Carda, M.; Marco, J. A. Tetrahedron 2007, 63, 12131-12137. 
148 Fujioka, H.; Ohba, Y.; Nakahara, K.; Takatsuji, M.; Murai, K.; Ito, M.; Kita, Y. Org. Lett. 2007, 9, 
5605-5608. 
149 Snider, B. B.; Zhou, J. Org Lett. 2006, 8, 1283-1286. 
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as well as its close relationship to the macrolactone nigrosporolide (2, an isomer of which 
could be involved in the biosynthesis of 1).  
Scheme 4.2: Proposed biomimetic synthesis of 1 by Snider and co-workers. 
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Accordingly, treatment of advanced intermediate 3 with NaH affected the 
transannular Michael reaction to provide 4, however, the transformation led 
predominately to the undesired epimer at C6 (Scheme 4.3).  Equilibration to provide the 
desired stereoisomer (5) required forcing conditions, even though MM2 calculations 
suggested compound 5 should be 1 kcal/mol lower in energy than 4.  In this case, an 
alternative approach, such as the application of a chiral catalyst, would be imperative to 
controlling the diastereoselectivity of the transformation.  Snider’s synthesis therefore 
provided an excellent forum in which to test our previously stated questions while 
underscoring the importance of being able to use a chiral catalyst to override the inherent 
selectivity of a molecule and the ability to actively select for the desired stereochemistry. 
Scheme 4.3: Transannular Michael reaction leading to the opposite epimer at C6. 
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During our work on the synthesis of (+)-Sch 642305, Jacobsen and co-workers 
elegantly demonstrated the successful application of this strategy by employing a chiral 
catalyst to alter the inherent diastereoselectivity of a transannular Diels-Alder (TADA) 
reaction, controlling the stereochemical outcome of the transformation.150  Importantly, in 
the case of conformationally biased substrates, the formation of disfavored 
diastereomeric products would require a chiral catalyst capable of overcoming a 
substantially higher activation barrier.  For example, in order to maintain the methyl 
group in a pseudoequatorial position, biased macrocycle 6 was expected to adopt a 
conformation leading predominantly to one of four possible diastereomeric products 
(Scheme 4.4).  As anticipated, when promoting the TADA reaction of 6 with an achiral 
Lewis acid (MeAlCl2, 0.8 equiv) or under thermal conditions, high diastereoselectivity 
was achieved, providing endo-7a as the major product.  On the other hand, when 
macrocycle 6 was subjected to catalyst 8 (20 mol %), an oxazaborolidine derivative based 
on catalysts developed by Corey and co-workers for inter- and intramolecular Diels-
Alder reactions, 151  they were able to alter the product distribution.  While endo-7a 
remained the major product, the authors were nonetheless able to produce diastereomer 
endo-7b in 30% yield.  Although the inherent selectivity could not be completely 
overridden, they were able to affect the outcome, leading to a diastereomeric ratio (dr) of 
2:1 from 27:1, and synthesize and otherwise inaccessible compound.   
                                                 
150 Balskus, E. P.; Jacobsen, E. N. Science, 2007, 317, 1736-1740. 
151 (a) Corey, E. J.; Shibata, T.; Lee, T. W. J. Am. Chem. Soc. 2002, 124, 3808-3809. (b) Ryu, D. H.; Corey, 
E. J. J. Am. Chem. Soc. 2003, 125, 6388-6389. (c) Zhou, G.; Hu, Q.-Y.; Corey, E. J. Org. Lett. 2003, 5, 
3979-3982. 
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Scheme 4.4: Catalyst-controlled diastereoselective TADA of a biased macrocycle. 
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Jacobsen and co-workers were able to demonstrate catalyst control in a similar 
TADA reaction of an unbiased macrocycle (9).  Using an achiral catalyst, or under 
thermal conditions, poor selectivity was achieved due to the presence of 1,3-anti methyl 
substitution (Figure 4.4).  On the other hand, exquisite control was obtained when 
macrocycle 9 was exposed to catalyst 8 and endo-10b was obtained in 34:1 dr.  The 
selective formation of endo-10a was achieved by use of the opposite enantiomer of 
catalyst 8, ent-8.  
Figure 4.4: Catalyst-controlled diastereoselective TADA of unbiased macrocycle 8. 
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4.4 Retrosynthetic Analysis 
Our synthesis of (+)-Sch 642305 (1) will allow for the examination of the 
Rauhut-Currier methodology in more than one setting: first, in an acyclic reaction 
reminiscent of our previous work, and secondly, in a yet untested setting of a transannular 
reaction (Scheme 4.5).  The importance of controlling chemoselectivity and 
diastereoselectivity will be critical to both reactions.  Once the inherent selectivity of our 
system is established through the use of an achiral catalyst in both pathways, we will 
attempt to override it using either our previously discovered chiral RC catalyst, or a 
peptide derivative thereof, in concert with our continuing interest regarding peptidic 
structures as elements of stereocontrol. 
We envisage 1 arising from two alternative approaches that diverge from a 
common intermediate, 11 (Scheme 4.5).  In pathway A, the decalactone ring would be 
generated through macrolactonization of compound 12 which would be prepared from 
common intermediate 11 using our RC methodology to form the C5-C6 bond.  
Alternatively in plan B, disconnection of the decalactone yields transannular RC substrate 
13 which would be derived from 11 via macrolactonization.  In both cases, we rely on our 
newly developed RC catalyst to dictate stereochemistry in the key reaction regardless of 
the starting olefin geometry or inherent conformational bias.  
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Scheme 4.5: Retrosynthetic analysis displaying two alternative routes, A and B. 
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Common intermediate 11 can be disassembled to afford intermediates 14 and 15 
through a modified Still-Gennari HWE reaction (Scheme 4.6). 152   We envision 
phosphonate 15 ultimately arising from an α-aminooxylation reaction followed by an in 
situ HWE reaction of known aldehyde 17.153  Protected aldehyde 14 can ultimately be 
derived from epoxide opening of commercially available (S)-propylene oxide with 
3-butenylmagnesium bromide 154 followed by ozonolysis. 
                                                 
152 Still, W. C.; Gennari, C. Tetrahedron Lett. 1983, 24, 4405-4408. 
153 Mangion, I. K.; MacMillan, D. W. C.  J. Am. Chem. Soc. 2005, 127, 3696-3697. 
154 Dixon, D. J.; Ley, S. V.; Tate, E. W. J. Chem. Soc., Perkin Trans. 1 2000, 2385-2394. 
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Scheme 4.6: Retrosynthetic analysis of common intermediate 11. 
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4.5 Synthesis of (+)-Sch 642305: Route A 
4.5.1 Synthesis of Divergent Intermediate 11 
Our synthesis commenced with the execution of pathway A in which the RC 
reaction was used to promote the first cyclization, followed by macrolactonization.  To 
begin, aldehyde 17 was synthesized by mono-TBS protection (92%)155 of commercially 
available pentane-1,5-diol (18) followed by Parikh-Doering156 oxidation of 19 (96%) 
(Scheme 4.7).  Using the one pot aminooxylation/ Horner-Wadsworth-Emmons (HWE)/ 
N-O cleavage reaction described by MacMillan and coworkers,157  we then obtained 
alcohol 20 in 40% yield over three steps.  Since aldehyde 21 was oligomeric in solution, 
the HWE reaction was performed in situ. 
                                                 
155 McDougal, P. G.; Rico, J. G.; Oh, Y-I.; Codon, B. D J. Org. Chem. 1986, 51, 3388-3390. 
156 Parikh, J. R.; Doering, W. von E. J. Am. Chem. Soc. 1967, 89, 5505-5507. 
157 (a) Mangion, I, K.; MacMillan, D. W. C. J. Am. Chem. Soc. 2005, 127, 3696-3697. (b) Zhong, G.; Yu, 
Y. Org Lett. 2004, 6, 1637-1639. (c) Varseev, G. N.; Maier, M. E. Org Lett. 2007, 9, 1461-1464. 
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Scheme 4.7: In-situ aminooxylation/ HWE/ N-O Cleavage: 
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A stepwise procedure, where intermediate 22 was isolated and subjected to a 
separate N-O cleavage step, was examined as well and found to be less efficient.  
Accordingly, a screen of various reagents demonstrated that cleavage with copper(II) 
acetate was optimal, providing desired product 20 (42%) in addition to by-product 23 
(26%, Table 4.1).  Copper(II) sulfate afforded 20 in slightly diminished yield (36%) in 
addition to another by-product (24).  N-O cleavage promoted by alternative reagents led 
to unsatisfactory results: Zn/THF/AcOH provided alcohol 20 in low yield (29%) due to 
TBS deprotection, Mo(CO)6 provided 37% yield of 20, possibly due to molybdenum 
coordination to the olefin, and MeOH/NH4Cl led to recovered starting material. 
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Table 4.1: N-O cleavage experiments. 
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O
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0%
15%
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-  
Furthermore, resubjection of product 20 to the reaction conditions employing 
copper(II) acetate afforded to recovered starting material, without formation of by-
product 23 (Scheme 4.8).  Analogous resubjection of 20 to copper(II) sulfate resulted in 
TBS deprotection, providing bis(alcohol) by-product 25 without the formation of 24.  
Thus, it appeared that by-product formation in the copper-catalyzed cleavage reactions 
was not due to oxidation or further reaction of product 20.  Ultimately, a one-pot reaction 
sequence was more favorable compared to the less efficient stepwise procedures 
involving isolation of intermediate 22.158 
Scheme 4.8: Resubjection of alcohol 20 to reaction conditions with copper(II) species. 
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158 Additionally, intermediate 22 was not stable to silica gel chromatography and decomposed in part to 
desired alcohol 20, in addition to multiple unidentifiable by-products. 
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As illustrated in Scheme 4.9, alcohol 20 was then subjected to silylation using 
tert-butyldiphenylchlorosilane (85%) followed by selective deprotection of the primary 
TBS group with PPTS (94%).  Dess-Martin159 oxidation to the corresponding aldehyde 
and further oxidation under Kraus-Pinnick160 conditions with NaClO2 provided acid 26 
quantitatively.  A one step oxidation procedure of alcohol 27 using PDC and DMF161 was 
less efficient and led to a diminished yield of 24%.  Acid 26 was then converted to the 
corresponding acid chloride using thionyl chloride, which was reacted immediately with 
the lithium anion of methyl phosphonate 28.  This two-step procedure provided β-
ketophosphonate 15 in 69% yield.   
Scheme 4.9: Synthesis of common intermediate 11. 
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The aldehyde coupling partner, 14, was prepared in a three-step sequence 
involving copper catalyzed epoxide ring opening of (-)-(S)-propylene oxide with 
3-butenylmagnesium bromide,154 and subsequent conversion to the silyl ether followed 
                                                 
159 Dess, D. B.; Martin, J. C. J. Org. Chem. 1983, 48, 4155. 
160 (a) Lindgren, B. O.; Nilsson, T. Acta. Chem. Scand. 1973, 27, 888-890. (b) Bal, B. S.; Childers, W. E. J.; 
Pinnick, H. W. Tetrahedron 1981, 37, 2091-2096. 
161 Corey, E. J.; Schmidt, G. Tetrahedron Lett. 1979, 5, 399-402. 
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by ozonolysis of the terminal olefin (Scheme 4.10).162  Next, Still-Gennari modified 
HWE coupling of advanced phosphonate 15 with aldehyde 14 produced enone-enoate 11 
as a 2:1 mixture of Z and E olefins.  These isomers were easily separable, allowing us to 
test our hypothesis that equilibration under our reaction conditions would enable the 
catalyst to override the diastereoselectivity of the RC reaction using either isomer, 
obviating the need to control the geometry of this olefin in our final synthetic route. 
Scheme 4.10: Synthesis of aldehyde fragment 14. 
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4.5.2 Preliminary Studies of the RC Reaction in Route A  
With both isomers of common enone-enoate 11 in hand, we were able to test our 
key Rauhut-Currier step under pathway A.  Crucially, we have been able to demonstrate 
catalysis using an achiral catalyst, PBu3, in the cycloisomerization of enone-enoate 11 to 
generate intermediate 12 (Scheme 4.11).  Initial experiments showed that both cis and 
trans isomers underwent catalysis at room temperature and led to the desired product (as 
determined by 1H NMR and HRMS) in addition to an unidentifiable by-product. 
                                                 
162  The characterization data for compound 14, including optical rotation, matched that which has 
previously been reported, please see the Experimental and: Ernst, B.; Wagner, B. Helv. Chim. Acta 1989, 
72, 165-171.   
  
- 218 - 
Scheme 4.11: Initial study of the key RC reaction in route A with an achiral catalyst. 
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On the other hand, preliminary exploration into catalysis with our protected 
cysteine derivative (29) proved to be more difficult.  Reaction under previously 
optimized conditions163 (-40 °C, t-BuOK (4 equiv); entries 1 and 2, Table 4.2) as well as 
at elevated temperatures (23 °C, 70 °C; entries 3 and 4, Table 4.2) led only to recovered 
starting material.  In the case of enone-enoate 11-cis, isomerization to 11-trans was rapid 
(less than 1 h) and in each case only trans starting material was recovered.  Interestingly, 
in the absence of base (entry 5, Table 4.2) no isomerization was seen and 11-cis was 
recovered. 
 
                                                 
163 Please refer to Chapter 3 for a full discussion. 
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Table 4.2: Preliminary experiments in the Rauhut-Currier reaction in route A catalyzed by 
protected cysteine catalyst 29. 
O
NHAc
MeO
SH
∗
OMe
O
O OTBS
Me
5
6
OTBDPS
OMe
O
O OTBS
Me
OTBDPS
MeCN-H2O (3:1)
cis
trans
cis
cis
cis
0.02
0.02
0.05
0.05
0.05
-40
-40
23
70
23
conv to 11-trans
rec 11-trans
conv to 11-trans
2 d, conv to 11-trans
rec 11-cis
t-BuOK (4 )
t-BuOK (4)
t-BuOK (1.5)
t-BuOK (1.5)
-
11 conc(M) rxn outcome
1
2
3
4
5
entry
11-cis/trans 12
base
(equiv)
temp
(°C)
29
 
While the further exploration of this reaction is currently on-going in our 
laboratory, we simultaneously investigated the possibility of employing alternative 
derivatives of 11 in the key RC transformation.  We speculated that the steric 
environment imposed by the large silyl ether may impede the cycloisomerization, and 
therefore investigated the RC reaction of analogous methyl ether 11-OMe (Figure 4.5).  
Additionally, methyl esters are known to be poor coupling partners in the RC reaction, 
demonstrating low reactivity.164  Consequently, the possibility of employing analogous 
thioester 30 was considered (Figure 4.5).  Furthermore, due to the high reactivity 
displayed by achiral phosphine catalyst PBu3 in this reaction, the use of a chiral 
phosphine catalyst will be discussed subsequently.  Finally, it is possible that the 
rotational freedom of substrate 11 is too great, precluding cyclization.  Substrate 31 could 
                                                 
164 (a) Agapiou, K.; Krische, M. J. Org. Lett. 2003, 5, 1737-1740. (b) Aroyan, C. E.; Miller, S. J. J. Am. 
Chem. Soc. 2007, 129, 256-257 and references therein. 
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test this hypothesis, bringing the reacting olefins into close proximity, as well as leading 
to a more expeditious endgame with a simultaneous dehydration/deprotection step 
(Figure 4.5). 
Figure 4.5: Possible substrates for the Rauhut-Currier reaction in Route A.  
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4.5.3 Thioenoates as Reactive Rauhut-Currier Substrates 
Although enoates have been shown to be viable electrophilic partners in Rauhut-
Currier reactions by our group as well as the groups of Krische164 and Roush,165 they are 
nonetheless, much less reactive towards conjugate addition than their enone counterparts.  
Thioenoates, on the other hand, have demonstrated superior reactivity to enoates with 
their reactivity lying closer to that of enones.166  In addition, the cycloisomerization of 
bis(enoates) has been shown to be problematic (as in the case of substrate 32, Figure 4.6), 
while the use of mixed thioenoate-enoate 33 was demonstrated to be highly efficient, 
providing cyclohexene 34 in 82% yield (Figure 4.6).  It is important to note that the 
reaction displayed high chemoselectivity as well, with 34 as the exclusive 
cycloisomerization product (99:1). 
                                                 
165 Frank, S. A.; Mergott, D. J.; Roush, W. R. J. Am. Chem. Soc. 2002, 124, 2404-2405. 
166 Keck, G. E.; Welch, D. S. Org. Lett. 2002, 4, 3687-3690. 
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Figure 4.6: Heightened thioenoate reactivity in the RC reaction. 
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In view of this heightened reactivity and high chemoselectivity, the possibility of 
employing thiol ester 30 in our synthesis provided an intriguing opportunity to enhance 
the reactivity of our system under sulfur-based catalysis (Figure 4.7).  Hence, substrate 36 
was synthesized as a model compound to further test the scope of our reaction conditions 
and investigate the effects of a thioenoate in lieu of an enoate.  Unfortunately, enone-
thioenoate 36 was not a viable substrate under our catalytic system, providing enone-
enoate product 37 in low yield (22%, Figure 4.7).  The abnormal reactivity displayed by 
this system is not fully understood at this time and is currently being explored further. 167 
Figure 4.7: Model system employing a thiol ester electrophilic partner. 
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167  This abnormal reactivity was determined during the further exploration of reaction scope of our 
previously reported Rauhut-Currier reaction.  Thioenoates are of general interest in the RC reaction and the 
related Morita-Baylis-Hillman reaction and will therefore be investigated further.  It is worth noting that 
while we are interested in this substrate class, we would nonetheless like to find a more general catalytic 
system which would not require substrate manipulation.  
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4.5.4 Phosphine Catalysis 
As illustrated in section 4.5.2, PBu3 was found to be an excellent catalyst for the 
acyclic Rauhut-Currier reaction.  Although our work in the RC reaction revealed sulfur-
based catalyst 29 as the optimal catalyst, we had prior experience using a chiral 
phosphine catalyst as well in the context of amino acid diphenylphosphinoserine (Pps, 
39).168  In analogy to other reports using phosphine-based catalysts, our work on the RC 
reaction empirically determined the order of reactivity to increase with the number of 
aliphatic substituents: Bu3P > MePh2P >>> homo-Pps (40) >> Pps (39) > Ph3P.  As 
illustrated in Figure 4.8, our model catalyst (MePh2P) was sufficiently reactive to 
catalyze the cycloisomerization of bis(enone) 41 to generate cyclized product 42 in 100% 
conversion.  However, when this moiety was incorporated into an amino acid (Pps, 
39),169 the reaction no longer proceeded with a useful level of conversion (5%).  Homo-
Pps (40) was tested as well in an attempt to minimize the electron withdrawing effects of 
the amino acid and decrease steric bulk near the phosphorous center, however, was found 
to provide only a modest increase in reactivity. 
                                                 
168 Please refer to Chapter 3 for a discussion of our work using phosphine-based catalysts in the Rauhut-
Currier reaction. 
169 Gilbertson, S. R.; Chen, G.; McLoughlin, M.  J. Am. Chem. Soc. 1994, 116, 4481. 
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Figure 4.8: Phosphine catalysis in the Rauhut-Currier reaction. 
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With this knowledge of phosphine reactivity in a model system, we examined the 
possibility of employing a phosphine-based catalytic system with the more complex 
substrate 11.  Excited that Bu3P was able to catalyze the cyclization of enone-enoate 11 to 
12 (section 4.5.2), we next turned to catalysis with MePh2P.  Unfortunately, this catalyst 
was ineffective in our new system and provided recovered starting material at room 
temperature as well as at elevated temperatures (Scheme 4.12).  While this catalyst was 
not reactive with the acyclic substrate in route A, we were optimistic that we would be 
able to fine-tune the reactivity of our system under sulfur-based catalysis.  Additionally, 
we have not dismissed the possibility of returning to a phosphine-based catalyst in the 
further study of route B. 
Scheme 4.12: Phosphine catalysis in Route A. 
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4.5.5 Examination of Sterics: Synthesis of 11-OMe 
To address the possibility that Rauhut-Currier cyclization of substrate 11 was 
impeded due to steric hindrance from the bulky silyl ether, we elected to synthesize an 
analogous substrate that would unambiguously answer the question of steric interference.  
After considering various alternative protecting groups, we decided the use of a methyl 
ether protecting group would best address the initial question we set out to answer; the 
ability of a chiral catalyst to override the inherent diastereoselectivity of a reaction 
involving a chiral a molecule.  This objective presents a complex challenge, as it 
potentially requires the chiral catalyst to overcome a substantially higher activation 
barrier of the pathway leading to the disfavored diastereomer.  Therefore, we set out to 
test the RC reaction with the analogous methyl ether compound, 11-OMe, which would 
examine the cycloisomerization in the absence of a potentially dominating bulky 
protecting group. 
As illustrated in Scheme 4.13, the successful synthesis of 11-OMe was analogous 
to the synthesis we reported for 11-OTBDPS (see section 4.5.1).  Beginning with alcohol 
20, methylation with Meerwein’s salt (88%) followed by deprotection of the primary 
TBS group with PPTS (90%) cleanly provided methyl ether 43.  Dess-Martin159 oxidation 
followed by Kraus-Pinnick 170  oxidation provided quantitative conversion to the 
corresponding acid (44).  Acid 44 was then converted to β-ketophosphonate 45 in 60% 
yield.  Finally, Still-Gennari modified HWE coupling of advanced phosphonate 45 with 
aldehyde 14 produced enone-enoate 11-OMe.  We obtained a similar ratio of 
                                                 
170 (a) Lindgren, B. O.; Nilsson, T. Acta. Chem. Scand. 1973, 27, 888-890. (b) Bal, B. S.; Childers, W. E. J.; 
Pinnick, H. W. Tetrahedron 1981, 37, 2091-2096. 
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approximately a 2:1 mixture of Z and E olefins which were easily separable in this case 
as well, allowing both isomers to be carried forward independently. 
Scheme 4.13: Synthesis of analogous 11-OMe cis/trans. 
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4.5.6 Preliminary Rauhut-Currier Studies in Route A: 11-OMe 
With both isomers of enone-enoate 11-OMe in hand, we were able to 
reinvestigate our key Rauhut-Currier step under pathway A and test our hypothesis that 
the steric environment with the TBDPS protected substrate was preventing cyclization.  
Initial experiments demonstrated that we were able once again to promote the 
cycloisomerization of both cis and trans isomers of 11-OMe using an achiral catalyst, 
PBu3, affording desired product 46 (as determined by 1H NMR and HRMS) in addition to 
an unidentified by-product (Scheme 4.14). 
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Scheme 4.14: Initial study of the RC reaction of 11-OMe in route A with an achiral phosphine-
based catalyst. 
OMe
O
O OTBS
Me
5
6
OMe
OMe
O
O OTBS
Me
OMe
PBu3
t-BuOH
11-OMe cis/trans
by-product+
46  
Excitingly, while 11-OTBDPS did not lead to the desired product using our Cys-
derived catalyst 29, catalysis of the RC reaction of 11-OMe generated trace amounts of 
the desired product after 24 h at 50 °C,171 suggesting that our hypothesis about the effect 
of the bulky protecting group on the C4 hydroxyl group could be correct (Scheme 4.15).  
We are encouraged by these initial results and are optimistic that with a multidimensional 
study of the reaction parameters (solvent, temperature, concentration, and catalyst 
loading) we will be able to efficiently catalyze this transformation.  The RC reaction has 
been utilized successfully in the synthesis of several natural products, with each case 
proving to be highly substrate dependent and requiring an independent optimization 
study.172 
Scheme 4.15: Preliminary experiments in the Rauhut-Currier reaction of 11-OMe catalyzed by 
protected cysteine catalyst 29.  
O
NHAc
MeO
SH ∗
OMe
O
O OTBS
Me
5
6
OMe
OMe
O
O OTBS
Me
OMe
t-BuOK, MeCN-H2O
(23 to 50°C)
46
trace (1H NMR)
29
11-OMe cis/trans
 
                                                 
171 As determined by 1H nuclear magnetic resonance analysis. 
172 Please refer to chapter 2 for a full discussion of the application of the Rauhut-Currier reaction to the 
synthesis of natural products. 
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4.5.7 Synthesis in Route A 
After the key Rauhut-Currier reaction, our synthesis would proceed in six steps to 
provide the natural product, 1, as well as the C5 epimer of the natural product (Scheme 
4.16).  Reduction of enone 46 with triethylsilane in the presence of Wilkinson’s catalyst 
would provide ketone 47 after treatment of the resultant silyl enol ether with K2CO3 in 
MeOH, establishing the syn-anti relationship of the three contiguous stereocenters.173  
Conjugate reduction could also be effected using sodium borohydride (NaBH4) in 
pyridine, as demonstrated by Krische and co-workers in the synthesis of (±) ricciocarpin 
A.174  Deprotection of the secondary alcohol followed by hydrolysis of the methyl ester 
would provide advanced cyclohexanone derivative 49, which would serve as the substrate 
for a Yamaguchi macrocyclization to generate the decalactone, 50.  Saegusa-Ito 175 
oxidation, as reported by the groups of Trauner146 and Carda,147 would deliver the 
penultimate unsaturated protected intermediate, 51.  Alternatively, dehydration via a 
phenylselenation-selenoxide elimination sequence could be employed, as by Mehta and 
co-workers,144 whereas IBX-mediated dehydrogenation 176  was reported to be 
unsuccessful.  Final deprotection of 51, (51-OTBDPS; TBAF/HOAc, 1:1)144 or (51-OMe; 
Me3SiI or BBr3, CH2Cl2),177 would provide natural product 1 as well as the C5 epimer of 
(+)-Sch 642305. 
                                                 
173 (a) Sakai, M.; Sasaki, M.; Tanino, K.; Miyashita, M. Tetrahedron Lett. 2002, 43, 1705-1708. (b) Ojima, 
I.; Kogure, T.; Nagai, Y. Tetrahedron Lett. 1972, 13, 5035-5038. 
174 (a) Agapiou, K.; Krische, M. J. Org. Lett. 2003, 5, 1737-1740. (b) Jackson, W. R.; Zurqiyah, A. J. 
Chem. Soc. 1965, 5280-5287. 
175 Ito, Y.; Hirao, T.; Saegusa, T. J. Org. Chem. 1978, 43, 1011-1013. 
176 Nicolaou, K. C.; Zhong, Y. L.; Baran, P. S. J. Am. Chem. Soc. 2000, 122, 7596-7597. 
177 Greene. T. W.; Wuts, P. G. M. Protective Groups in Organic Synthesis, 4th ed.; John Wiley & Sons: 
New York, 2006; pp 25-29. 
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Scheme 4.16: Synthesis of (+)-Sch 642305 in route A. 
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4.6 Synthesis of (+)-Sch 642305: Route B 
4.6.1 Synthetic Plan for Route B 
As mentioned earlier, our synthetic plan for (+)-Sch 642305 allows for the 
examination of the Rauhut-Currier methodology in two alternative settings.  While 
optimization of the Rauhut-Currier reaction was proceeding on the acyclic substrate in 
route A, we were eager to test the reaction simultaneously in a previously unexplored 
transannular mode (Figure 4.9).  This would allow us first to establish the inherent 
diastereoselectivity of the cyclization reaction on this chiral macrocycle, and second, to 
attempt to override this preference using our chiral catalyst, overcoming a potentially 
substantially higher activation barrier leading to the alternative diastereomer. 
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Figure 4.9: Application of the Rauhut-Currier reaction in route B. 
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The exploration of route B required that common intermediate 11 be carried 
forward to the transannular substrate 13 (Scheme 4.17).  We envisioned that this could be 
achieved by hydrolysis of the methyl ester followed by deprotection of the secondary 
alcohol and Yamaguchi macrocyclization to provide 13.  Once the key Rauhut-Currier 
step is optimized, the remaining steps would parallel those presented in route A.  The 
synthesis would proceed in three steps to produce the desired natural product, 1, as well 
as the C5 epimer of the natural product. 
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Scheme 4.17: Synthesis of (+)-Sch 642305 in route B. 
OMe
O
OR
O OTBS
Me
LiOH
O
O
Me
OR
O
O
O
Me
OR
O
O
O
Me
OR
O
O
O
Me
OR
O
deprotection
Et3SiH, (Ph3P)3RhCl
K2CO3, MeOH
OH
O
OR
O OTBS
Me
OH
O
OR
O OH
Me
Pyr⋅HF, THF
Key RC Step
Route BC6Cl3H2COCl, Et3N
then DMAP, tol
5311
THF-H2O
52
13 54
50 51
O
O
Me
OH
O
1
5NaHMDS, TESCl
Pd(OAc)2
 
4.6.2 Synthesis with TBDPS Protecting Group 
By investigating route A we learned that the bulky TBDPS protecting group of 
common intermediate 11 interfered with the acyclic Rauhut-Currier reaction.  Because 
route B involved catalysis of the cycloisomerization in a completely new forum as a 
transannular reaction, the steric and electronic requirements of this system were 
unknown.  Therefore, we preceded with both the TBDPS and methyl ether protected 
compounds, beginning first with the bulkier silyl protected compound. 
Exploration of route B began from common intermediate 11 with cleavage of the 
methyl ester using LiOH in THF-H2O-MeOH (Scheme 4.18).  However, instead of 
hydrolysis of the methyl ester, these conditions led exclusively to the conjugate addition 
of methoxide into the α,β-unsaturated carbonyl affording 55.  The high electrophilicity of 
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this enone towards conjugate addition was determined to be problematic at later points in 
the synthesis as well, and will be revisited throughout the discussion of route B. 
Scheme 4.18: Hydrolysis of divergent intermediate 4. 
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Fortunately, we were able to overcome this undesired reactivity in the hydrolysis 
step and found that quantitative cleavage could be obtained at room temperature in the 
absence of methanol (THF-H2O, 1:1) providing advanced carboxylic acid 52-cis (Scheme 
4.19).  Although the cis-acid was configurationally unstable, isomerizing to 52-trans 
within 24 h when stored either under vacuum at ambient temperature or under nitrogen at 
-20 °C, isolation and immediate use was sufficient to overcome this problem. 
Scheme 4.19: Successful hydrolysis of methyl ester 11. 
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Simultaneous investigation into silyl deprotection of common intermediate 11 
was met with greater difficulty.  We were able to selectively deprotect the secondary TBS 
ether over the TBDPS ether using PPTS in ethanol or HF·pyridine.  However, the desired 
product was not stable under these deprotection conditions (eq 1, Scheme 4.20).  Instead, 
we isolated tetrahydropyran 56, the product of silyl deprotection followed by 
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intramolecular conjugate addition, as the major product in addition to recovered starting 
material.  It is important to note that the recovered starting material was no longer in the 
cis configuration, but that it had isomerized under these conditions to the trans 
configuration.  
Scheme 4.20: Selective silyl deprotection. 
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A similar outcome ensued when HF·pyridine was used in the deprotection step 
(eq 2, Scheme 4.20).  Initial hydrolysis of the methyl ester of 11-cis (LiOH, THF-H2O) 
provided carboxylic acid 52-cis.  Subsequent deprotection with HF·pyridine provided the 
desired product, 53, and unlike under deprotection conditions using PPTS we were now 
able to isolate the desired product.  Yet, 53 was highly configurationally unstable; the cis 
olefin rapidly isomerized to the trans geometry and furthermore the generated free 
hydroxyl group rapidly underwent conjugate addition into the α,β-unsaturated ketone to 
provide 57 (Figure 4.10). 
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Figure 4.10: Rapid 6-exo-trig cyclization leading to undesired cyclic by-product. 
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Although we were able to isolate a small amount of 53 for a fleeting moment, we 
were apprehensive of continuing forward with this route.  The next step in the synthesis is 
a Yamaguchi macrocyclization.  Once 53 is subjected to the reaction conditions for the 
macrocyclization, the alcohol or alkoxide will be poised for rapid intramolecular 6-exo-
trig cyclization to produce undesired by-product 57 (Figure 4.10).  This pathway should 
be more facile, forming a 6-membered ring, than the desired 14-membered ring formation 
required in the macrolactonization. 
4.6.3 Synthesis with Me Ether Protecting Group 
In analogy to our work with the TBDPS-protected compound, we explored route 
B with the sterically smaller methyl ether-protected compound, 11-OMe.  We began by 
studying 11-OMe cis and 11-OMe trans, which were independently subjected to the 
optimized hydrolysis conditions (LiOH, THF-H2O) to provide quantitative conversion to 
acid 58-cis and 58-trans, respectively (Scheme 4.21).   
Scheme 4.21: Hydrolysis of 11-OMe cis and 11-OMe trans. 
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As illustrated in Scheme 4.22, the advanced cis and trans acids were then 
subjected to silyl deprotection with both PPTS and HF·pyridine.  Similarly, under PPTS 
deprotection conditions, we were not able to isolate the desired free secondary alcohol 
and isolated tetrahydropyran 59 as the major product in addition to recovered starting 
material (58-trans in both cases).  Deprotection using HF·pyridine led to a mixture of 
recovered starting material (58-cis did not undergo isomerization), tetrahydropyran by-
product 59, and trace amounts of the desired product (60-cis and 60-trans, respectively).  
As with compound 53, we were able to isolate 60 in only trace quantities and were 
cognizant that the next step would require the formation of a 14-membered ring versus 
the extremely facile 6-membered ring.  Consequently, we decided it would be judicious 
to modify this route and investigate protection of the α,β-unsaturated ketone. 
Scheme 4.22: Silyl deprotection of 58-cis and 58-trans. 
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4.6.4 1,3-Dioxolane 
Our apprehension about the instability of compounds 53 and 60 compelled us to 
modify route B by investigating protection of the α,β-unsaturated ketone as a 1,3-
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dioxolane.  The new synthetic plan for (+)-Sch 642305 would parallel that already 
disclosed for this route with the addition of a protection and deprotection step.  Hence, 
ketalization would be followed by hydrolysis of the methyl ester, deprotection of the 
secondary alcohol, Yamaguchi macrolactonization, and finally deprotection of the 1,3-
dioxolane as reported by Snider and co-workers,149 providing the original substrate for 
the Rauhut-Currier reaction (Scheme 4.23).  Completion of the synthesis would be 
identical to that described in section 4.6.1. 
Scheme 4.23: Synthetic plan for (+)-Sch 642305 in route B with a ketal protected α,β-
unsaturated ketone. 
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Ketal protection of α,β-unsaturated ketone 11-OMe was attempted under mild 
conditions reported by Noyori and coworkers 178  (Scheme 4.24).  However, upon 
subjection to bis-O-(trimethylsilyl)ethylene glycol and catalytic trimethylsilyl 
trifluoromethanesulfonate (TMSOTf) we obtained undesired product 61 as the sole 
product, and not the desired 1,3-dioxolane, 62.  We found that ketalization did occur; 
however, it occurred after 6-exo-trig cyclization/silyl deprotection.  Once again, the 
                                                 
178 Tsunoda, T.; Suzuki, M.; Noyori, R.  Tetrahedron Lett. 1980, 21, 1357-1358. 
  
- 236 - 
electrophilicity of the α,β-unsaturated ketone drove the reaction outcome and required us 
to modify our system. 
Scheme 4.24: Attempted ketalization of 11-OMe. 
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4.6.5 1,3-Dioxolane with OAc Protecting Group 
As illustrated in Scheme 4.25, our revised plan incorporated an orthogonal 
protecting group on the secondary alcohol, to replace the TBS protecting group with an 
acetate group, which will remain intact under the ketalization conditions.  The amended 
synthesis began with a Still-Gennari modified HWE coupling of advanced phosphonate 
45 and known aldehyde 63 to provide acetate-protected intermediate 64 in 46% yield and 
2:1 cis:trans ratio.  To complete the synthesis, intermediate 66 would be synthesized via 
ketalization of the α,β-unsaturated ketone followed by simultaneous deprotection of the 
methyl ester and secondary alcohol.  Macrolactonization and deprotection of the ketal 
would then provide transannular RC substrate 68. 
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Scheme 4.25: Synthetic plan incorporating a modified protecting group scheme. 
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With acetate-protected intermediate 64 in hand, we were able to attempt the 
ketalization once again.  Initial experiments with the mild Noyori protocol178 (subjection 
to bis-O-(trimethylsilyl)ethylene glycol and catalytic TMSOTf at -78 °C) led to recovered 
starting material and olefin isomerization in the case of 64-cis to 64-trans (entries 1 and 
2, Table 4.3).  Under identical conditions with modest warming of the reaction mixture 
(-78 °C to -50 °C) we obtained isomerized starting material in addition to multiple 
unidentifiable by-products (entry 3).179  Alternative conditions employing ethylene glycol 
and triethyl orthoformate with catalytic p-toluenesulfonic acid also led to multiple 
unidentifiable by-products (entry 4).180  Finally, a report from Wicha and co-workers 
described irreproducible yields when employing the Noyori conditions and found that a 
                                                 
179 NMR experiments suggest that one of the many by-products is the product of olefin migration from the 
α,β position to the β,γ position.  This is a known issue in the ketalization of α,β-unsaturated ketones and 
was expected as we increased to warmer reaction conditions.  Noyori’s anhydrous conditions were 
developed in part to overcome this side reactivity.  Please see reference 178. 
180 a) Becher, E.; Albrecht, R.; Bernhard, K.; Leuenberger, H. G. W.; Mayer, H.; Müller, R. K.; Schüep, 
W.; Wagner, H. P. Helv. Chim. Acta. 1981, 64, 2419-2435. b) Rao, K. S.; Reddy, D. S.; Mukkanti, K.; Pal, 
M.; Iqbal, J. Tetrahedron Lett. 2006, 47, 6623-6626. 
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5:1 ratio of bis-O-(trimethylsilyl)ethylene glycol to ethylene glycol with TMSOTf was 
critical to obtain consistent high yields.181  However, our system was unreactive under 
these conditions and we recovered starting material for both the cis and trans isomers 
(entries 5 and 6).   
Table 4.3: Ketalization conditions tested in the protection of α,β-unsaturated ketone 64.  
CO2Me
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Me
OMe
64-cis/trans
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O
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Me
OMe
O O
65
cis
trans
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trans
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(TMSOCH2)2 (1.5)
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64-cis
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64 conditions(equiv)
catalyst
(0.1 equiv) rxn outcome
1
2
3
4
5
6
entry
-78
-78
-78 to -50
23
-78
-78
temp
(°C)
 
4.6.6 Masked α,β-Unsaturated Carbonyl 
Protection of the α,β-unsaturated ketone as a 1,3-dioxolane in both the TBS 
protected compound (11-OMe) as well as the acetate protected compound (64-OMe) 
proved to be problematic for several reasons as described above.  This prompted us to 
explore an alternative approach to protect the enone.  In our new plan, the α,β-unsaturated 
ketone would be converted to a β-thioether (69) to mask the highly reactive enone moiety 
                                                 
181 Chochrek, P.; Kurek-Tyrlik, A.; Michalak, K.; Wicha, J. Tetrahedron Lett. 2006, 47, 6017-6020. 
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until regeneration prior to the Rauhut-Currier cyclization.  The synthesis, as outlined in 
Scheme 4.26, involved the conversion of α,β-unsaturated ketone 64 to intermediate 69 as 
a mixture of diastereomers using benzenethiol with catalytic triethylamine (70% yield).  
Simultaneous hydrolysis of the methyl ester and acetate protecting group using LiOH in 
THF-H2O did not lead to the desired product, 70, and instead produced undesired by-
products, tetrahydropyran 59 and partially deprotected intermediate 71, in a 1:2 ratio.  
Moreover, upon re-subjection to the reaction conditions, 71 was readily converted to 
tetrahydropyran 59.  Monitoring the reaction revealed that ester hydrolysis and 
elimination of benzenethiol were rapid whereas cleavage of the acetate protecting group 
was more sluggish.182  Therefore, the α,β-unsaturated ketone was regenerated and un-
masked prior to deprotection of the acetate group, leading to rapid cyclization upon 
liberation of the free alkoxide.  Because the thioester was not stable to hydrolysis/ 
deprotection conditions, an alternative approach was required. 
                                                 
182 By 1H NMR and TLC. 
  
- 240 - 
Scheme 4.26: Synthesis of masked α,β-unsaturated ketone 69. 
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4.6.7 Initial Yamaguchi Cyclization 
A brief attempt at the Yamaguchi macrolactonization was explored with by-
product tetrahydropyran 59 (obtained during silyl deprotection of 58 as well as hydrolysis 
of β-thioether 69).  This reaction would require retro-conjugate addition of the secondary 
alcohol to generate α,β-unsaturated ketone intermediate 73 and subsequent 
macrocyclization.  As illustrated in Scheme 4.27, subjection of 59 to cyclization 
conditions led to decomposition of the starting material with no detectable product 
(68).183   
                                                 
183 Mulzer, J.; Kirstein, H. M.; Buschmann, J.; Lehmann, C.; Luger, P. J. Am. Chem. Soc. 1991, 113, 910-
923. 
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Scheme 4.27: Initial attempt at the Yamaguchi macrolactonization with substrate 59. 
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4.6.8 Carbonyl Reduction/Protection 
Thus far, we have been exploring the synthesis of (+)-Sch 642305 in route B with 
several modifications of our original plan (1,3-dioxolane protection and β-thioether 
formation) in order to control the high electrophilicity of the α,β-unsaturated ketone.  
Ultimately, we found that a carbonyl reduction/protection sequence was successful.   
Proceeding with acetate protected compound 64, the synthesis would continue 
with a Luche reduction of the α,β-unsaturated ketone followed by TBS protection of the 
allylic alcohol (Scheme 4.28).  Hydrolysis of the methyl ester and acetate protecting 
group would be effected in one step followed by macrolactonization.  A final 
deprotection of the allylic alcohol and subsequent oxidation would generate 68 for the 
key transannular Rauhut-Currier reaction. 
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Scheme 4.28: Synthetic plan employing a reduction/protection sequence. 
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Alternatively, selective macrolactonization could be achieved on fully deprotected 
substrate 75 (Scheme 4.29).  This would require exclusive ring closure resulting from the 
C11 hydroxyl group with no by-product formed from ring closure of the hydroxyl at C1.  
This is effectively a competition between 14-membered macrolide formation and 8-
membered macrolide formation, with the former being preferred.184   
Scheme 4.29: Synthesis employing carbonyl reduction and macrolactonization on fully 
deprotected intermediate 75. 
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184 (a) Schreiber, S. L.; Kelly, S. E.; Porco, J. A.; Sammakia, T.; Suh, E. M. J. Am. Chem. Soc. 1988, 110, 
6210-6218. (b) White, J. D.; Blakemore, P. R.; Browder, C. C.; Hong, J.; Lincoln, C. M.; Nagornyy, P. A.; 
Robarge, L. A.; Wardrop, D. J. J. Am. Chem. Soc. 2001, 123, 8593-8595. 
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As illustrated in Scheme 4.29, Luche reduction185 of intermediate 64 provided 
allylic alcohol 74 (73%) which then underwent deprotection of both the methyl ester and 
the acetate protecting group to provide substrate 75 for the selective macrolactonization.  
However, upon subjection of fully deprotected intermediate 75 to Yamaguchi cyclization 
conditions,184 the starting material was fully consumed and an unidentifiable mixture of 
by-products was formed.  One point of concern was the potential for 6-exo-trig 
intramolecular conjugate addition of the C1 hydroxyl once the carboxylic acid was 
activated as either the corresponding mixed anhydride (77a) or as the acetylpyridinium 
ion (77b) (Figure 4.11). 
Figure 4.11: Potential side reactivity in macrolactonization of the fully deprotected intermediate. 
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To avoid these aforementioned complications, we proceeded with the protected 
compound (Scheme 4.30).  Once again, Luche reduction was followed by silylation using 
tert-butylchlorodimethylsilane (78, 96%) and hydrolysis of both the methyl ester and 
acetate protecting groups with LiOH.  Acetate cleavage was significantly slower than 
ester hydrolysis, leading to a mixture of partially deprotected 79 and fully deprotected 80 
(39%).  In the initial attempt, intermediate 79 was re-subjected to the reaction conditions 
for full conversion to 80, however, future syntheses of this route will simply be run under 
longer times.  
                                                 
185 Adams, C. Synth. Commun. 1984, 14, 1349-1353. 
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Scheme 4.30: Synthesis employing carbonyl reduction/protection. 
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With substrate 80 in hand, we were able to perform an initial test of the final 
reaction sequence on small scale.  Yamaguchi macrocyclization of the C1 hydroxyl-
protected compound was successful, providing compound 81 in 57% un-optimized yield.  
Deprotection of the allylic alcohol with PPTS (86%) followed by Dess-Martin159 
oxidation finally provided the key transannular Rauhut-Currier substrate (68, 2 mg) in a 
1:1 cis to trans ratio for preliminary examination. 
4.6.9 Preliminary Studies of the Rauhut-Currier Reaction in Route B 
Exploration of the Rauhut-Currier reaction in route A involved the use of an 
acyclic substrate, while synthesis of (+)-Sch 642305 in route B demanded that our 
Rauhut-Currier methodology could be expanded to include a transannular cyclization.  
With intermediate 68 in hand, we were able to test our key step under this alternative 
pathway.  Preliminary examination of this cycloisomerization on very small scale (2 mg) 
has demonstrated that an optimization study will be critical in route B.  Subjection of 
macrolide 68 to protected cysteine derivative 29 under previously optimized conditions 
(23 °C, t-BuOK, 1.5 equiv) as well as at elevated temperatures (up to 60 °C) led to the 
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recovery of starting material in the trans configuration (Scheme 4.31).  As mentioned 
previously, we are optimistic that a systematic variation of reaction parameters, including 
solvent, concentration, temperature, and possibly catalyst structure, will ultimately lead to 
the successful catalysis of the key RC reaction in both the acyclic reaction as well as the 
transannular reaction.  Once sufficient catalysis is demonstrated, we will be able to 
determine the inherent diastereoselectivity of the reaction using an achiral catalyst and 
then attempt to override it using our chiral catalyst. 
Scheme 4.31: Rauhut-Currier reaction in route B. 
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4.7 Conclusion 
Our study of the synthesis of (+)-Sch 642305 (1) has provided an exciting forum 
in which to address several on-going questions in our laboratory.  We are interested in the 
ability to utilize catalyst control to drive reaction selectivity as well as demonstrate the 
application of our previously developed Rauhut-Currier methodology in a complex 
setting.  Excitingly, we have presented our initial investigations into these questions, 
demonstrating a viable route to both key Rauhut-Currier substrates in pathways A and B 
(11 and 68) and have begun preliminary optimization studies thereof.  We are inspired by 
our initial success in the acyclic RC transformation and are eager to continue studying the 
application of this methodology in full detail.  Once we are able to establish the inherent 
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diastereoselectivity of the cyclization reaction on the acyclic substrate and the macrolide, 
we will study the use of a chiral catalyst to override this preference.  This is a great 
challenge, as it may necessitate overcoming a substantially higher activation barrier if the 
substrate conformation strongly favors formation of one diastereomer over another.  
Then, using the newly developed methodology for setting the stereocenter at C5, we hope 
to actively select for the exclusive formation of the natural product (1) in addition to 
difficult-to-obtain unnatural analogs.  This synthesis would then satisfy our original 
goals, to address our continuing interest regarding elements of stereocontrol, demonstrate 
the application of our RC methodology in a complex setting, and finally provide an 
expedient synthesis of (+)-Sch 642305. 
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4.8 Experimental 
General.  Proton NMR spectra were recorded on a 500 or 400 MHz spectrometer.  
Proton chemical shifts are reported in ppm (δ) relative to internal tetramethylsilane 
(TMS, δ 0.0 ppm) or with the solvent reference relative to TMS employed as the internal 
standard (CDCl3, δ 7.26 ppm; d6-DMSO, δ 2.50 ppm; CD3OD, δ 3.31 ppm; D2O, δ 4.79 
ppm).  Data are reported as follows: chemical shift (multiplicity [singlet (s), doublet (d), 
triplet (t), quartet (q), and multiplet (m)], coupling constants [Hz], integration).  Carbon 
NMR spectra were recorded at 125 or 100 MHz with complete proton decoupling. 
Carbon chemical shifts are reported in ppm (δ) relative to TMS with the respective 
solvent resonance as the internal standard (CDCl3, δ 77.0 ppm).  Infrared spectra were 
obtained on a Perkin-Elmer Spectrum 1000 spectrometer.  Analytical thin-layer 
chromatography (TLC) was performed using Silica Gel 60 Å F254 precoated plates (0.25 
mm thickness).  TLC Rf values are reported. Visualization was accomplished by 
irradiation with a UV lamp and/or staining with KMnO4 or cerium ammonium 
molybdenate (CAM) solutions.  Flash column chromatography was performed using 
Silica Gel 60 Å (32-63 µm).186 Optical rotations were recorded on a Rudolf Research 
Analytical Autopol IV Automatic polarimeter at the sodium D line (path length 100 mm).  
High resolution mass spectra were obtained at the Mass Spectrometry Facility of either 
Boston College (Chestnut Hill, MA) or the University of Illinois (Urbana-Champaign, 
IL).  The method of ionization is given in parentheses.  Analytical normal phase HPLC 
was performed on a Hewlett-Packard 1100 Series chromatograph equipped with a diode 
                                                 
186 Still, W.C.; Kahn, M.; Mitra, J. J. Org. Chem. 1978, 43, 2923. 
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array detector (214 nm and 254 nm).  All reactions were carried out under an argon or 
nitrogen atmosphere employing oven- and flame-dried glassware. All solvents were 
purified using a Seca Solvent Purification System by GlassContour.  t-BuOK was freshly 
sublimed prior to use. 
 
Experimental Procedures – Route A 
 
Synthesis of Intermediate 11. 
HO OTBS  
5-(tert-butyldimethylsilyloxy)pentan-1-ol (19).  A mixture of NaH (95%, 2.18 g, 86.4 
mmol) and THF (173 mL) was cooled to 0 °C and 1,5-pentanediol (18.1 mL, 173 mmol) 
was added dropwise over 5 minutes.  The ice bath was removed after 5 minutes and the 
reaction mixture was allowed to stir at room temperature for 30 minutes.  The mixture 
was then cooled to 0 °C and tert-butyldimethylchlorosilane (13.0 g, 86.4 mmol) was 
added portionwise over 10 minutes.  After 15 minutes, the mixture was allowed to warm 
to room temperature and stir for an additional 2 h.  The reaction mixture was cooled to 
0 °C and quenched by the slow addition of water (100 mL).  The mixture was diluted 
with Et2O (200 mL) and washed with 10% aqueous K2CO3 (200 mL).  The aqueous layer 
was extracted with Et2O (2 x 100 mL) and the combined organic layers were washed with 
10% aqueous K2CO3 (100 mL), saturated aqueous NaCl (100 mL), dried over MgSO4, 
and concentrated under reduced pressure in a 0 °C bath.  The crude oil was purified by 
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silica gel chromatography (hexanes-EtOAc, 9:1 to 5:1) to afford 19 as a clear oil (17.4 g, 
79.6 mmol, 92%). 1H NMR (CDCl3, 500 MHz) δ 3.61-3.57 (m, 4H), 1.95 (bs, 1H), 
1.58-1.49 (m, 4H), 1.40-1.34 (m, 2H), 0.86 (s, 9H), 0.02 (s, 6H); 13C NMR (CDCl3, 125 
MHz) δ 63.1, 62.7, 32.5, 32.4, 25.9, 22.0, 18.3, -5.4; IR (film, cm-1) 3346, 2934, 2856, 
1475, 1474, 1389, 1360, 1254, 1099, 1038, 833, 772; TLC Rf 0.29 (4:1 hexanes-EtOAc); 
HRMS (ESI) m/z 219.1787 (219.1780 calcd for C11H27O2Si [M+H]+). 
 
OTBS
ONHPh
O
MeO
 
Compound 22.  Nitrosobenzene (2.16 g, 20.2 mmol) was added to a solution of aldehyde 
17 (5.24 g, 24.2 mmol) in anhydrous DMSO (97 mL) followed by D-proline (1.16 g, 10.1 
mmol).  After stirring at ambient temperature for 15 min, the teal solution turned bright 
orange and was cooled to -15 ºC.  A premixed solution of methyl 
diethylphosphonoacetate (11.1 mL, 60.5 mmol), DBU (9.12 mL, 60.5 mmol), and LiCl 
(2.56 g, 60.5 mmol) in CH3CN (97 mL) was cooled to -15 ºC and added quickly via 
cannula.  The resulting solution was maintained at -15 ºC until the reaction was 
determined to be complete by TLC (35 min), at which point cooled (0 °C) saturated 
aqueous NH4Cl (200 mL) was added.  The mixture was extracted with ethyl acetate (3 x 
200 mL) and the combined organic layers were washed with water (3 x 100 mL), 
saturated aqueous NaCl (150 mL), and dried over MgSO4 to provide 22 as an orange oil 
(4.70 g, 12.4 mmol, 61%) after silica gel chromatography (hexanes-Et2O, 18:1 to 9:1).  
1H NMR (CDCl3, 400 MHz) δ 7.23-7.18 (m, 2H), 6.93-6.85 (m, 5H), 6.00 (d, J = 17.1 
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Hz, 1H), 4.40-4.35 (m, 1H), 3.71 (s, 3H), 3.62-3.59 (m, 2H), 1.83-1.55 (m, 4H), 0.85 (s, 
9H), 0.02 (s, 6H); 13C NMR (CDCl3, 100 MHz) δ 166.5, 148.2, 147.3, 128.9, 122.4, 
122.0, 114.3, 82.7, 62.6, 51.6, 29.6, 28.2, 25.9, 18.2, -5.3; IR (film, cm-1) 3289, 2950, 
2925, 2856, 1728, 1659, 1601, 1495, 1254; TLC Rf 0.44 (2:1 hexanes-Et2O); HRMS 
(ESI) m/z 380.2251 (380.2257 calcd for C20H34NO4Si [M+H]+). 
 
OTBS
OH
O
MeO
 
Compound 20.  Nitrosobenzene (2.66 g, 24.9 mmol) was added to a solution of aldehyde 
17 (5.38 g, 24.9 mmol) in anhydrous DMSO (96 mL) followed by D-proline (1.14 g, 9.9 
mmol).  After stirring at ambient temperature for 30 min, the teal solution turned bright 
orange and was cooled to 0 ºC.  A premixed solution of methyl diethylphosphonoacetate 
(11.4 mL, 62.2 mmol), DBU (9.40 mL, 62.2 mmol), and LiCl (2.60 g, 62.2 mmol) in 
CH3CN (96 mL) was cooled to -15 ºC and added quickly via cannula.  The resulting 
solution was maintained at 0 ºC for 30 min and then diluted with cooled (0 °C) methanol 
(500 mL) and NH4Cl (3.33g, 62.2 mmol) and Cu(OAc)2 (0.45 g, 2.5 mmol) were added.  
The mixture was allowed to warm to ambient temperature and was maintained for 2 d.  
Methanol was then removed under reduced pressure and the mixture was diluted with 
water (500 mL) and extracted with Et2O (3 x 150 mL).  The combined organic layers 
were washed with water (2 x 150 mL), saturated aqueous NaCl (150 mL), and dried over 
sodium sulfate.  Flash chromatography (hexanes-EtOAc, 8:1 to 2:1) provided alcohol 20 
as a pale orange oil (3.01 g, 10.4 mmol, 42%) with >98% ee. 1H NMR (CDCl3, 500 
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MHz) δ 6.95 (dd, J = 15.4, 4.4 Hz, 1H), 6.09 (d, J = 15.5 Hz, 1H), 4.36-4.31 (m, 1H), 
3.74 (s, 3H), 3.68-3.66 (m, 2H), 3.48 (d, J = 4.4 Hz, 1H), 1.84-1.78 (m, 1H), 1.74-1.61 
(m, 3H), 0.91 (s, 9H), 0.08 (s, 6H); 13C NMR (CDCl3, 125 MHz) δ 167.1, 150.6, 119.6, 
70.5, 63.3, 51.5, 34.3, 28.6, 25.8, 18.3, -5.4; IR (film, cm-1) 3438, 2952, 2928, 2853, 
1726, 1651, 1473, 1433, 1311; TLC Rf 0.14 (2:1 hexanes-Et2O); HRMS (ESI) m/z 
289.1835 (289.1835 calcd for C14H29O4Si [M+H]+); Assay of enantiomeric purity: 
Enantiomers of product were separated by chiral HPLC employing a Chiralcel OD 
column (Daicel).  Conditions: 94:6 hexanes-isopropanol; Flow rate 0.70 mL/min; 10.1 
min (major ent), 11.4 min (minor ent). 
 
Representative procedure for separate N-O cleavage. 
Cu(OAc)2 (1.10 g, 6.10 mmol) was added to a solution of 22 (4.40 g, 20.3 mmol) in 
i-PrOH (203 mL) at 0 ºC.  The mixture was allowed to stir for 15 h at 4.1 ºC and then 
quenched with cooled (0 °C) saturated aqueous NH4Cl (100 mL).  The yellow mixture 
was extracted with ethyl acetate (3 x 1500 mL) and the combined organic layers were 
washed with water (2 x 100 mL), saturated aqueous NaCl (150 mL), and dried over 
Na2SO4.   The crude material was purified by silica gel chromatography (hexanes-Et2O, 
9:1 to 4:1) to provide 20 as a pale orange oil (2.46 g, 8.53 mmol, 42%) as well as by-
product 23 (1.51 g, 5.28 mmol, 26%). 
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OTBS
O
MeO
O  
Compound 23.  1H NMR (CDCl3, 400 MHz) δ 7.08 (d, J = 15.9 Hz, 1H), 6.68 (d, 
J = 15.9 Hz, 1H), 3.81 (s, 3H), 3.64 (t, J = 5.9 Hz, 2H), 2.72 (t, J = 7.1 Hz, 2H), 1.88-
1.82 (m, 2H), 0.88 (s, 9H), 0.03 (s, 6H); 13C NMR (CDCl3, 125 MHz) δ 199.5, 166.0, 
139.6, 130.0, 61.8, 52.2, 37.9, 26.7, 25.8, 18.2, -5.4; TLC Rf 0.63 (1:1 hexanes-Et2O); 
HRMS (ESI) m/z 309.1501 (309.1498 calcd for C14H26O4NaSi [M+Na]+). 
 
OTBS
O
MeO
OMe  
Compound 24.  1H NMR (CDCl3, 500 MHz) δ 6.80 (dd, J = 15.8, 6.3 Hz, 1H), 6.98 (d, 
J = 15.8 Hz, 1H), 3.77-3.75 (m, 4H), 3.63-3.58 (m, 2H), 2.30 (s, 3H), 1.65-1.52 (m, 4H), 
0.88 (s, 9H), 0.04 (s, 6H); 13C NMR (CDCl3, 125 MHz) δ 166.6, 148.4, 121.5, 80.3, 62.7, 
56.9, 51.5, 31.1, 28.2, 25.9, 18.2, -5.3; TLC Rf 0.43 (6:1 hexanes-EtOAc); HRMS (ESI) 
m/z 303.1992 (303.1992 calcd for C15H31O4Si [M+H]+). 
 
OTBS
OTBDPS
O
MeO
 
Compound 20b.  Alcohol 20 (1.40 g, 4.85 mmol) was dissolved in CH2Cl2 (24 mL) and 
cooled to 0 ºC.  Imidazole (0.76 g, 11.2 mmol) and tert-butyldiphenylchlorosilane (1.90 
mL, 7.28 mmol) were successively added and the orange mixture was allowed to stir for 
  
- 253 - 
30 min, then at room temperature for 12 h.  Water (30 mL) was added and the solution 
was extracted with CH2Cl2 (3 x 50 mL) and washed with saturated aqueous NH4Cl (50 
mL), NaCl (50 mL), dried over MgSO4, and concentrated under reduced pressure.  The 
crude oil was purified by silica gel chromatography (hexanes-Et2O, 10:1 to 8:1) to afford 
the bis-silyl ether 20b as a clear oil (2.17 g, 4.12 mmol, 85%). 1H NMR (CDCl3, 500 
MHz) δ 7.68 (d, J = 6.6 Hz, 2H), 7.62 (d, J = 6.6 Hz, 2H), 7.46-7.35 (m, 6H), 6.89 (dd, J 
= 15.5, 5.0 Hz, 1H), 5.95 (d, J = 15.8 Hz, 1H), 4.43-4.41 (m, 1H), 3.73 (s, 3H), 3.51-3.41 
(m, 2H), 1.56-1.39 (m, 4H), 1.10 (s, 9H), 0.87 (s, 9H), 0.03 (d, J = 3.15 Hz, 6H); 13C 
NMR (CDCl3, 125 MHz) δ 166.9, 150.3, 135.7, 133.8, 133.4, 129.7, 129.7, 127.6, 127.5, 
119.9, 72.1, 62.9, 51.4, 33.1, 27.2, 27.0, 25.9, 19.3, 18.2, -5.3; IR (film, cm-1) 3074, 2953, 
2929, 2887, 2852, 1725, 1661, 1109; TLC Rf 0.45 (4:1 hexanes-Et2O); HRMS (ESI) m/z 
527.3008 (527.3013 calcd for C30H47O4Si2 [M+H]+). 
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Compound 27.  Bis-silyl ether 20b (1.36 g, 2.58 mmol) was dissolved in absolute EtOH 
(14 mL) and pyridinium p-toluenesulfonate (259 mg, 1.03 mmol) was added in one 
portion.  The pale yellow solution was allowed to stir at room temperature for 18 h and 
then concentrated under reduced pressure.  The crude oil was purified by silica gel 
chromatography (hexanes-Et2O, 9:1 to 1:2) to afford 27 as a clear oil (1.01 g, 2.45 mmol, 
94%). 1H NMR (CDCl3, 500 MHz) δ 7.66 (dd, J = 8.0, 1.4 Hz, 2H), 7.59 (dd, J = 7.9, 1.3 
Hz, 2H), 7.43-7.32 (m, 6H), 6.85 (dd, J = 15.8, 5.2 Hz, 1H), 5.93 (dd, J = 15.8, 1.4 Hz, 
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1H), 4.44-4.40 (m, 1H), 3.69 (s, 3H), 3.45-3.42 (m, 2H), 1.57-1.38 (m, 5H), 1.08 (s, 9H); 
13C NMR (CDCl3, 125 MHz) δ 166.8, 149.9, 135.7, 133.7, 133.1, 129.8, 129.7, 127.6, 
127.5, 120.0, 71.9, 62.5, 51.4, 32.8, 27.0, 26.9, 19.2; IR (film, cm-1) 3431, 2950, 2858, 
1724, 1660, 1427, 1303, 1275, 1111, 702; TLC Rf 0.28 (2:1 hexanes-EtOAc); HRMS 
(ESI) m/z 435.1969 (435.1968 calcd for C24H32O4SiNa [M+Na]+). 
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Compound 27b.  Alcohol 27 (1.32 g, 3.15 mmol) was dissolved in CH2Cl2 (10 mL) and 
added dropwise to a stirred suspension of Dess-Martin periodinane (1.47 g, 3.47 mmol) 
in CH2Cl2 (12 mL) at 0 °C.  The resulting mixture was allowed to warm to room 
temperature and maintained for 1.5 h, then filtered over celite and concentrated under 
reduced pressure.  The crude residue was purified by silica gel chromatography (hexanes-
EtOAc,10:1 to 4:1) to aldehyde 27b as a clear oil (1.30 g, 3.16 mmol, quantitative). 1H 
NMR (CDCl3, 500 MHz) δ 9.61 (s, 1H), 7.65 (d, J = 7.9 Hz, 2H), 7.59 (d, J = 8.1 Hz, 
2H), 7.46-7.34 (m, 6H), 6.79 (dd, J = 15.5, 5.0 Hz, 1H), 5.94 (d, J = 17.0 Hz, 1H), 4.52-
4.49 (m, 1H), 3.72 (s, 3H), 2.50-2.31 (m, 2H), 1.83-1.72 (m, 2H), 1.09 (s, 9H); 13C NMR 
(CDCl3, 125 MHz) δ 201.3, 166.5, 149.0, 135.7, 135.7, 133.4, 133.0, 130.0, 129.9, 127.7, 
127.6, 120.8, 71.0, 51.5, 38.2, 28.5, 27.0, 19.3; IR (film, cm-1) 2949, 2929, 2853, 1994, 
1723, 1429, 1110; TLC Rf 0.39 (3:1 hexanes-EtOAc); HRMS (ESI) m/z 411.2002 
(411.1992 calcd for C24H31O4Si [M+H]+). 
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Compound 26.  Silyl-protected aldehyde 27b (1.35 g, 3.29 mmol) was dissolved in tert-
butanol (33 mL) and 2-methyl-2-butene (6.30 mL, 59.2 mmol).  A clear solution of 
sodium chlorite (0.60 g, 6.58 mmol) and sodium dihydrogen phosphate (2.72 g, 19.7 
mmol) in water (33 mL) was added via cannula over 10 min.  After 3 h, the reaction 
mixture was diluted with saturated aqueous NaCl (50 mL) and extracted with CH2Cl2 (3 x 
50 mL).  The combined organic layers were washed with saturated aqueous NaCl 
(50 mL) and dried over Na2SO4 to provide 26 as a clear oil (1.41 g, 3.30 mmol, 
quantitative) after silica gel chromatography (hexanes-EtOAc, 2:1 to 1:2). 1H NMR 
(CDCl3, 400 MHz) δ 10.79 (bs, 1H), 7.66 (d, J = 6.6 Hz, 2H), 7.62 (d, J = 6.6 Hz, 2H), 
7.46-7.33 (m, 6H), 6.83 (dd, J = 15.7, 5.3 Hz, 1H), 5.93 (d, J = 15.7 Hz, 1H), 4.50-4.46 
(m, 1H), 3.71 (s, 3H), 2.43-2.23 (m, 2H), 1.82-1.76 (m, 2H), 1.09 (s, 9H); 13C NMR 
(CDCl3, 125 MHz) δ 178.5, 166.6, 148.9, 135.7, 135.7, 133.3, 133.0, 129.9, 129.8, 127.7, 
127.6, 120.8, 71.0, 51.5, 30.9, 28.2, 27.0, 19.3; IR (film, cm-1) 3068, 2954, 2934, 2856, 
1728, 1708, 1426, 1307, 1275, 1111; TLC Rf 0.46 (1:2 hexanes-EtOAc); HRMS (ESI) 
m/z 427.1985 (427.1941 calcd for C24H31O5Si [M+H]+). 
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Compound 15.  Acid 26 (0.20 g, 0.47 mmol) was dissolved in thionyl chloride (2 mL) 
with catalytic DMF (0.1 mL) and was allowed to stir for 1.5 h at ambient temperature.   
The crude acid chloride was then concentrated under reduced pressure and dried under 
vacuum for 30 min.  Lithium hexamethyldisilazide (1M in THF, 0.99 mL, 0.99 mmol) 
was added dropwise over 5 min to bis(2,2,2-trifluoroethyl) methylphosphonate (0.24 g, 
0.94 mmol) in THF (3.1 mL) at -100 ºC.  After 15 min, the acid chloride was dissolved in 
THF (3.1 mL) and added dropwise over 10 min.  The reaction mixture was maintained at 
-100 ºC for 1 h and then quenched with saturated aqueous NH4Cl (5 mL) and allowed to 
warm to room temperature.  After dilution with saturated aqueous NH4Cl (20 mL), the 
mixture was extracted with CH2Cl2 (3 x 20 mL) and the combined organic extracts were 
washed with saturated aqueous NaCl (50 mL), dried (Na2SO4), and purified via silica gel 
chromatography (toluene-EtOAc, 9:1 to 4:1) to provide 15 as a clear oil (0.22 g, 
0.32 mmol, 69%). 1H NMR (CDCl3, 500 MHz) δ 7.65 (d, J = 6.6 Hz, 2H), 7.58 (d, J = 
6.6 Hz, 2H), 7.46-7.34 (m, 6H), 6.78 (dd, J = 15.4, 4.7 Hz, 1H), 5.97 (d, J = 15.4 Hz, 
1H), 4.51-4.36 (m, 5H), 3.72 (s, 3H), 3.16-3.03 (m, 2H), 2.57-2.42 (m, 2H), 1.75-1.71 
(m, 2H), 1.08 (s, 9H); 13C NMR (CDCl3, 125 MHz) δ 125.7, 125.7, 123.5, 123.4, 121.3, 
121.2, 119.1, 119.0, 120.7, 127.8, 127.7, 130.0, 129.9, 133.4, 132.8, 135.7, 135.6, 149.0, 
166.5, 200.2, 200.2, 70.7, 62.7, 62.7, 62.4, 62.4, 62.1, 62.1, 61.8, 61.8, 51.5, 41.6, 40.5, 
38.6, 38.5, 29.5, 19.2, 26.9; IR (film, cm-1) 2962, 2929, 2857, 1717, 1297, 1265, 1164, 
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1103, 1067; TLC Rf 0.68 (2:1 toluene-EtOAc); HRMS (ESI) m/z 691.1691 (691.1692 
calcd for C29H35F6O7NaSiP [M+Na]+). 
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Compounds 11-cis and 11-trans.  Barium hydroxide (0.16 g, 0.52 mmol) was added to a 
solution of phosphonate 15 (0.43 g, 0.65 mmol) in THF (18 mL) and allowed to stir for 
30 min.  Aldehyde 14 (0.15 g, 0.65 mmol) was dissolved in THF-H2O (40:1, 4 mL) and 
added to the mixture.  After 4 h, the reaction mixture was diluted with CH2Cl2 (100 mL), 
washed with saturated aqueous NaHCO3, and extracted with CH2Cl2 (2 x 100 mL).  The 
combined organic layers were washed with saturated aqueous NaCl (50 mL), dried 
(Na2SO4), and the crude oil was purified via silica gel chromatography (petroleum ether-
Et2O, 15:1 to 7:1) to provide 11-cis (0.25 g, 0.39 mmol, 61%) and 11-trans (0.11 g, 0.16 
mmol, 25%) in 86% overall yield as a clear oil. 
11-cis. 1H NMR (CDCl3, 400 MHz) δ 7.62-7.54 (m, 4H), 7.41-7.29 (m, 6H), 6.76 (dd, 
J = 15.5, 5.1 Hz, 1H), 6.00-5.92 (m, 2H), 5.88 (dd, J = 15.5, 1.5 Hz, 1H), 4.45-4.41 (m, 
1H), 3.77-3.71 (m, 1H), 3.70 (s, 3H), 2.55-2.26 (m, 4H), 1.76-1.70 (m, 2H), 1.47-1.31 
(m, 4H), 1.08 (d, J = 6.1 Hz, 3H), 1.06 (s, 9H), 0.85 (s, 9H), 0.02 (d, J = 3.5 Hz, 6H); 13C 
NMR (CDCl3, 125 MHz) δ 200.3, 166.6, 149.6, 148.6, 135.8, 135.7, 133.5, 133.1, 129.9, 
129.8, 127.7, 127.6, 126.4, 120.4, 71.3, 68.2, 51.4, 39.1, 38.3, 30.2, 29.6, 29.3, 27.0, 25.8, 
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25.3, 23.7, 19.3, 18.1, -4.3, -4.7; TLC Rf 0.50 (3:1 petroleum ether-Et2O); HRMS (ESI) 
m/z 637.3730 (637.3745 calcd for C37H57O5Si2 [M+H]+). 
11-trans. 1H NMR (CDCl3, 500 MHz) δ 7.65 (d, J = 6.6 Hz, 2H), 7.59 (d, J = 6.6 Hz, 
2H), 7.45-7.33 (m, 6H), 6.83 (dd, J = 15.8, 5.0 Hz, 1H), 6.70 (dt, J = 15.8, 6.9 Hz, 1H), 
5.98 (dt, J = 15.8, 1.6 Hz, 1H), 5.93 (dd, J = 15.7, 1.26 Hz, 1H), 4.50-4.47 (m, 1H), 3.81-
3.77 (m, 1H), 3.72 (s, 3H), 2.58-2.38 (m, 2H), 2.19-2.15 (m, 2H), 1.81-1.75 (m, 2H), 
1.57-1.36 (m, 4H), 1.12 (d, J = 6.3 Hz, 3H), 1.09 (s, 9H), 0.89 (s, 9H), 0.04 (s, 6H); 13C 
NMR (CDCl3, 125 MHz) δ 199.5, 166.7, 149.6, 147.1, 135.8, 135.7, 133.5, 133.1, 130.1, 
130.0, 129.8, 127.7, 127.6, 120.4, 71.4, 68.1, 51.5, 39.0, 34.2, 32.4, 30.4, 30.2, 27.0, 25.8, 
24.1, 23.8, 19.3, 18.0, -4.3, -4.7; TLC Rf 0.31 (3:1 petroleum ether-Et2O); HRMS (ESI) 
m/z 637.3750 (637.3745 calcd for C37H57O5Si2 [M+H]+). 
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Compound 14.  The characterization data for this compound matched that which has 
previously been reported.162  [α]D +15  (c 1.0, CHCl3). 
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Compound 12.  Tributylphosphine (46 µL, 0.19 mmol) was added to a solution of 11-cis 
(12 mg, 0.019 mmol) in tert-butanol (1 mL).  The clear solution was allowed to stir for 
24 h at 23 ºC at which point the reaction was diluted with EtOAc (20 mL) and washed 
with water (2 x 20 mL), saturated aqueous NaCl (20 mL), and dried over Na2SO4.  Flash 
chromatography (hexanes-EtOAc, 10:1) afforded compound 12 as a clear oil for 
characterization. 1H NMR (CDCl3, 500 MHz) δ 7.65-7.62 (m, 4H), 7.47-7.33 (m, 6H), 
6.67 (t, J = 5.0 Hz, 1H), 4.10 (bs, 1H), 3.79-3.73 (m, 1H), 3.47 (s, 3H), 3.38-3.34 (m, 
1H), 2.83-2.76 (m, 1H), 2.39-2.34 (m, 2H), 2.18-2.14 (m, 4H), 1.93-1.85 (m, 2H), 1.46-
1.38 (m, 3H), 1.12-1.09 (m, 3H), 1.04 (s, 9H), 0.89 (s, 9H), 0.05 (s, 6H); HRMS (ESI) 
m/z 659.3565 (659.3564 calcd for C37H56O5NaSi2 [M+Na]+). 
 
Synthesis of Intermediate 11-OMe. 
 
OTBS
OMe
O
MeO
 
Compound 20c.  Alcohol 20 (1.82 g, 6.31 mmol) was dissolved in CH2Cl2 (79 mL) and 
cooled to 0 °C.  Proton SpongeTM (8.10 g, 37.9 mmol) and trimethyloxonium 
tetrafluoroborate (4.70 g, 1.03 mmol) were added sequentially and the pale brown 
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mixture was allowed to stir at room temperature for 2 h.  The reaction mixture was then 
quenched with saturated aqueous NaHCO3 (100 mL) and extracted with CH2Cl2 (3 x 100 
mL).  The organic layers were combined and washed with 0.5 N HCl (2 x 100 mL), 
saturated aqueous NaCl (100 mL), dried (MgSO4), and filtered over a 2.5 cm plug of 
silica gel, flushing with hexanes-Et2O, 1:1 (300 mL) to afford 20c as a pale yellow oil 
(1.65 g, 5.46 mmol, 87%). 1H NMR (CDCl3, 500 MHz) δ 6.77 (dd, J = 15.8, 6.6 Hz, 1H), 
5.95 (d, J = 15.8 Hz, 1H), 3.76-3.69 (m, 4H), 3.61-3.54 (m, 2H), 3.27 (s, 3H), 1.63-1.48 
(m, 4H), 0.85 (s, 9H), 0.01 (s, 6H); 13C NMR (CDCl3, 125 MHz) δ 166.5, 148.3, 121.5, 
80.2, 62.7, 56.9, 51.4, 31.0, 28.1, 25.8, 18.2, -5.4; IR (film, cm-1) 2954, 2925, 2856, 1728, 
1659, 1475, 1438, 1254, 1168, 1099, 833, 772; TLC Rf 0.43 (6:1 hexanes-EtOAc); 
HRMS (ESI) m/z 303.2001 (303.1992 calcd for C15H31O4Si [M+H]+). 
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Compound 43.  Methyl ether 20c (415 mg, 1.37 mmol) was dissolved in absolute EtOH 
(7.6 mL) and pyridinium p-toluenesulfonate (138 mg, 0.55 mmol) was added in one 
portion.  The pale yellow solution was allowed to stir at room temperature for 19 h and 
then concentrated under reduced pressure.  The crude oil was purified by silica gel 
chromatography (hexanes-Et2O, 10:1 to 1:4) to afford 43 as a clear oil (232 mg, 1.23 
mmol, 90%). 1H NMR (CDCl3, 400 MHz) δ 6.80 (dd, J = 15.7, 6.3 Hz, 1H), 5.99 (d, J = 
15.7 Hz, 1H), 3.82-3.77 (m, 1H), 3.75 (s, 3H), 3.66-3.62 (m, 2H), 3.32 (s, 3H), 1.89-1.83 
(m, 1H), 1.63-1.48 (m, 4H); 13C NMR (CDCl3, 125 MHz) δ 166.5, 147.9, 121.7, 80.3, 
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62.4, 57.0, 51.6, 31.3, 28.3; IR (film, cm-1) 3423, 2947, 2870, 1724, 1659, 1438, 1304, 
1272, 1163; TLC Rf 0.29 (1:4 hexanes-Et2O); [α]D -27.0 (c 1.0, CHCl3); HRMS (ESI) 
m/z 211.0940 (211.0946 calcd for C9H16O4Na [M+Na]+). 
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Compound 43b.  Alcohol 43 (1.30 g, 6.90 mmol) was dissolved in CH2Cl2 (20 mL) and 
added dropwise to a stirred suspension of Dess-Martin periodinane (3.22 g, 7.60 mmol) 
in CH2Cl2 (33 mL) at 0 °C.  The resulting mixture was allowed to warm to room 
temperature and maintained for 1.5 h, then filtered over celite and concentrated under 
reduced pressure.  The crude residue was purified by silica gel chromatography (hexanes-
Et2O, 9:1 to 5:1) to afford 43b as a clear oil (1.22 g, 6.56 mmol, 95%). 1H NMR (CDCl3, 
400 MHz) δ 9.69 (t, J = 1.2 Hz, 1H), 6.72 (dd, J = 15.8, 6.2 Hz, 1H), 5.95 (dd, J = 15.8, 
1.1 Hz, 1H), 3.78-3.72 (m, 1H ), 3.70 (s, 3H), 3.23 (s, 3H), 2.55-2.41 (m, 2H), 1.93-1.75 
(m, 2H); 13C NMR (CDCl3, 100 MHz) δ 201.5, 166.3, 147.1, 122.0, 79.0, 56.9, 51.5, 
39.2, 26.9; IR (film, cm-1) 2950, 2934, 2826, 1720, 1431, 1303, 1271, 1163, 1115; TLC 
Rf 0.42 (1:1 hexanes-EtOAc); [α]D -29.0 (c 1.0, CHCl3); HRMS (ESI) m/z 209.0790 
(209.0790 calcd for C9H14O4Na [M+Na]+). 
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Compound 44.  43b (0.230 g, 1.24 mmol) was dissolved in tert-butanol (12 mL) and 2-
methyl-2-butene (2.36 mL, 22.2 mmol).  A clear solution of sodium chlorite (224 mg, 
2.48 mmol) and sodium dihydrogen phosphate (1.03 g, 7.44 mmol) in water (12 mL) was 
added via cannula over 10 min.  After 3 h, the reaction mixture was diluted with saturated 
aqueous NaCl (50 mL) and extracted with CH2Cl2 (3 x 50 mL).  The combined organic 
layers were washed with saturated aqueous NaCl (50 mL) and dried over Na2SO4 to 
provide 44 as a clear oil (0.252 g, 1.24 mmol, quantitative) after silica gel 
chromatography (hexanes-EtOAc, 2:1 to 1:2). 1H NMR (CDCl3, 500 MHz) δ 10.41 (bs, 
1H), 6.79 (dd, J = 15.8, 6.0 Hz, 1H), 6.02 (d, J = 15.8 Hz, 1H), 3.85-3.81 (m, 1H), 3.76 
(s, 3H), 3.31 (s, 3H), 2.50-2.42 (m, 2H), 1.97-1.82 (m, 2H); 13C NMR (CDCl3, 125 MHz) 
δ 178.9, 166.4, 147.2, 122.1, 79.0, 57.1, 51.6, 29.4, 29.3; IR (film, cm-1) 2950, 2827, 
1728, 1658, 1438, 1307, 1275, 1168, 1111; TLC Rf 0.30 (1:2 hexanes-EtOAc); [α]D -17.0 
(c 0.89, CHCl3); HRMS (ESI) m/z 225.0750 (225.0739 calcd for C9H14O5Na [M+Na]+). 
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Compound 45.  Acid 44 (0.733 g, 3.63 mmol) was dissolved in thionyl chloride (7 mL) 
with catalytic DMF (0.1 mL) and was allowed to stir for 1.5 h at ambient temperature.   
The crude acid chloride was then concentrated under reduced pressure and dried under 
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vacuum for 30 min.  Lithium hexamethyldisilazide (1M in THF, 7.99 mL, 7.99 mmol) 
was added dropwise over 10 min to bis(2,2,2-trifluoroethyl) methylphosphonate (1.89 g, 
7.26 mmol) in THF (24 mL) at -100 ºC.  After 15 min, the acid chloride was dissolved in 
THF (24 mL) and added dropwise over 10 min.  The reaction mixture was maintained 
at -100 ºC for 1 h and then quenched with saturated aqueous NH4Cl (30 mL) and allowed 
to warm to room temperature.  After dilution with saturated aqueous NH4Cl (75 mL), the 
mixture was extracted with CH2Cl2 (3 x 50 mL) and the combined organic extracts were 
washed with saturated aqueous NaCl (100 mL), dried (Na2SO4), and purified via silica 
gel chromatography (hexanes-EtOAc, 5:1) to provide 45 as a clear oil (0.966 g, 
2.18 mmol, 60%). 1H NMR (CDCl3, 500 MHz) δ 6.76 (dd, J = 15.8, 6.0 Hz, 1H), 6.01 (d, 
J = 15.8 Hz, 1H), 4.48-4.41 (m, 4H), 3.81-3.77 (m, 1H), 3.76 (s, 3H), 3.32-3.26 (m, 5H), 
2.72-2.59 (m, 2H), 1.98-1.91 (m, 1H), 1.84-1.77 (m, 1H); 13C NMR (CDCl3, 125 MHz) δ 
200.7, 200.6, 166.7, 147.4, 126.2, 124.0, 122.6, 121.7, 119.2, 79.2, 62.9, 62.6, 57.4, 52.0, 
42.2, 41.1, 40.1, 40.0, 28.6; IR (film, cm-1) 2950, 2831, 1720, 1442, 1418, 1303, 1258, 
1176, 1103, 1074; TLC Rf 0.35 (1:1 toluene-EtOAc); [α]D -13.0 (c 1.0, CHCl3); HRMS 
(ESI) m/z 445.0855 (445.0851 calcd for C14H20F6O7P [M+H]+). 
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Compounds 11-OMe cis and 11-OMe trans.  Barium hydroxide (491 mg, 1.56 mmol) 
was added to a solution of phosphonate 45 (864 mg, 0.65 mmol) in THF (53 mL) and 
allowed to stir for 30 min.  Aldehyde 14 (448 mg, 1.95 mmol) was dissolved in THF-H2O 
(40:1, 12 mL) and added to the mixture via cannula.  After 4 h, the reaction mixture was 
diluted with CH2Cl2 (250 mL), washed with saturated aqueous NaHCO3, and extracted 
with CH2Cl2 (2 x 200 mL).  The combined organic layers were washed with saturated 
aqueous NaCl (150 mL), dried (Na2SO4), and the crude oil was purified via silica gel 
chromatography (petroleum ether-Et2O, 15:1 to 7:1) to provide 11-OMe cis (338 mg, 
0.82 mmol, 42%) and 11-OMe trans (144 mg, 0.35 mmol, 18%) in 60% overall yield as 
a clear oil. 
11-OMe cis. 1H NMR (CDCl3, 500 MHz) δ 6.77 (dd, J = 15.8, 6.3 Hz, 1H), 6.12-5.97 
(m, 3H), 3.82-3.75 (m, 2H), 3.74 (s, 3H), 3.27 (s, 3H), 2.61-2.50 (m, 4H), 1.94-1.77 (m, 
2H), 1.52-1.35 (m, 4H), 1.09 (d, J = 6.3 Hz, 3H), 0.86 (s, 9H), 0.01 (d, J = 3.5, Hz, 6H); 
13C NMR (CDCl3, 125 MHz) δ 200.4, 166.5, 148.7, 147.7, 126.5, 121.8, 79.2, 68.2, 57.0, 
51.6, 39.1, 39.0, 29.3, 28.4, 25.8, 25.3, 23.7, 18.0, -4.4, -4.7; IR (film, cm-1) 2954, 2929, 
2851, 1724, 1691, 1617, 1437, 1274, 1254, 1164, 1094; TLC Rf 0.42 (2:1 petroleum 
ether-Et2O); HRMS (ESI) m/z 435.2534 (435.2543 calcd for C22H40O5NaSi [M+Na]+). 
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11-OMe trans. 1H NMR (CDCl3, 500 MHz) δ 6.85-6.77 (m, 2H), 6.08 (d, J = 16.1 Hz, 
1H), 6.00 (d, J = 15.8 Hz, 1H), 3.83-3.77 (m, 2H), 3.75 (s, 3H), 3.29 (s, 3H), 2.69-2.56 
(m, 2H), 2.22-2.18 (m, 2H), 1.97-1.78 (m, 2H), 1.60-1.38 (m, 4H), 1.10 (d, J = 6.3 Hz, 
3H), 0.88 (s, 9H), 0.04 (d, J = 3.2 Hz, 6H); 13C NMR (CDCl3, 125 MHz) δ 199.6, 166.5, 
147.7, 147.4, 130.2, 121.8, 79.2, 68.1, 57.0, 51.6, 39.0, 34.8, 32.4, 28.6, 25.8, 24.1, 23.7, 
18.0, -4.3, -4.7; IR (film, cm-1) 2951, 2926, 2853, 1726, 1693, 1669, 1629, 1433, 1270, 
1254; TLC Rf 0.32 (2:1 petroleum ether-Et2O); HRMS (ESI) m/z 435.2545 (435.2543 
calcd for C22H40O5NaSi [M+Na]+). 
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Compound 46.  Tributylphosphine (92 µL, 0.37 mmol) was added to a solution of 
11-OMe cis (15.4 mg, 0.037 mmol) in tert-butanol (1.85 mL).  The clear solution was 
allowed to stir for 24 h at 23 ºC at which point the reaction was diluted with EtOAc 
(20 mL) and washed with water (2 x 20 mL), saturated aqueous NaCl (20 mL), and dried 
over Na2SO4.  Flash chromatography (petroleum ether-Et2O, 10:1 to 2:1) afforded 
compound 46 as a clear oil for characterization. 1H NMR (CDCl3, 500 MHz) δ 6.61 (t, J 
= 7.6 Hz, 1H), 3.81-3.75 (m, 2H), 3.69 (s, 3H), 3.37 (s, 3H), 2.61-2.53 (m, 2H), 2.39-2.33 
(m, 2H), 2.23-1.96 (m, 6H), 1.52-1.35 (m, 3H), 1.11 (d, J = 6.0 Hz, 3H), 0.91-0.84 (m, 
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9H), 0.05-0.03 (m, 6H); TLC Rf 0.21 (1:1 petroleum ether-Et2O); HRMS (ESI) m/z 
435.2527 (435.2543 calcd for C22H40O5NaSi [M+Na]+). 
 
Experimental Procedures – Route B 
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Compound 55.  11-trans (12 mg, 0.02 mmol) was dissolved in THF-H2O-MeOH (2:2:1, 
2.0 mL) and aqueous LiOH (2N, 0.1 mL) was added.  After 12 h at ambient temperature, 
the reaction mixture was acidified to pH 3 with 1N HCl and extracted with EtOAc (3 x 
15 mL).  The combined organic layers were washed with saturated aqueous NaCl (15 
mL) and dried (Na2SO4) to afford 55 (12 mg, 0.018 mmol, 90%) as a mixture of 
diastereomers after purification via silica gel chromatography (hexanes-EtOAc, 10:1). 1H 
NMR (CDCl3, 500 MHz) δ 7.65 (d, J = 6.6 Hz, 4H), 7.58 (d, J = 6.6 Hz, 4H), 7.46-7.29 
(m, 12H), 6.82-6.77 (m, 2H), 5.93 (d, J = 15.8, 6.9 Hz, 2H), 4.47-4.44 (m, 2H), 3.80-3.75 
(m, 2H), 3.72 (s, 6H), 3.60-3.56 (m, 2H), 3.26 (s, 3H), 3.24 (s, 3H), 2.55-2.25 (m, 8H), 
1.76-1.69 (m, 4H), 1.41-1.21(m, 12H), 1.12-1.10 (m, 6H), 1.08 (s, 18H), 0.88 (s, 18H), 
0.04 (s, 12H); TLC Rf 0.49 (3:1 hexanes-EtOAc); HRMS (ESI) m/z 669.4021 (669.4007 
calcd for C38H61O6Si2 [M+H]+). 
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Representative procedure for methyl ester hydrolysis. 
11-cis (125 mg, 0.20 mmol) was dissolved in THF-H2O (1:1, 10 mL) and aqueous LiOH 
(2N, 1.0 mL) was added.  After 12 h at ambient temperature, the reaction mixture was 
acidified to pH 3 with 1N HCl (3 mL), extracted with EtOAc (3 x 75 mL).  The combined 
organic layers were washed with saturated aqueous NaCl (75 mL) and dried (Na2SO4) to 
afford 52-cis (124 mg, 0.20 mmol, quantitative) and used without further purification. 
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Compound 52-cis.  1H NMR (CDCl3, 400 MHz) δ 7.66-7.59 (m, 4H), 7.46-7.34 (m, 6H), 
6.95-6.87 (m, 1H), 6.00-5.90 (m, 3H), 4.52-4.47 (m, 1H), 3.81-3.74 (m, 1H), 2.58-2.32 
(m, 4H), 1.83-1.72 (m, 2H), 1.52-1.35 (m, 4H), 1.11 (d, J = 6.1 Hz, 3H), 1.09 (s, 9H), 
0.87 (s, 9H), 0.05-0.03 (m, 6H); 13C NMR (CDCl3, 100 MHz) δ 200.5, 171.3, 152.2, 
148.9, 135.8, 133.5, 133.1, 130.0, 129.9, 127.7, 127.6, 126.5, 120.0, 71.3, 68.4, 39.2, 
38.3, 30.2, 29.4, 27.1, 25.9, 25.3, 23.8, 19.4, 18.2, -4.3, -4.7; IR (film, cm-1) 3070, 2957, 
2925, 2893, 2852, 1697, 1648, 1423, 1113; TLC Rf  0.57 (1:1 hexanes-EtOAc). 
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Compound 56.  11-cis (10 mg, 0.016 mmol) was dissolved in absolute EtOH (0.53 mL) 
and pyridinium p-toluenesulfonate (1.6 mg, 0.006 mmol) was added in one portion.  The 
clear solution was allowed to stir at room temperature for 12 h and then diluted with 
EtOAc (10 mL), washed with saturated aqueous NaCl (15 mL) and dried (Na2SO4).  
Crude 1H NMR analysis indicated a 1:3 mixture of 11-trans and by-product 56.  Flash 
chromatography (hexanes-Et2O, 10:1) afforded compound 56 as a clear oil for 
characterization. 1H NMR (CDCl3, 500 MHz) δ 7.64 (d, J = 6.6 Hz, 2H), 7.59 (d, J = 6.6 
Hz, 2H), 7.44-7.33 (m, 6H), 6.78 (dd, J = 15.5, 5.0 Hz, 1H), 5.91 (d, J = 15.5 Hz, 1H), 
4.47-4.43 (m, 1H), 3.72-3.67 (m, 4H), 3.44-3.37 (m, 1H), 2.57-2.27 (m, 4H), 1.79-1.71 
(m, 2H), 1.56-1.47 (m, 6H), 1.10 (d, J = 6.0 Hz, 3H), 1.08 (s, 9H); TLC Rf 0.42 (4:1 
hexanes-EtOAc); HRMS (ESI) m/z 523.2881 (523.2880 calcd for C31H43O5Si [M+H]+). 
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Compound 53-cis/trans.  HF·pyridine (21 µL, 0.064 mmol) was added to a solution of 
52-cis (10 mg, 0.016 mmol) in THF (0.32 mL) at 0 ºC.  The reaction was allowed to 
warm to room temperature and stir for 5 h, at which point it was quenched with saturated 
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aqueous NaHCO3 (5 mL) until the evolution of CO2 ceased.  The mixture was extracted 
with EtOAc (2 x 10 mL) and the combined organic extracts were washed with saturated 
aqueous NaCl (10 mL) and dried over Na2SO4 to afford a mixture of desired product 53-
cis/trans and 52-cis/trans.  Purification via silica gel chromatography afforded 53-
cis/trans as a mixture of diastereomers for characterization. 1H NMR (CDCl3, 400 MHz) 
δ 7.66-7.59 (m, 4H), 7.45-7.34 (m, 6H), 6.90-6.69 (m, 2H), 6.00-5.92 (m, 2H), 4.52-4.45 
(m, 1H), 385-3.80 (m, 1H), 2.62-2.211 (m, 4H), 1.88-1.73 (m, 3H), 1.59-1.41 (m, 4H), 
1.18 (d, J = 6.3 Hz, 3H), 1.09 (s, 9H); TLC Rf 0.15 (1:1 hexanes-EtOAc). 
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Compounds 58-cis and 58-trans. 
58-cis.  Prepared according to the general procedure for methyl ester hydrolysis from 
11-OMe cis (50 mg, 0.12 mmol) to afford 58-cis (48 mg, 0.12 mmol, quantitative) and 
used without further purification.  1H NMR (CDCl3, 400 MHz) δ 10.98 (bs, 1H), 6.89 
(dd, J = 15.6, 5.8 Hz, 1H), 6.14-5.99 (m, 3H), 3.89-3.76 (m, 2H), 3.31 (s, 3H), 2.63-2.53 
(m, 4H), 1.90-1.80 (m, 2H), 1.53-1.34 (m, 4H), 1.11 (d, J = 5.8 Hz, 3H), 0.88 (s, 9H), 
0.04 (d, J = 3.5, Hz, 6H); TLC Rf 0.64 (6:1 CH2Cl2-MeOH). 
58-trans.  Prepared according to the general procedure for methyl ester hydrolysis from 
11-OMe trans (113 mg, 0.27 mmol) to afford 58-trans (107 mg, 0.27 mmol, quantitative) 
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and used without further purification. 1H NMR (CDCl3, 500 MHz) δ 10.25 (bs, 1H), 
6.93-6.81 (m, 2H), 6.09 (d, J = 15.8 Hz, 1H), 6.02 (d, J = 15.8 Hz, 1H), 3.88-3.77 (m, 
2H), 3.31 (s, 3H), 2.68-2.47 (m, 3H), 2.23-2.19 (m, 1H), 1.99-1.79 (m, 2H), 1.56-1.39 
(m, 4H), 1.12 (d, J = 6.0 Hz, 3H), 0.89 (s, 9H), 0.04 (d, J = 2.8 Hz, 6H); TLC Rf 0.64 (6:1 
CH2Cl2-MeOH). 
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Compound 59.  58-cis (17 mg, 0.06 mmol) was dissolved in absolute EtOH (3 mL) and 
pyridinium p-toluenesulfonate (6.6 mg, 0.02 mmol) was added in one portion.  The clear 
solution was allowed to stir at room temperature for 12 h and then diluted with EtOAc 
(10 mL), washed with saturated aqueous NaCl (15 mL) and dried (Na2SO4).  Purification 
via silica gel chromatography (6:1 CH2Cl2-MeOH) afforded 59 for characterization. 1H 
NMR (CDCl3, 400 MHz) δ 10.88 (bs, 1H), 6.88 (dd, J = 15.8, 6.1 Hz, 1H), 6.00 (d, J = 
15.7 Hz, 1H), 3.85-3.73 (m, 2H), 3.47-3.39 (m, 1H), 3.30 (s, 3H), 2.70-2.37 (m, 4H), 
1.96-1.74 (m, 3H), 1.61-1.46 (m, 3H), 1.21-14 (m, 2H), 1.12 (d, J = 6.1, 3H); TLC Rf 
0.73 (6:1 CH2Cl2-MeOH). 
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Compound 61. Trimethylsilyl trifluoromethanesulfonate (TMSOTf, 0.9 µL, 
0.005 mmol) was added to 11-OMe cis (20 mg, 0.048 mmol) and ethylene glycol 
bis(trimethylsilyl ether) (99 mg, 0.48 mmol) at -78 ºC.  Methylene chloride (50 µL) and 
TMSOTf (0.9 µL, 0.005 mmol) were added after 1.5 h, as no reaction had occurred by 
TLC analysis.  No reaction was determined after 6 h at -78 ºC, and the reaction was 
allowed to warm to -25 ºC over 12 h and stir for an additional 12 h.  Saturated aqueous 
NaHCO3 (5 mL) was added and the mixture was extracted with CH2Cl2 (2 x 5 mL), 
washed with saturated aqueous NaCl (5 mL) and dried (Na2SO4).  Purification via silica 
gel chromatography (9:1 hexanes-EtOAc) provided 61 for characterization. 1H NMR 
(CDCl3, 500 MHz) δ 6.81-6.75 (m, 1H), 6.00-5.95 (m, 1H), 3.92-3.88 (m, 3H), 3.76-3.72 
(m, 4H), 3.48-3.62 (m, 2H), 3.29 (s, 3H), 1.89-1.46 (m, 10H), 1.25-1.15 (m, 3H), 1.12 (d, 
J = 6.3 Hz, 3H); 13C NMR (CDCl3, 125 MHz) δ 166.6, 148.4, 121.5, 110.6, 80.4, 74.2, 
73.7, 64.8, 64.7, 56.9, 51.5, 43.7, 33.0, 32.9, 32.2, 28.6, 23.8, 22.1; TLC Rf 0.34 (3:1 
hexanes-EtOAc). 
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Compounds 64-cis and 64-trans.  Barium hydroxide (235 mg, 0.74 mmol) was added to 
a solution of phosphonate 45 (415 mg, 0.93 mmol) in THF (25 mL) and allowed to stir 
for 30 min.  Aldehyde 63 (150 mg, 0.93 mmol) was dissolved in THF-H2O (40:1, 6 mL) 
and added dropwise over 5 min.  After 4 h, the reaction mixture was concentrated under 
reduced pressure and the crude mixture was purified via silica gel chromatography 
(hexanes-EtOAc, 8:1 to 1:1) to provide 64-cis (97 mg, 0.28 mmol) and 64-trans (50 mg, 
0.15 mmol) in 46% overall yield as a clear oil.  64-cis. 1H NMR (CDCl3, 400 MHz) δ 
6.79 (dd, J = 15.9, 6.3 Hz, 1H), 6.15-5.98 (m, 3H), 4.93-4.85 (m, 1H), 3.84-3.79 (m, 1H), 
3.75 (s, 3H), 3.29 (s, 3H), 2.64-2.52 (m, 4H), 2.02 (s, 3H), 1.96-1.77 (m, 2H), 1.64-1.39 
(m, 4H), 1.20 (d, J = 6.3 Hz, 3H); 13C NMR (CDCl3, 100 MHz) δ 200.4, 170.7, 166.4, 
147.9, 147.7, 126.8, 121.8, 79.2, 70.7, 57.0, 51.6, 39.0, 35.4, 29.1, 28.3, 24.9, 21.3, 19.9; 
TLC Rf  0.61 (2:1 hexanes-EtOAc).  64-trans. 
1H NMR (CDCl3, 400 MHz) δ 6.84-6.77 
(m, 2H), 6.08 (d, J = 15.9 Hz, 1H), 6.01 (d, J = 15.9 Hz, 1H), 4.93-4.87 (m, 1H), 3.84-
3.79 (m, 1H), 3.75 (s, 3H), 3.29 (s, 3H), 2.65-2.60 (m, 2H), 2.25-2.19 (m, 2H), 2.03 (s, 
1H), 1.99-1.78 (m, 2H), 1.62-1.44 (m, 4H), 1.21 (d, J = 6.3 Hz, 3H); TLC Rf 0.57 (2:1 
hexanes-EtOAc). 
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Compound 69.  Benzenethiol (5.6 µL, 0.055 mmol) and Et3N (0.014 M in CH2Cl2, 175 
µL, 0.0025 mmol) were added to a solution of 64-cis (17 mg, 0.050 mmol) in CH2Cl2 (0.5 
mL) and the mixture was allowed to stir at ambient temperature for 24 h.  Direct 
purification via silica gel chromatography (CH2Cl2-EtOAc, 10:1 to 5:1) provide 69 (15.4 
mg, 0.34 mmol) as a mixture of diastereomers in 70% yield. 1H NMR (CDCl3, 500 MHz) 
δ 7.33-7.31 (m, 2H), 7.24-7.16 (m, 4H), 6.68 (dd, J = 15.8, 5.9 Hz, 1H), 5.91 (d, J = 15.8 
Hz, 1H), 4.82-4.75 (m, 1H), 3.72-3.68 (m, 4H), 3.53-3.48 (m, 1H), 3.19 (s, 3H), 2.67-
2.49 (m, 2H), 2.46-2.32 (m, 2H), 1.95 (s, 3H), 1.85-1.75 (m, 1H), 1.72-1.64 (m, 1H), 
1.53-1.35 (m, 5H), 1.14-111 (m, 3H); 13C NMR (CDCl3, 125 MHz) δ 207.9, 170.6, 166.4, 
147.6, 147.5, 134.4, 134.3, 132.4, 132.3, 128.9, 127.1, 122.0, 121.9, 79.1, 79.0, 70.6, 
70.5, 57.0, 51.6, 48.3, 48.2, 43.7, 43.6, 38.5, 38.4, 35.4, 34.7, 34.5, 28.1, 22.7, 22.6, 21.3, 
19.9, 19.8; TLC Rf  0.56 (6:1 CH2Cl2-EtOAc). 
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Compound 74.  Cerium trichloride heptahydrate (19.7 mg, 0.053 mmol) was added to a 
solution of 64-cis/trans (18 mg, 0.053 mmol) in DMSO (0.53 mL) until the cerium salt 
was fully dissolved (approx. 20 min).  NaBH4 (2 mg, 0.053 mmol) was added and the 
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mixture was allowed to stir at 23 ºC for 1 h, at which point the reaction was quenched by 
the addition of saturated aqueous NH4Cl (2 mL) and extracted with Et2O (3 x 5 mL).  The 
combined organic extracts were washed with water (5 mL), saturated aqueous NaCl (5 
mL), and dried over Na2SO4 to afford 74 as a mixture of diastereomers (13.2 mg, 0.039 
mmol, 73%) after purification via silica gel chromatography. 1H NMR (CDCl3, 400 
MHz) δ 6.79 (dd, J = 15.9, 6.6 Hz, 2H), 5.98 (d, J = 15.9 Hz, 2H), 5.65-5.57 (m, 1H), 
5.48-5.37 (m, 3H), 4.92-4.85 (m, 2H), 4.43-4.38 (m, 1H), 4.06-4.02 (m, 1H), 3.80-3.75 
(m, 2H), 3.74 (s, 6H), 3.30 (s, 6H), 2.18-1.97 (m, 10H), 1.70-1.54 (m, 10H), 1.51-1.34 
(m, 8H), 1.18 (d, J = 6.1 Hz, 6H); 13C NMR (CDCl3, 125 MHz) δ 171.1, 166.9, 148.4, 
148.3, 133.5, 131.9, 131.8, 122.2, 122.1, 80.8, 80.8, 73.0, 72.9, 71.2, 71.1, 57.4, 51.9, 
35.8, 35.7, 33.2, 33.1, 32.3, 32.2, 31.1, 25.2, 25.2, 21.7, 20.3; TLC Rf 0.44 (1:1 
hexanes-EtOAc). 
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Compound 75.  Prepared according to the general procedure for methyl ester hydrolysis 
from 74 (13 mg, 0.038 mmol) to afford 75 (5 mg, 0.017 mmol, 46%) after silica gel 
chromatography (CH2Cl2-MeOH, 7:1). 1H NMR (CDCl3, 400 MHz) δ 6.89 (dd, J = 15.5, 
6.1 Hz, 1H), 6.00 (d, J = 15.4 Hz, 1H), 5.68-5.62 (m, 1H), 5.49-5.43 (m, 1H), 4.09-4.04 
(m, 1H), 3.85-3.78 (m, 2H), 3.33 (s, 3H), 2.08-2.03 (m, 2H), 1.69-1.57 (m, 4H), 1.50-
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1.39 (m, 6H), 1.26-1.24 (m, 1H), 1.18 (d, J = 6.1 Hz, 3H); TLC Rf 0.21 (7:1 
CH2Cl2-MeOH). 
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Compound 78.  Allylic alcohol 74 (35 mg, 0.102 mmol) was dissolved in CH2Cl2 (1 mL) 
and DMF (0.25 mL) and cooled to 0 ºC.  Imidazole (16 mg, 0.235 mmol) and tert-
butyldimethylchlorosilane (23 mg, 0.153 mmol) were successively added and the white 
mixture was allowed to stir for 30 min, then at room temperature for 3.5 h.  Water 
(10 mL) was added and the solution was extracted with CH2Cl2 (3 x 10 mL) and washed 
with saturated aqueous NH4Cl (10 mL), NaCl (10 mL), dried over Na2SO4, and 
concentrated under reduced pressure.  The crude oil was purified by silica gel 
chromatography (hexanes-EtOAc, 10:1) to afford 78 as a mixture of diastereomers (45 
mg, 0.099 mmol, 96%). 1H NMR (CDCl3, 500 MHz) δ 6.80-6.75 (m, 2H), 5.97 (d, 
J = 15.8 Hz, 2H), 5.51-5.46 (m, 1H), 5.38-5.27 (m, 3H), 4.90-4.86 (m, 2H), 4.41-4.35 (m, 
1H), 4.05-4.00 (m, 1H), 3.75-3.69 (m, 8H), 3.28 (s, 6H), 2.05-1.98 (m, 10H), 1.64-1.25 
(m, 16H), 1.18 (d, J = 6.1 Hz, 6H), 0.87 (s, 18H), 0.01 (d, J = 3.5, Hz, 12H); 13C NMR 
(CDCl3, 125 MHz) δ 170.7, 170.6, 166.5, 148.4, 148.3, 134.2, 134.1, 133.8, 133.7, 130.0, 
128.7, 128.6, 121.6, 121.5, 80.6, 80.5, 80.4, 73.4, 73.2, 70.9, 70.7, 70.6, 68.5, 68.3, 56.9, 
51.5, 35.8, 35.6, 35.4, 33.8, 33.7, 33.6, 31.7, 30.5, 30.2, 29.6, 27.6, 25.9, 25.8, 25.4, 25.3, 
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25.0, 21.2, 19.9, 18.2, 18.1, 18.0, -4.1, -4.2, -4.4, -4.7, -4.8; TLC Rf 0.59 (10:1 
hexanes-EtOAc). 
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Compound 80.  Prepared according to the general procedure for methyl ester hydrolysis 
from 78 (44 mg, 0.098 mmol) to afford 80 (15.1 mg, 0.038 mmol, 39%) after silica gel 
chromatography (CH2Cl2-MeOH, 7:1). 1H NMR (CDCl3, 500 MHz) δ 6.88 (dd, J = 15.7, 
6.1 Hz, 2H), 6.52 (bs, 2H), 5.98 (d, J = 15.7 Hz, 2H), 5.54-5.48 (m, 1H), 5.39-5.28 (m, 
3H), 4.42-4.37 (m, 1H), 4.09-4.01 (m, 1H), 3.84-3.74 (m, 4H), 3.30 (s, 6H), 2.08-1.98 
(m, 4H), 1.68-1.36 (m, 18H), 1.18 (d, J = 6.0 Hz, 6H), 0.87-0.86 (m, 18H), 0.02-0.01 (m, 
12H); 13C NMR (CDCl3, 125 MHz) δ 171.0, 151.0, 150.9, 134.5, 134.4, 134.0, 133.9, 
130.7, 130.7, 129.3, 129.3, 121.6, 121.6, 80.8, 80.7, 73.7, 73.6, 68.9, 68.8, 68.6, 68.4, 
68.3, 57.5, 57.4, 39.3, 39.2, 39.1, 39.0, 34.1, 34.0, 33.9, 32.3, 30.7, 30.5, 30.4, 28.2, 28.1, 
26.3, 26.2, 26.1, 26.0, 25.7, 23.8, 23.7, 18.6, 18.5, -3.7, -3.8, -4.3, -4.4. 
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Compound 81.  Acid 80 (15 mg, 0.037 mmol) in THF (2 mL) was treated with Et3N 
(25.8 µL, 0.185 mmol) for 10 min at 23 ºC.  2,4,6-trichlorobenzoyl chloride (17.6 µL) 
was added and the mixture was allowed to stir for 2 h.  The reaction mixture was then 
diluted with toluene (11 mL) and added to a refluxing solution of DMAP (54.2 mg, 0.44 
mmol) in toluene (24 mL) via syringe pump through a Vigreux column over 9 h.  Once 
the reaction was cooled to ambient temperature, saturated aqueous NaHCO3 (75 mL) was 
added and the mixture was extracted with EtOAc (3 x 100 mL).  The combined organic 
extracts were washed with 0.1N HCl (75 mL), saturated aqueous NaCl (100 mL) and 
dried over Na2SO4.  Flash chromatography (hexanes-EtOAc, 10:1) provided 81 (8.1 mg, 
0.021 mmol, 57%) as a clear oil. 1H NMR (CDCl3, 500 MHz) δ 6.92-6.70 (m, 2H), 6.09-
5.89 (m, 2H), 5.62-5.55 (m, 1H), 5.43-5.21 (m, 3H), 5.09-4.98 (m, 2H), 4.37-3.81 (m, 
4H), 3.34-3.31 (m, 6H), 2.04-1.40 (m, 20H), 1.32-1.26 (m, 6H), 0.89-0.86 (m, 18H), 
0.08-0.01 (m, 12H); TLC Rf  0.4, 0.37 (8:1 hexanes-EtOAc). 
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Compound 81b.  81 (5 mg, 0.013 mmol) was dissolved in absolute EtOH (1 mL) and 
pyridinium p-toluenesulfonate (4.2 mg, 0.017 mmol) was added in one portion.  The clear 
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solution was allowed to stir at room temperature for 12 h at which point excess 
pyridinium p-toluenesulfonate (4.2 mg, 0.017 mmol) was added.  After 24 h, the reaction 
was diluted with EtOAc (10 mL) and washed with saturated aqueous NaHCO3 (10 mL).  
The aqueous phase was extracted with EtOAc (2 x 10 mL) and the combined organic 
layers were washed with saturated aqueous NaCl (10 mL) and dried (Na2SO4).  Flash 
chromatography (CH2Cl2-EtOAc, 10:1 to 1:10) afforded compound 81b (3 mg, 0.011 
mmol, 86%) as a clear oil. 1H NMR (CDCl3, 500 MHz) δ 6.88-6.72 (m, 2H), 6.12-5.92 
(m, 2H), 5.79-5.42 (m, 2H), 5.39-5.30 (m, 2H), 5.12-4.94 (m, 2H), 4.41-3.78 (m, 4H), 
3.37-3.30 (m, 6H), 2.15-1.45 (m, 22H), 1.30-1.25 (m, 6H); 13C NMR (CDCl3, 125 MHz) 
δ 166.3, 166.2, 149.4, 149.0, 147.3, 133.5, 133.4, 133.2, 132.9, 132.8, 132.7, 131.7, 
131.4, 124.3, 123.7, 123.1, 122.2, 121.2, 81.2, 80.1, 79.7, 79.6, 73.0, 72.9, 72.8, 71.4, 
71.0, 70.6, 67.5, 67.1, 57.3, 57.2, 35.5, 36.5, 35.1, 34.7, 34.3, 32.9, 32.1, 32.0, 31.0, 30.8, 
30.7, 30.2, 30.0, 29.8, 29.3, 29.1, 28.6, 28.3, 27.7, 26.7, 26.2, 26.1, 26.0, 24.8, 24.7, 23.6, 
21.3, 21.1, 20.7, 19.5; TLC Rf  0.39, 0.30 (1:1 CH2Cl2 -EtOAc). 
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Compound 68-cis/trans.  Alcohol 81b (3 mg, 0.011 mmol) was dissolved in CH2Cl2 (1 
mL) and Dess-Martin periodinane (5.2 mg, 0.012 mmol) was added at 0 ºC.  The 
resulting mixture was allowed to warm to room temperature and maintained for 1 h, then 
filtered over celite and concentrated under reduced pressure.  The crude residue was 
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purified by silica gel chromatography (CH2Cl2-EtOAc, 10:1 to 1:1) to afford 68-cis/trans 
as a clear oil (2 mg, 0.0075 mmol, 67%) in approximately a 1:1 cis to trans ratio. 1H 
NMR (CDCl3, 400 MHz) δ 6.77-6.44 (m, 3H), 6.16-5.87 (m, 5H), 5.11-5.01 (m, 2H), 
3.91-3.72 (m, 2H), 3.35-3.29 (m, 7H), 2.96-2.88 (m, 1H), 2.64-2.03 (m, 12H), 1.82-1.46 
(m, 6H), 1.27-1.19 (m, 6H); TLC Rf  0.82, 0.75 (1:1 CH2Cl2 -EtOAc); LRMS (ESI) m/z 
289.11 (289.14 calcd for C15H22O4NaSi [M+Na]+).  Recovered 68-trans. 1H NMR 
(CDCl3, 400 MHz) δ 6.70-6.63 (m, 1H), 6.47-6.41 (m, 1H), 6.02 (d, J = 15.7 Hz, 1H), 
5.84 (d, J = 15.8 Hz, 1H), 5.02-4.92 (m, 1H), 3.79-3.68 (m, 1H), 3.27-3.20 (m, 4H), 2.44-
2.07 (m, 6H), 1.68-1.50 (m, 3H), 1.17-1.14 (m, 3H); TLC Rf  0.75 (1:1 CH2Cl2 -EtOAc).   
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4.8.1 NMR Spectra 
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Compound 20. 
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Compound 23. 
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Compound 24. 
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Compound 20b. 
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Compound 27. 
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Compound 27b. 
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Compound 26. 
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Compound 15. 
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Compound 11-cis. 
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Compound 11-trans. 
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Compound 12. 
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Compound 20c. 
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Compound 43. 
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Compound 43b.   
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Compound 44. 
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Compound 45. 
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Compound 11-OMe cis. 
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Compound 11-OMe trans. 
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Compound 46. 
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Compound 55. 
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Compound 52-cis. 
 
 
012345678910
0255075100125150175200
OH
O
OTBDPS
O OTBS
Me
  
- 303 - 
Compound 56. 
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Compound 53-cis/trans. 
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Compound 58-cis. 
 
 
 
 
 
 
 
 
 
0123456789101112
OH
O
OMe
O OTBS
Me
  
- 306 - 
Compound 58-trans. 
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Compound 61. 
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Compound 64-cis. 
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Compound 64-trans. 
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Compound 69. 
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Compound 74. 
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Compound 75. 
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Compound 78. 
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Compound 80. 
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Compound 81. 
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Compound 81b. 
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Compound 68-cis/trans. 
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Compound 68-trans. 
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